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SUMMARY
A modified assay to detect interferon production from individual 
cells has been designed which is more accurate than those already 
described. Use of this modified assay has demonstrated that the diff­
erence between cell lines that can be induced to produce high yields 
of interferon, and those which are only capable of producing low yields 
of interferon, resides in the number of individual cells able to prod­
uce interferon in that culture. Thus the apparent homogeneous response 
of a cell culture to an interferon inducing agent, masks the heterogene­
ous response of the individual cells which make up that culture. This 
modified assay is probably sensitive enough to detect all cells capable 
of producing interferon within a given cell population; and the data 
presented in section one suggests that this assay can be used with 
confidence to assay interferon production in cell systems which only 
produce small amounts of interferon.
Cloned 'nullipotent' embryonal carcinoma (ec) cells, like the pluri- 
potent ec cells described by Burke et al (1978), do not possess an active 
interferon system, and it is proposed that such cells lack the ability 
to produce interferon mRNA in response to an interferon-inducing agent. 
When these 'nullipotent' ec cells are treated with retinoic acid they 
show an activation of the interferon system which extends for approxima­
tely ten to fifteen days. The extent of activation seen varied between 
different embryonal carcinoma cell lines. In these differentiating cult­
ures there is a parallel increase, both in the percentage of individual 
cells able to produce interferon, and in the yield of interferon per 
producer cell. The percentage of single cells able to produce interferon 
always remained small compared to the non-producer cell3 in the culture. 
The pattern of development of interferon inducibility and sensitivity 
does not distinguish between the different types of endoderm-like cell 
generated by the various differentiating teratocarcinoma cell lines, nor 
can the amount of interferon produced by different cell lines be used 
to quantitate the extent of differentiation which has occurred. However, 
the activation of the interferon system; because it coincides with changes 
in morphology and in protein synthesis, can be used as an additional 
positive marker for the production of differentiated cells in this system.
The data presented in section three demonstrates that during the 
first third of pregnancy the embryo is unable to produce interferon 
in response to a virus infection, and furthermore suggests that the 
antiviral action of interferon may be non-specifically inhibited by the 
tissues of the reproductive system from the adult female mbuse. A 
functional interferon system develops during the seventh day of embry­
onic development , and the embryonic ectoderm and the visceral extra- 
embryonic endoderm are the last tissues to show a lack of interferon 
inducibility. Thus, the mouse embryo can be seen to become capable of 
mounting an interferon-based antiviral response during a period when 
it is unable to mount a humoral and cell mediated antiviral immune 
response. This factor may be of importance in the reduced susceptibility 
to the pathogenic effects of virus infections, which is a feature of 
the mid to late term mammalian embryo.
\
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INTRODUCTION
The role of interferon as an anti-viral agent has been known
and accepted for over two decades. However its pleiotropic effects
on cell function have only recently been described; and serve to
highlight how little is known of the extent and behaviour of the
interferon system in vivo. The molecular biology of this system
has yielded under a sustained assault over recent years, and it can
now be seen that interferon comprises multigene families whose
6
members are functionally heteroger^us and whose mode of action involves 
both induction of specific enzymes and the alteration of cell surface 
behaviour. Interferon is by definition an anti-viral agent, but 
because it is an agent which has a wide range of non anti-viral effects 
on cells it becomes necessary to have a more complete understanding 
of the role and status of the interferon system in vivo.
Efforts in this direction have mainly centred on attempts to 
gain an understanding of the role of interferon in in vivo pathogenesis, 
with the aim of evaluating interferon as a possible therapeutic agent. 
This aim, albeit worthy, has resulted in the neglect of the wider 
potential of the interferon system.
It is generally thought that the interferon system is not 
restricted to individual tissues or organs but can be expressed 
throughout the whole of the animal. However very little is known 
concerning its ontogeny and phylogeny even though such knowledge is 
necessary if the understanding of the role of interferon is to extend 
beyond its action 83 a component of the hosts' anti-viral response.
Interest in the developmental aspects of the interferon system 
stem from the observation of ilurkc et al. (1978) that thi3 system
3is inactive in undifferentiated teratocarcinoma cells but becomes 
active when the teratocarcinoma cells are caused to differentiate.
The aim of this study is to examine the ontogeny of the interferon 
system in the developing mouse embryo, and also to examine in more 
detail the kinetics of the appearance of the interferon system in 
teratocarcinoma cell cultures undergoing the transition from multi- 
potent stem cell to a differentiated cell type. This study therefore 
combines aspects of interest to two disparate fields and thus the aim 
of this introduction is two-fold; to describe the potential role and 
use as an experimental tool of the interferon system, and to describe 
the concepts underlying both mouse embryogenesis and the use of 
teratocarcinoma cells as in vitro analogues of development.
\
4THE INTERFERON SYSTEM
What_is interferon ?
Interferon is defined a3 an anti-viral activity (see reviews in 
Burke 1977, Baglioni 1979, Marx 1977a,b). It was first described 
by Isaacs and Lindeman (1957) who demonstrated that cells exposed to 
a virus released a substance which could be shown to protect other 
cells from subsequent virus attack. The principle involved was named 
interferon. In recent years other functions have been attributed to 
the interferon molecule, e.g.; inhibition of cell growth (see review 
in Taylor-Papidomitriou 1980) and regulation of the immune response 
(see review in Eloom 1980). The discovery of these other functions 
led to the description of interferon as a cellular mediator or 
regulator (Clemens 1979, Cohen and Bigazzi 1980) or a pleiotropic 
modifier of cellular function (Stewart 1979a)and even to the proposal 
that interferon be classified as a hormone. This latter proposal is 
based on three criteria; these are that interferon interacts with a 
specific plasma membrane receptor as an initial step in affecting 
cell function, that it can affect a range of cell functions in a 
variety of cell types (Taylor-Papidomitriou 1980), and that one class 
of human interferon strongly resembles the neuroendocrine hormones 
and is thus capable of mediating some of the effects associated with 
interferon through interaction with thi3 system (Blalock and Smith 
1981). In addition to the proposed functions of interferon, the 
molecular biology of interferon production and anti-viral sensitivity 
provides a model system to study the induction and expression of a 
eukaryotic gene (Havell 1977, Burke 198B).
Interferon has therefore a wide spectrum of effects, it also has
5considerable potential as an experimental tool and is thus of interest 
to workers in several fields which includes virologists, cell and 
cancer biologists and immunologists. However because interferon is 
just one of a variety of biologically active molecules which can be 
elicited under pathological conditions in vivo (Cohen and Bigazzi 1980), 
it is necessary to define precisely what is meant by the term interferon. 
The acceptance of a working definition will provide a coordinating 
influence under which the numerous other proposed functions can be 
examined. The Committee of Interferon Nomenclature (Stewart et al.
1980) have accepted the following definition for interferon; "to 
qualify as an interferon, a factor must be a protein which exerts 
virus non-specific anti-viral activity at least in homologous cells 
through cellular metabolic processes involving synthesis of both 
RNA and protein".
The term 'interferon system' used in this study is used to 
denote both interferon production and sensitivity to its pleiotropic 
effects. These are separate and distinct cellular phenomena and 
occur by separate pathways. Most differentiated cell lines can produce, 
and are sensitive to the effects of interferon. This is in contrast 
to undifferentiated teratocarcinoma cells which cannot produce inter­
feron and are insensitive to its anti-viral (Burke et^  cü. 1978) and 
anti-proliferative effects (Wood and Hovanessian 1979). Some 
differentiated cell lines, e.g.; African green monkey kidney (vero), 
baby hamster kidney-21, and Chinese hamster ovary kl cannot produce 
interferon but are sensitive to its effects (Desmyter et^  jjK  1968, 
Taylor-Papidomitrious and Stoker 1971, Morgan 1976). Thus although 
interferon production and sensitivity are properties which can both 
reside in one cell they can be separated or temporally absent from 
some cell lines.
Induction and production of interferon
The presence of interferon cannot be detected in the normal 
state in vivo and in vitro, but interferon production can be stimulated 
by exposure of the cell to a specific inducer of interferon. The 
inducer enters the cell and either directly or indirectly causes the 
transcription of the interferon gene mRNA and the translation of it 
into a secretory protein. Interferon production continues for a set 
period of time which depends on the particular inducer/cell system, 
and is then switched off (Burke 1980), and this shut-off of interferon 
synthesis requires post-transcriptional modification of the mRNA 
(Sehgal et al. 1977). Interferon production has been shown to be due 
to cte novo transcription and translation and not merely activation of 
pre-existing molecules by enucleation experiments which demonstrated 
the necessity of the nucleus (Burke and Veomett 1977), and by the use 
of inhibitors of transcription and translation, which were shown to 
inhibit the production of interferon (see review in Burke 1980 and 
Stewart 1979 p.90-109). There are numerous agents (called inducers) 
which can stimulate the production of interferon. Most inducers are 
viruses (Jameson 1977, Stewart 1979 p28-34) but non-viral substances 
can also induce interferon. These include micro-organisms (Stewart 
1979 p39-41) chemical polymers and low molecular weight compounds 
(Stewart 1979 p47-48).
It is not yet known how the various inducers act within the cell 
to activate the cellular gene for interferon, or whether thi3 happens 
directly or indirectly. Because of the known ability of RNA viruses 
to induce high yields of interferon (Meager and Burke 1971) and the 
ability of natural and synthetic dsRNA to similarly induce high yields 
of interferon (Marcus and Sekellick 1977 have shown that one molecule
1of dsRNA can induce anti-viral resistance in a human fibroblast cell 
in vitro) it has been proposed that viruses induce interferon via 
synthesis of a dsRNA intermediate (Morser and Burke 1979).
Thus interferon is not seen in vivo and in vitro unless the 
cells are first exposed to an inducer, and then its appearance is 
transient. There are however pathological and other conditions under 
which interferon is produced by cells which have had no apparent 
contact with an inducer. This phenomenon may have one of two possible 
explanations, either the interferon gene has altered and become 
permanently expressed or an inducer is permanently present in that 
cell. Since the true nature of the interferon inducer is not clear 
these two possibilities cannot be distinguished, and the production 
of interferon in cells not exposed to an inducer will be termed 
spontaneous interferon production. This phenomenon will be described 
later in this section.
Classes of interferon
Three main classes of interferon have been identified in all of 
the animals so far studied. These classes are designated alpha, beta 
and gamma, and interferons assigned to each on the basis of antigenic 
similarity.
Class alpha and beta are produced transiently following the 
exposure to non-mitogen inducers of most differentiated cells, 
including cells of the immune system. The ratio of alpha to beta 
interferons produced within a cell depends on the cell type and the 
inducer, e.g.: human leukocytes produce predominantly alpha, and 
human fibroblasts predominantly beta. Class gamma i3 produced by
\
8immunocompetent lymphocytes following exposrue to a mitogenic 
stimulus, e.g.: specific antigen or plant lectin, and it is thought 
that T lymphocytes are the main source of gamma interferon (Epstein 
1977). Since gamma interferon is produced from lymphocytes following 
exposure to a mitogen it can also be termed a lymphokine (Cohen and 
Bigazzi 1980).
Cloned human interferon genes
The concept of the interferon molecule has altered since the 
availability of cloned interferon genes. So far only human alpha 
(Nagata et^  £l^ . 1980) and human beta (Derynck ejt ¿1. 1980) have been 
cloned. The human alpha class has been shown to consist of a family 
of different but homologous genes situated on the same chromosome, 
which are capable of cross hybridisation at the nucleic acid level 
and of cross neutralisation at the protein level. Up to ten alpha 
genes, including one pseudogene, have so far been identified (Goeddel 
£t a_l. 1981). These show little or no glycosylation (Allen and Fantes 
1980), and do not contain introns either in the coding or non-coding 
genomic sequences (Nagata et^  al_. 1980). The alpha multigene family 
once cloned into E. coli can all be translated (except the pseudogene) 
and therefore have the potential to be expressed within the cell, but 
it is not yet clear how many members of this family are expressed in 
cells treated with different inducers, or whether a particular 
pattern of expression occurs within certain cells treated with certain 
inducers. However it is thought that the alpha family are functionally 
hetcrogcrjjjuo and this is supported by the observations of Streuli 
et ni. (1981) on the different cross species reactivity amongst the
\
9members of the alpha family. Cloned alpha 1 and 2, which differ in 
only twenty nucleic acid positions, showed a large difference in 
inducing anti-viral resistance in mouse cells. It has long been 
known that some interferons can show reactivity on cell species 
different to that which produced the interferon (Stewart 1979 pl36-42), 
but interferons were thought in general to show broad species speci­
ficity. The cloning studies have clarified this situation and it 
appears the species restriction of sensitivity resides in specific 
interferon molecules and is not a general property of interferons.
The human beta class is antigenically different to alpha inter­
feron and also does not cross react at the nucleic acid level (Allen 
and Fantes 1980). The total number and extent of the beta gene family 
is not yet clear; Goeddel £t ajk (1981) found only one beta gene, 
while Weissenbach et (1980) identified two beta interferon genes 
in cell-free lysate translations of cloned DNA from poly rlrC induced 
fibroblasts. These two interferons were identified serologically as 
beta but did not cross-hybridise at the nucleic acid level, and 
interestingly were not produced in intact cello; suggesting that a 
sub-class of interferons are modified at a post-transcriptional level. 
Sehgal et^  si. (1981) found a similar situation in fibroblast cells 
induced in the presence of DRB (dichlororibofuranosylbenzimidazole), 
and has suggested that a second, hetero-disperse, set of interferon 
genes exist in both the alpha and beta classes. The second set are 
proposed to contain introns which prevent nucleic acid cross 
hybridisation.
Interferon was long thought to be a glycosylated protein, and 
the varied functions and properties of interferon were thought to be 
related to the degree of glycooylation of each molecule (Stewart et^  nl.
\
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1977, 1979). The amount of glycosylation has still not been fully 
resolved but Allen and Fantes (1980) and Derynck _et al_. (1980) have 
both shown that alpha and beta interferons do not need to be glycosy­
lated to be biologically active, although beta interferon is normally 
synthesised as a glycosylated protein.
The biological role of the alpha multigene family has not been 
clarified; the production of functionally heterogenous interferons may 
explain the ability of interferon to protect cells from a wide 
variety of viruses, or alternatively it may explain the large variety 
of target cells which are susceptible to the .effects of interferon.
R. M. Friedman has suggested (personal communication) that the 
different interferon species may be effective on different host tissues.
Mouse interferons
Full details of the structure of mouse interferons are not yet 
available, since the genetic engineering program has for obvious reasons 
concentrated on human interferon. However it is known that viral 
induction of non-lymphoid mouse cells, e.g.: Erlich ascites cells and 
C243, causes two species of interferono to be produced. The molecular 
weights are approximately 22 and 35 kd. (De Maeyer-Guignard et al. 1978, 
Kawakita £t al_. 1978, Iwakura j^ t al_. 1978). The lower molecular weight 
molecule shows some sequence homology with human alpha interferon.
The number of interferons produced in virus infected mouse cells doe3 
vary; Knight (1975) found ten interferon polypeptides were produced 
in MM virus-infected cells each with anti-viral activity. Heterogeneity 
of glycosylation was also found by Knight (1975) and by De Maeyer- 
Guignard e^ t o K  (197R).
\
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Assay of interferon yields
A large area of this study is concerned with the production and 
assay of interferon yield. The yield of interferon per cell is 
subject to regulatory controls within the cell (on transcription rate, 
half-life of mRNA and translation); but it is also regulated through 
genetic controls not associated with the structural genes. De Maeyer 
and co-workers (reviewed in De Maeyer and De Maeyer-Guignard 1979) have 
obtained mice through breeding experiments which have the ability to 
produce high or low levels of circulating interferon in response to 
the same virus inducer. This genetic control of interferon yields is 
only shown by macrophages _in vitro. A review of the intracellular 
regulation of interferon can be found in Havell (1977) and Burke (1980), 
Briefly it is proposed that expression of the interferon gene is 
inhibited in normal conditions by the synthesis of a repressor 
molecule and that interferon inducers act to disrupt this equilibrium 
and allow expression of the interferon gene (Vilcek and Ng 1971).
As yet there is no direct confirmation of the existence of the 
putative interferon repressor, or of any other eukaryotic gene 
repressor.
The amount of interferon in a preparation is assayed indirectly 
by measuring the effect that it can exert on cells. Since different 
mouse cells vary in their sensitivity to interferon the definition of 
a unit of interferon thus depends on its mode of assay. The effect 
most commonly measured is that of antiviral resistance. This can be 
assayed in a variety of ways including, virus RNA synthesis, yield 
and plaque reduction and cytopathic effect; all of which vary in 
sensitivity, reproducibility, speed and amount of labour and expense.
12
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This laboratory routinely employs the Inhibition of viral Nucleic Acid (INAS) 
assay • (Atkins et^  al^ . 1974). Units of interferon are reciprocals 
of end point dilutions of an interferon preparation and the end point 
of the INAS assay is the dilution at which virus nucleic acid synthesis 
is reduced by fifty percent. These assays are all biological assays 
and variations from many sources will occur; to eliminate these a 
laboratory standard interferon preparation is included in all assays 
and results corrected accordingly. To compare results between 
different laboratories the laboratory standard interferon is calibrated 
against an international research reference standard made available 
from the National Institute for Biological Standards, London. Use of 
a laboratory standard calibrated to the international research reference 
standard enables interferon titrcs to be expressed in international 
reference units.
The recent development of a monoclonal antibody to interferon 
(Secher and Burke I960) has enabled non-biological assays to be 
developed. Secher (1981) has devised an immunoradiometric assay which 
although it has reduced sensitivity compared to the biological assays 
is potentially useful since it can measure physical amounts of 
interferon.
Single cell assay for interferon
The assays described above measure interferon yields from a 
population of cells and thus represent the average response of many 
cell3. Since the minimum number of cells required to produce on 
interferon sample which can be used in these assays are approximately 
ten thousand, they cannot be used in situations in which only a
13
small number of cells are available, e.g. from early embryo tissues.
» \
In addition it is possible that by measuring only the average response, 
any heterogenous behaviour of either the cells or the inducer is 
masked. Interferon production from either single cells or from small 
groups of cells can be examined in a 'single cell assay'. Two types 
of single cell assay have been developed both based on the biological 
activity of interferon. Fleischman and Simon (1974) and Rodgers and 
Merigan (1974) examined interferon production from single cells 
isolated in microdrops, whilst Osbourn and Walker (1969) and Kronenberg 
(1977) measured the percentage of cells able to produce interferon in 
an assay analogous to the infectious centre assay for virus production 
from single cells. This study employs a modified version of the 
assay described by Kronenberg (1977).
PLEIOTROPIC ACTIVITIES OF INTERFERON
\
Interferon is capable of exerting a vast and often bewildering 
array of effects upon cellular structure and function (Stewart 1979 
p224-231). These effects may be due to a single action of interferon 
or more probably are effected through the concerted action of interferon 
on many aspects of cell biology. The activities ascribed to interferon 
mechanisms may be grouped into six major categories:
(a) Alteration in cell surface composition and behaviour.
(b) Antiviral actions against a wide range of viral pathogens.
(c) Alteration of induced and non-induced protein synthesis.
(d) Regulation of humoral and cellular mediated immune responses.
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(e) Inhibition of cell replication in normal and tumour cells.
(f) Possible role in the normal control mechanisms of growth and 
differentiation.
The order of the above groupings is arbitrary and serves to 
focus attention on the main effects of interferon, whilst not ignoring 
the fact that the causes of the observed phenomena may involve 
several of the effects listed above. It is still not clear whether 
or not all the activities listed above are secondary to the establish­
ment of the anti-viral state within the cell.
The first non anti-viral effects of interferon were described by 
Isaacs and Burke (1958) who demonstrated the cell multiplication 
inhibitory effect. These early experiments were performed with impure 
interferon preparations (probably less than l?o pure) and were open to 
criticism that these non anti-viral effects were due to impurities in 
the preparations. These criticisms have now been formally turned over 
by the use of electrophoretically pure interferon, Gresser et al.
(1979) used mouse interferon of specific activity 10 units per mg., 
which was resolvable to two bands on polyacrylamide gel electrophoresis, 
and clearly demonstrated that each band in this preparation could 
produce all of the effects listed above.
Cell surface receptors?
The interferon molecule is not itself directly the cause of 
the effects ascribed to interferon, for it is not active within the 
cell in which it was synthesised but needs first to be externalised 
(Vengris et^  jil_. 1975). Interferon does not need to enter the cell 
but it has not been formally shown that none of the molecule enters
\
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the cell (Burke 1977). This suggests that sensitivity to the pleio- 
tropic effects of interferon is mediated via the interaction between 
the interferon molecule and the cell surface. Such a step could act 
to amplify the action of interferon and might account for its high 
biological activity.
It has been proposed (Stewart 1979 pl85, Cupples and Ian 1977,
Tan 1976, Revel et al. 1976) that the sensitivity of cells to the 
effects of all the classes of interferon (alpha, beta and gamma) are 
mediated initially by a common pathway regulated by a gene on 
chromosome 21 in humans. The evidence for this is mainly based on 
the increased sensitivity to human interferon shown by cells trisornic 
for chromosome 21 and the complimentary decreased sensitivity shown 
by cells monosomie for chromosome 21. Revel jet al_. (1976) proposed 
that chromosome 21 codes for an interferon cell surface receptor, since 
they were able to demonstrate that antisera raised to the cell 
surface of human/mouse hybrids (which contained only chromosome 21 
as its human contribution) blocked the action of interferon. Tan (1976) 
proposed that chromosome 21 directs the production of an intermediate 
substance (not a receptor) which mediates the action of interferon 
within the cell. However contrary evidence has cast doubts on the 
role of chromosome 21 at all. De Clercq et^  al. (1976) examined 
interferon sensitivity in a wide range of cells both monosomie and 
trisomie for chromosome 21 and found that the difference in interferon 
sensitivities was not constant. Moreover they demonstrated that cells 
monosomie, disomie and trisomie for chromosome 21 had equal ability 
to remove interferon from culture fluids, suggesting that these cells 
all bind equal amounts of interferon. However since the experiments 
of De Clercq ct^  jü. (1976) were not performed on matched cells, the
\
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general consensus (see review in Stewart 1979 pl85-190) still supports 
a role for human chromosome 21 in mediating the effects of interferon.
The majority of work on interferons has involved the use of the 
alpha and beta types because in contrast to gamma interferon they are 
now available in relatively pure preparations; however it is considered 
that all three classes of interferons possess a similar range of 
pleiotropic effects.
Alteration in cell surface composition and behaviour
\
Interaction with or binding to the cell surface is a necessary 
preliminary to the manifestations of the effects of interferon. This 
reaction at the cell surface causes chemical, immunological and 
morphological changes within the membrane before any of the other 
effects of interferon can be demonstrated (Chang et^  al_. 1978,
Friedman 1979). These changes include inhibition of the binding of 
specific low molecular weight molecules; the binding of cholera toxin 
and thyroid stimulating hormone are inhibited by interferon whilst 
that of human chorionic gonadotrophin, leutinising hormone and follicle 
stimulating hormone are not. This interference with binding is not 
thought to be due to direct competition for receptors but rather due 
to conformational changes induced in the cell membrane by interferon. 
This alteration also changes the expression of some cell surface 
molecules; expression of cell surface gangliosides is decreased 
(Friedman 1979) but expression of beta-microglobulin and the major 
histocompatability antigens is increased (Lindahl et al^ . 1972, 1973; 
Heron et^  aJL 1979). Two general properties of the cell surface have 
been found to alter: there is an increase in the number of intra­
16
general consensus (see review in Stewart 1979 pl85-190) still supports 
a role for human chromosome 21 in mediating the effects of interferon.
The majority of work on interferons has involved the use of the 
alpha and beta types because in contrast to gamma interferon they are 
now available in relatively pure preparations; however it is considered 
that all three classes of interferons possess a similar range of 
pleiotropic effects.
Alteration in cell surface_composition_and behaviour
Interaction with or binding to the cell surface is a necessary
preliminary to the manifestations of the effects of interferon. This
reaction at the cell surface causes chemical, immunological and
morphological changes within the membrane before any of the other
effects of interferon can be demonstrated (Chang at ¿1. 1978,
Friedman 1979). These changes include inhibition of the binding of
specific low molecular weight molecules; the binding of cholera toxin
and thyroid stimulating hormone are inhibited by interferon whilst
§
that of human chorionic gonadotrophin, leutinising hormone and follicle 
stimulating hormone are not. This interference with binding is not 
thought to be due to direct competition for receptors but rather due 
to conformational changes induced in the cell membrane by interferon. 
This alteration also changes the expression of some cell surface 
molecules; expression of cell surface gangliosides is decreased 
(Friedman 1979) but expression of beta-microglobulin and the major 
histocompatability antigens is increased (Lindahl et al. 1972, 1973; 
Heron £t^  al_. 1979). Two general properties of the cell surface have 
been found to alter: there is an increase in the number of intra-
\
17
membranous granules of diameter 5-10um (Chang et al_. 1978), and an 
increase in the overall net negative charge of the cell (Knight and 
Korant 1977). This latter change may indicate that the membrane alters 
in its permeability to certain molecules. The relevance of the 
membrane changes to the effects of interferon is described later. 
Friedman (1979) has suggested that changes in the cell surface may 
be found to account for all of the non anti-viral effects of interferon.
The first detectable intracellular change after interferon 
interacts with the cell surface is the elevation of the concentration 
of the cyclic nucleotides adenine and guanosinc monophosphate. This 
elevation has been reported only in those cells sensitive to the 
effects of interferon (Friedman and Pastan 1969, Weber and Stewart 
1975, Meldolesi et jal. 1977 and Tovey et al^ . 1979). In non-interferon 
treated cells, the levels of these cyclic nucleotides can be affected 
by the rate of cell growth and cell density. Tovey et al.(1979) 
developed a system in which L1210 cells cultured in a chemostat 
produced constant levels of both cyclic nucleotides, and found that 
after interferon treatment of these cells the levels of CGMP rose 
within five minutes, but that in contrast, the levels of CAMP did 
not rice until several hours later. They suggest that CGMP functions 
as a membrane-nuclear signal. In addition Friedman and Pastan (1969) 
and Meldolesi et ol. (1977) have provided further evidence that cyclic 
nucleotides may be involved in the effects of interferon,by 
demonstrating that the administration of CAMP added simultaneously 
with interferon potientiated the degree of anti-viral resistance 
achieved in the cells, but had no anti-viral action by itself.
\
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ANTI-VIRAL ACTIONS AGAINST A WIDE RANGE OF VIRAL PATHOGENS
All six classes of animal viruses (i.e. enveloped and non- 
enveloped, single strand and double strand, and DNA and RNA classes - 
Matthews (1979) ) are sensitive to the inhibitory effects of interferon 
to a lesser or greater extent (Stewart 1979 p202-206). The total 
anti-viral response of an organism involves cells and other products 
of the immune system, as well as the production of interferon within 
infected cells (Roitt 1977 p201). Host humoral and cell-mediated 
responses are both involved in the immune response to a virus infection;
B lymphocytes are involved in antibody production directed towards 
virus antigens and T lymphocytes are directly involved in the recognition 
and lysis of virus infected cells. It is of interest that T cell 
recognition of virus-infected cells is directed through the major 
histocompatability antigens and that interferon enhances the 
expression of these antigens.
The production of interferon can be regarded as the first line 
of defence against virus infection. Gresser et al. (1976 a and b) have 
demonstrated the role of interferon in in vivo virus infections. They 
treated mice infected with a variety of viruses with antiserum to 
interferon, and found that in most cases, the disease showed a more 
rapid onset and greatly increased mortality. An interesting exception 
was that of Influenza type A in which the course of the disease was 
not affected.
Treatment of cells with interferon will induce nnti-viral 
resistance within the cell, but this resistance is not apparent until 
the cell is exposed to virus or to dsRNA (Burke 1977, Marx 1979, Revel 
1979). This covert antiviral state may be a mechanism to protect host
\
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cell synthesis. The development of this interferon-induced covert 
anti-viral state requires the presence of the cell nucleus (Radke 
et al. 1974) and requires de novo RNA and protein synthesis of molecules 
previously termed 'anti-viral' proteins (Burke 1977). Although 
interferon preparations can show broad species specificity the anti­
viral proteins can be transferred between, and are active in heterolo­
gous cells which are not responsive to the interferon molecule itself 
(Blalock and Baron 1977).
Interferon is able to inhibit the growth of a wide variety of 
viruses to varying degrees (Stewart 1979 p202-206), and this may 
reflect the ability of the interferon-induced anti-viral state to 
raise many and diverse barriers to virus replication. Interferon has 
been shown to inhibit uncoating, transcription and translation, and 
assembly and release of the virion (Revel 1979). The primary effect 
of the anti-viral state upon virus replication will depend on the 
particular virus/cell system under study, however effects upon 
translation are most commonly observed. Revel (1979) has shown that 
SV40 replication is inhibited at the early and late stages in inter­
feron treated cells affecting uncoating and DNA replication and later 
assembly and release of the virions. Strachen et^  a L  (1977) 
demonstrated that interferon can prevent expression of mouse mammary 
tumour virus in steroid induced cells probably acting at both trans­
cription and translation. Joklik and Merigan (1966) have shown that 
translation is inhibited in interferon treated vaccinia virus infected 
cells because of the disruption of the association between viral mRNA 
and host cell ribosomes.
A further example of the multiphasic antiviral state induced by 
interferon is seen in Murine Leukaemia virus infected cells. The
\
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production of virus RNA and protein is little affected but the yield 
of infective virus is considerably reduced due to a defect in the 
budding and release of virions on the host membrane (reviewed in 
Friedman 1979). Maheshwari and Friedman (1979) and Maheshwari et al. 
(1980) have demonstrated the same phenomena in interferon treated 
vesicular stomatitis virus infected cells which are released from the 
cell by a mechanism similar to that used by murine leukaemia virus.
Specific inhibition of virus synthesis
It has been suggested that virus protein synthesis is preferentially 
inhibited in interferon treated cells, and whilst this is not certain 
there may be physical reasons why this is so. Garry and Waite (1979) 
have shown that lytic viruses induce alterations in the Na+ and K+ 
concentrations within the cell, and that under these new conditions 
host cell synthesis is inhibited but virus synthesis is not affected 
and neither is the synthesis of interferon itself. In addition, Garry 
and Waite have demonstrated that experimental alteraton of the intra­
cellular concentration of these ions prolongs the synthesis of 
interferon, probably by inhibiting the synthesis of the host protein 
responsible for shut-off. In such cells virus synthesis will constitute 
the bulk of the cells synthetic effort and any inhibitors of protein 
synthesis will have a proportionally greater effect on virus synthesis.
In addition Baglioni (1979) suggests that since the antiviral state 
in an interferon treated cell is not activated until the cell is 
exposed to virus the inhibitory effect may be localised to the 
immediate area of the virus. An alternative to these views is the 
suggestion that exposure of an interferon treated cell to a virus may
\
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cause the destruction of that cell and thus destruction of the virus 
(Burke 1777).
Mechanism of antiviral action
\
As mentioned above, interferon induces de novo synthesis of 
anti-viral proteins. The nature of these proteins was elucidated by 
examining the antiviral action of lysates from interferon-treated and 
control ce 11s .Kerr et si (1977),Kerr and Brown (1978) and Farrell et al. 
(1978) demonstrated that lysates from interferon treated cells showed 
enhanced sensitivity to the protein synthesis inhibitory effects of 
dsRNA. This was shown to be due to two dsPNA dependent enzymes; 
elevated levels of inactive forms of these enzymes formed in interferon- 
treated cells being converted to an active form by exposure of the 
cell to dsRNA (or to virus). These enzymes were a cAMP dependent 
protein kinase and an oligonucleotide synthetase, termed 2,5 oligo A 
synthetase by Kerr et ail (1977).
(a) cAMP dependant protein kinase
In view of the reported elevation of cAMF by interferon (Tovey et al. 
1979) it is of interest that this enzyme is cAMP dependent. The 
protein kinase phosphorylâtes two cell proteins of molecular weights 
approximately 35Kd and 67Kd (Farrellet^ al. 1978). The smaller 
molecular weight protein is the alpha sub unit of cIF2 (eukaryotic 
initiation factor-2) (Hovanessian ¿1_. 1980). The nature of the 
larger protein is not clear;0htsuki et al. (1980) consider that it is 
a ribosomal protein that may act as an intermediate between the 
protein kinase and phosphorylation of eIF2. The phosphorylation of 
eIF2 prevents the initiation of protein synthesis (Lenz and Baglioni 
1978 and Bnqlioni 1979).
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(b) 2,5 Oligo A synthetase
This catalyses the formation of a low molecular weight oligonucleotide 
of the general formula pppA(2'p5'A)n where 'n' could be from 1-10 but 
most frequently the trinucleotide was observed (Kerr and Brown 1978). 
The trinucleotide consists of three adenosine residues linked by 
two phosphodiester bonds at the V  5' positions and linked to three 
phosphate groups; i.e.
A A A\
D
[\ [
P P P v ^ ^ ^
r\ l \ f
OH (2') 
OH
(51)
The trinucleotide activates an endonuclease which can degrade viral 
and cellular mRNA, and thus acts to inhibit virus replication at the 
level of transcription. Further actions of V  5' oligo A synthetase 
and the trinucleotide have been proposed; Thang et al. (1981) 
demonstrated that 2'5' oligo A synthetase catalyses the aderylation 
of tRNA and NAD+ . The function of this is not clear but this process 
does limit the size of oligo A nucleotide formed, in the absence of 
tRNA and NAD+ long chain oligo A polymers are synthesised. Wallach 
and Revel (1980) have suggested that the trinucleotide as well as 
activating the endonuclease, may have a more direct anti-viral role, 
since they detected the 2'5' A trinucleotide bound to the ribonuclear- 
protein core of VSV and MLV virions released from interferon-treated 
cells.
The 2'5' A trinucleotide is itself degraded by an interferon 
enhanced phosphodiesterase and Revel (1979) proposes that this PDE acts 
83 additional pathway to inhibit virus replication by inhibiting 
directly the amino acylation of tRNA and thu3 inhibiting peptide chain 
elongation.
23
The'role of 2'5' oligo A synthetase and the cAMP dependant 
protein kinase in mediating the antiviral action of interferon 
has been confirmed by many experiments which have correlated 
levels of these enzymes with both the degree of antiviral resis- 
tamce and the level of interferon. Williams and Reed (1981),
Krishnan and Baglioni (1980) and Hovanessian et_£l_ (1981) have 
demonstrated this correlation in in vivo pathogenesis, and Thang 
elt al^  (1981) have found this to be true in interferon treated 
cells infected with MLV in vitro. In addition Hovanessian et al 
(1981) have detected elevated levels of 2'5' oligo A synthetase 
in the sera of human volunteers treated with poly rA:rU, and 
also in the mononuclear cells of humans suffering from virus 
infection.
Role_of_'antiviral' enzymes inmediating the non-antiviral 
effects_of interferon
The interaction between the interferon molecule and the 
establishment of the covert antiviral state within the cell 
reflects a profound effect on the cells' biology, and because 
of this it may be considered that the other non-antiviral effects 
attributed bo interferon are secondary events and do not represent 
a series of distinct non-antiviral functions of interferon. Des­
pite intensive searches a further series of interferon-induced 
enzymes specific to other effects have not been found, and it is 
therefore possible that the induction of antiviral enzymes and 
changes at the cell surface mediate the other effects of inter feron.
If this is so, it should be possible to demonstrate that the 
interferon-induced antiviral enzymes can produce the non-antiviral 
effects of interferon.Xinyan £t £l (1981) in addition to demonstrating
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that 2'5' oligo A trinucleotide can confer anti-vira.1 resistance 
against a wide variety of viruses, has shown that this trinucleotide 
can inhibit DMA synthesis in a variety of human and mouse cells and 
enhance the activity of macrophages and natural killer cells; and 
thus can have anti-proliferative and immunoregulatory effects. The 
anti-proliferative effects of 2'5' oligo A trinucleotide have also 
been demonstrated by Baglioni (1979) and Kimchi et al. (1981)
who used this trinucleotide to inhibit the mitogen-induced prolifer­
ation of both serum starved 3T3 mouse fibroblasts and mouse 
lymphocytes.
An interesting adjunct to the role of 2'5' oligo A has come from 
studies on cells insensitive to the action of interferon. Wood and 
Hovanessian (1980) have shown that in stem cell teratocarcinoma cells 
which are insensitive to the actions of interferon, that levels of 
2'5' oligo A synthetase arc elevated by exposure to interferon but 
those of the cAIIP dependent protein kinase are not. Epstein et al.
(1981) have shown that in a mouse fibroblast line insensitive to
interferon the levels of both the 2'5' oligo A synthetase and the
protein kinase are enhanced by interferon hut no endonuclease
activity can be detected. These experiments suggest that other
factors are necessary for the functioning of 2*5' oligo A and also
that it may be too simplistic on interpretation to propose this
molecule os the common pathway through which interferon exerts its effects
Alteration of induced and non-inducedgrotein synthesis
Interferon is known to influence the synthesis of specific 
induced and non-induced proteins as well as changing the overall bio­
synthetic activity of the cell. These changes may represent a specific
action of interferon or alternatively they may represent the
* \
differential stability of cell mRNAs to the intracellular changes 
induced by interferon, or even the alteration in uptake of component 
molecules caused by changes in the cell membrane.
Treatment of cells with high or low concentrations of interferon 
can respectively depress or enhance the production of interferon 
itself, phenomena celled blocking and priming (Stewart 1979 p233-238).
Interferon i3 also known to enhance the synthesis of factors 
associated with the immune response, e.g. IgE-induced histamine 
release is enhanced (Bloom I960) and so is the synthesis of prosta­
glandin E (PG-E) (Yarron et^^l. 1977), PG-E is known to be involved 
in the inflammatory process associated with infection. The release 
of molecules such as histamine and PG-E may contribute to the febrile 
illness often associated with interferon therapy (Gresser 1961).
Levels of DNA, RNA and protein synthesis are generally depressed 
irt interferon-treated cells but in some cell systems the synthesis 
of specific proteins is depressed more than this background level, 
e.g. globin synthesis in interferon treated differentiating Friend 
leukaemia cells (Possi £t £l_. 1977a,b), and the enzyme ornithine 
decarboxylase in mitogen treated cells (Taylor-Papidomitriou 1980).
Regulation of_humoral and_cellular mediated immune responses
Interferon has effects on all aspects of the immune response 
including cell mediated and humoral reactions and the production of 
soluble factors, e.g. complement. Many of the recent papers (see 
reviews in Bloom 1980, Ortaldo e^ t al_. 1981 and Oe Maeyer 1981) 
describe the paradoxical effects of interferon upon immune responses,
and by this is meant that an opposite effect can be seen if the dosage 
or timing of administration is altered. It is not clear why these 
effects occur but they may represent a combination of direct effects 
upon the cell and the induced release of other mediators of the immune 
response. The influence of interferon upon the immune response will 
first be described end then its mechanism of action considered.
Cell mediated immunity
These responses are carried out via T lymphocyts, and they include the 
lysis of virus infected cells, delayed hypersensitivity (OHS) and 
allograft rejection. Interferon has been shown to inhibit mitogen- 
stimulated T cell proliferation (Matheson £t al_. 1981), and to depress 
DHS as measured by its in vitro counterpart, leukocyte migration 
inhibition (Sziegeti et ¿1. 1980). However it has also been shown 
that if the timing of interferon treatment is altered to after the 
administration of the antigen stimulus, then the DHS response can be 
enhanced in vivo (reviewed in Gresser 1981). A similar dual response 
is seen in allograft rejection, low concentrations of interferon 
accelerate allograft rejection (Lindahl 1973) and high concentrations 
prolong survival.
Humoral immunity
a
Production of antibody from antigen stimul^ed B lymphocytes is 
altered by treatment with interferon but the direction depends on the 
timing of treatment; cells treated at the same time an the antigen 
stimulus show decreased production (reviewed in Stewart 1979 p254-256). 
It has been thought that interferon depressed mitogen-induced pro­
liferation in all lymphocytes but recently llatheson £t^  al. (1981) 
have shown that human interferon produced on enhanced proliferation of
of mitogen-stimulated B cells. Whilst this is contrary to the known 
cell multiplication inhibition of interferon, it may represent 
elicitation of other factors which cause mitogenesis; Blomgren and 
Einhorn (1981) have shown that interferon enhances the release of 
lymphokines which contain mitogen factors.
Antibody-dependent cell-mediated cytotoxicity is enhanced by 
interferon. This response does not primarily involve B cells, but 
requires circulating antibody, complement and macrophages (Heberman 
et al. 1979).
Macrophage and monocyte response
Interferon can enhance or restore phagocytic ability to both monocytes 
and macrophages, and this effect can be seen in both in vivo and 
in vitro (Gresser 1981). However Degree et _al. (1981) report that 
this enhancement is only seen if low levels of interferon are used; at 
high levels the response is depressed. Hovi et_ al. (1981) have also 
shown that interferon at low to moderate concentrations can inhibit 
the differentiation of monocytes to macrophages, whilst at the same 
time increasing the phagocytic ability of the monocytes.
Natural killer cells (NK cells)
These are non-T and non B-lymphocytes, which although cytotoxic for 
all cells show enhanced cytotoxicity for neoplastically transformed 
cells (Bloom 1980). There is a positive correlation between resistance 
to transplanted tumours and the level of NK activity (Gidlund et al. 
1978). Many workers have shown that interferon increases the level 
of activity of NK cells in vivo and in vitro (Wigzell 1981, Gidlund 
et a K  1978, Zarling ejt al. 1979, Heberman et al_. 1979 and Huddlestone
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al_. 1979). The interferon-enhanced activity of NK cells ha3 
two causes; there is an increase in the number of functional NK cells 
by promotion of differentiation of precursor N'K cells (Bloom 1980, 
Ortaldo et^  al^ 1981), and an increase in the lytic activity of pre­
existing NK cells (Ortaldo 1981).
From the involvement of interferon in the immune responses 
described above, it is evident that interferon can influence the 
overall immune response in a variety of ways. Friedman et_ aJL (1981) 
has suggested that since the majority of the immunoregulatory effects 
of interferon only require brief treatment, and do not require DNA 
synthesis or differentiation (NK cells are an exception), then such 
effects could be mediated via changes in cell surface antigens. It 
is known that interferon enhances expression of the major histo­
compatibility antigens on all cells including lymphocytes (Gresser 
1981). Fridman et al. (1981) have demonstrated that expression of 
Fc-gamma receptors, which mediate many immune functions, are enhanced 
by interferon.
It should be appreciated that although application of exogenous 
interferon can have profound effects upon the immune system, the 
production of interferon itself by mitogen or antigen stimulated 
lymphocytes is part of the immune response itself (Roitt 1977, Cohen 
and Bigazzi 1980). This close involvement of interferon in the 
immune response and the fact that not only can interferon promote 
differentiation of NK cells but may be essential to their normal 
differentiation in vivo (Heberman et al. 1979) does strongly suggest 
that interferon has a natural role in the regulatory machinery of 
the immune response of the host to virus infection and to tumouri- 
genesis.
V
replication in_normal_and tumour cells
The anti-proliferative effects of interferon were initially 
demonstrated by Paucker et^  al. (1962) and these effects were later 
confirmed by several groups using pure interferon (Gresser 1979,
De Maeyer-Guignard et al_. 1978, Iwakura et al. 1978, Knight 1976, reviewed 
in Stewart 1979 and in Taylor-Papidomitrious 1980),
In multicellular organisms in the animal kingdom, cells grow at 
different rates to reach a finite cell number and therefore an 
inherent ability to control cell and tissue growth must be present in 
all cells. In addition it may be that organisms which contain cells 
growing at different rates and with different regenerative capacities 
employ various methods to regulate growth applicable to different cell 
types. Malignant transformed cells can be considered as cells which 
have escaped the influence of these normal growth control mechanisms; 
and it ha3 been proposed (Gresser 1981, Hicks et j^ _. 1981) that the 
mechanism underlying the antiproliferative effects of interferon may 
be one which increases the sensitivity of normal and tumour cells to 
these various normal growth control mechanisms. This increase in 
sensitivity would be analogous to that seen in interferon-treated cells 
exposed to dsRNA which results in increased sensitivity to the 
inhibition of protein synthesis.
Interferon can inhibit cell replication in both normal and tumour 
cells in vivo and in vitro, but it does not have a significantly 
greater activity or bind preferentially to tumour cells (Taylor- 
Papidomitriou 1980). The majority of normal and transformed cells are 
sensitive to the anti-proliferative effects of interferon to varying 
degrees, but some exceptions have been identified. Some of these cells
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(Wood and Hovanessian 1979, and Epstein ct^  aJL 1981) have been shown 
to lack components of the interferon system; however there is no 
evidence to suggest that similar abnormalities of the interferon system 
are involved in in vivo tumourigenesis.
The anti-proliferative action of interferon causes many changes in 
cell phenotype and behaviour which vary according to the cell system 
under study; these changes can be seen to have two main effects. These 
are inhibition of cell replication and in some tumour cells, a reversion 
towards a more normal phenotype.
dresser et_ 3^(1975) demonstrated that replication of transplanted 
normal bone marrow and spleen cells i3 inhibited by interferon in 
immune-suppressed hosts, and that interferon could also inhibit 
regeneration in partially hepatectomised mice. Pfeffer et^  al. (1979) 
has shown that cell replication jin vitro in human fibroblasto is 
inhibited by interferon but the rate of cell growth, as determined by 
increase in cell volume and area, was not altered. Similar inhibitory 
effects on tumour cell replication have also been observed (Delleyer-
Eichberqcr et al. 1981). The cell replication inhibitory effect of 
interferon acts to progressively lengthen the cell cycle at each 
mitotic division thus reducing the overall rate of replication; the 
period of G1 is seen to be extended by several hours (Taylor-Papidomi- 
triou 1980). This effect is not often directly lethal but it can be 
to some cells that seem to require a minimum replication rate to be 
viable, e.g. human Rurkitt Daudi cells (Cresser 1981).
It has been reported that interferon treatment of some transformed 
cell lines produces a reversion towards a more normal phenotype and this
Guignard et^  al. (1978) and Hick3 et aJL (1981) both report changes in
may be the cause or effect of interferon on growth. De Maeyer-
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the cytoskeleton of-interferon treated transformed cells cultured 
in vitro. They observed a partial restoration of the microfilament 
bundles associated with increased cell spreading. In additon 
Hicks et_ al.. have shown that the in vitro transformation-specific 
phenomena of focus formation, and colony formation in agar are 
similarly inhibited by interferon.
Other reports have noted that interferon-treated transformed 
cells show a reduction in cell saturation density (Taylor-Papidomitriou 
and Stoker 1971, 3routy-Boye £t al_. 19C0).
Mechanism of action.
The mechanism of action of the growth inhibitory effects of 
interferon are not as fully understood as are the mechanisms con­
trolling the anti-viral state. As mentioned above these anti­
proliferative actions may be secondary to the establishment of a 
covert anti-viral state; this idea is supported by the experiments 
which demonstrate the anti-proliferative actions of the induced anti­
viral enzymes, and also by the fact that a specific factor is not 
induced by interferon to mediate its effects on growth. Interferon 
may act to inhibit cell replication by general inhibiton of cell 
biosynthetic machinery, since there are many reports citing the anti­
proliferative effects of interferon which have also reported a 
depression of DNA, RNA and protein synthesis (reviewed in Taylor- 
Papadomitriou 19D0). However the reports on the intiibition of DNA 
synthesis do vary in the extent to which DNA synthesis is affected 
(Stewart 1979 p242). This variation may bn related to the stage of 
the cell cycle when the cells wore treated.
The role of interferon during in vivo tumourigenesis is not
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limited to its direct effect on the tumour cell because it is also 
involved in mediating the immune response to the tumour (see above); 
and possibly also in increasing the antigenicity of tumour cells by 
alteration of cell surface antigens. There has been one report by Attollah 
et al_ (1979) which has shown that interferon increased the expression 
of a tumour specific antigen (Carcinoembryonic antigen) on the surface 
of human colon carcinoma cell lines.
Possible role in the normal control mechanisms of_growth_and 
differentiation
It has been proposed that since effects on cell replication and 
differentiation have been observed with exogenous applications of 
interferon that this might suggest that interferon has a natural 
function in regulating these phenomena (Taylor-Papidomitrious 1980,
Stark et _al_. 1979). If interferon has such a function then it would be 
expected that either interferon or enzymes induced by interferon could 
be detected in cells growing and undergoing differentiation.
There have been many reports of cells not previously treated 
with interferon, but containing high levels of the anti-viral enzymes 
known to be induced by interferon. Rabbit reticulolysate (RRL) ha3 
been shown by Petryshyn et al.. (1979), Ernst crt al. (1979), Datta 
et al. (1977) to hove a high degree of sensitivity to the protein 
synthetic inhibitory effects of dsRN'A; similar to that found in 
extracts of interferon-treated cells. These RRL samples are found to 
contain a cAMP dependent protein kinase, activated in response to dsRNA 
which, like the interferon-induced cAMP dependent protein kinase, can 
phosphorylate the alpha sub-unit of eIF2. RRL samples contain an
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additional cAMP independent protein kinase, antigenically distinct
activated by the absence of haemin. A 2'5' oligo A synthetase has also 
been shown to be activated in RRL samples by dsRN'A (Hovanessian and 
Kerr 1979). This has led to the suggestion by Hunt (1978) that either 
interferon or the anti-viral enzymes themselves have a natural role 
in the growth and differentiation of reticulocytes.
Stark et_al_. (1979) have identified inactive 2’5' oligo A 
synthetase in a wide range of mammalian and chick tissues. The levels 
were found to vary considerably and all could be elevated by treatment 
of the cell with interferon. This led to their intriguing suggestion 
that the interferon-induced elevation of 2'5' oligo A synthetase during 
the anti-viral response is only one function of this synthetase.
These workers propose that 2'5' oligo A synthetase could function as a 
general agent to regulate cell translation in normal conditions in the
Shimizu and Sokawa (1979) have shown that quiescent lymphocytes 
have high levels of 2'5' oligo A synthetase, similar to those seen in 
interferon-treated cells, and propose thi3 may be to prevent 
replication until the cell is exposed to a specific mitogen stimulus.
In addition Kimchi ert ad. (1979, 1981) found that the levels of 2'5' 
oligo A synthetase rise in cultures of Friend leukaemic cells during 
the transition from growth to quiescence. In support of this finding 
it is interesting to note that interferon can inhibit the growth of 
these cells (Posai et al. 1977a,b).
Kimchi et_ al_. (1981) have proposed a model whereby levels of 
2'5' oligo A synthetase within the cell regulate the ability of that 
cell to replicate; mitogen stimulated lymphocytes have decreased levels
from the dsRNA activated protein kinase, which is
cell
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of 2'5' oiigo A synthetase and high levels of phosphodiesterase
(which degrades the trinucleotide), interferon increases the levels
of 2'5' oiigo A synthetase (and to a lesser extent the phosphodiesterase).
Thus mitogens act to remove the 2'5' oiigo A trinucleotide block on 
translation and interferon acts to reimpose it.
Control of differentiation
There has been some support for the suggestion that either interferon 
or 2'5' oiigo A synthetase are involved in the regulation of some cell 
differentiation events. Some differentiation events in the immune 
system have been shown to be influenced by interferon. Natural killer 
cell differentiation is enhanced whilst the differentiation of 
monocytes into macrophages is inhibited (see above). Kimchi et al.
(1981) have found that levels of 2'5' oiigo A synthetase increase 
(fifty times beyond control cultures) in Friend cells induced to 
differentiate by addition of dimethylsulphoxide. Moreover it was shown 
that addition of antisera to mouse interferon could abolish this rise.
There is also some evidence that interferon or 2'5' oiigo A 
synthetase are involved in differentiative events outside of the bone 
marrow stem cells. Chick oviducts if treated with oestrogen synthesise 
specific proteins, and withdrawal of the steroid results in inhibition 
of synthesis of these specific proteins. The kinetics of this inhibition 
are paralled by a rise in 2'5' oiigo A synthetase. Stark et al. (1979) 
propose that the role of interferon is to cause the degradation of the 
mRNA and thus to rapidly terminate protein synthesis.
The report of Kimchi et jal^ (1981) appeared initially to contradict an 
earlier finding by Ros3i et al (1977) who demonstrated that the different­
iation of Friend cells could be inhibited by interferon.However this laboratory
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has since • reported (Dolei et_ al. 1980) that although high doses 
of interferon do inhibit differentiation in DMSO induced Friend cells, 
low doses enhance differentiation and will even promote differentiation 
in Friend cells not exposed to DMSO. The inhibitory effect seen at 
high doses might reflect a need for cell division to occur during 
differentiation.
The work of Kimchi et al. (19B1), Stark et al. (1979) and Dolei 
et al. (1980) might be seen to indicate that interferon acts to promote 
differentiation, hut the work of Hovi et^  al_. (1981) on monocyte 
differentiation, and a recent paper bu Grossberg et al. (1981) suggest 
that this might be a too simplistic interpretation. Grossberq et al. 
have observed that very low amounts of interferon (approximately one 
unit per ml) inhibit the differentiation of 3T3L1 mouse fibroblasts 
to adipocytes when the former are exposed to insulin. The transition 
to adipocytes involves loss of cytoskeleton, collagen synthesis and 
the accumulation of lipid, and all these are prevented by interferon.
This report is interesting in that although it suggests that interferon 
is inhibiting differentiation it also indirectly suggests that interferon 
is promoting a phenotype more commonly associated with the normal cell, 
i.e. well defined cytoskeleton and synthesis of collagen.
These reports on the influence of interferon in growth and 
differcntiative events are interesting, and if nothing else demonstrate 
that the area deserves further attention. These reports all involved 
cells which were partially differentiated; the reports that exist con­
cerning undifferentiated cells show thot these cells are not sensitive 
to the effects of interferon. Thus interferon cannot be proposed a3 a 
universal regulator of cell differentiation and growth per se. The
reports do however suggest that interferon can interfere with 
terminal cell differentiation in some cell systems; in accordance 
with the other known effects of interferon it may "interfere" by 
establishing an interferon-specific pattern of cell growth, morphology 
and replication; which acts as the trigger to promote synthesis of 
certain differentiative products.
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MOUSE EMBRYOGENESIS
Mammalian development consista of many processes, which interact 
continuously, whereby a single fertilised egg gives rise to a complex 
differentiated organism. These processes include determination and 
differentiation; which leads to the acquisition of phenotypic variation 
amongst cells of an identical genotype, morphogenesis; which is the 
attainment of correct spatial and temporal relationships between 
phenotypically different cells, and growth; the increase in size of 
the organism.
These processes must also include the interaction between the 
embryo and its maternal host, defined by Johnson (1977 ) a3 "a para­
biotic liaison with a genetically alien individual". It has been 
suggested (Billington and V.’ild 1979) that the maternal response to 
embryonic antigens may influence some differentiative events. However 
this has been shown not to be true for early developmental events, mainly 
because it can be seen that transplantation of early cleavage embryo 
(two to four cell 3tage) to ectopic sites does not impair development 
to egg cylinder or neural plate formation (Herbert and Craham 1974).
The maternal environment can however negatively effect normal growth 
and development of the later foetus, and pathological conditions in the 
maternal host can induce stunted growth and foetal malformations 
(Cohen 1979, Morris 1979, reviewed by Newth and Balls 1979).
Observation of embryogenesis has shown that there exists a 
synchrony of development amidst animals of one species, such that the 
timing of crucial events can be expressed in hours and even minutes
S
since the initiation of development. It is therefore conceivable that 
a timing mechanism may operate to control the emergence of developmental 
events; for example, Tarkowski and V.'roblewska (1967) demonstrated that 
the accumulation of fluid in individual cells of the eight cell 
embryo was a process which occurred after a definite period of time, 
irrespective of the number of nuclear cycles or of cleavage inhibition. 
However, most agree that later embryological development is not timed 
by a biological clock set in motion at the time of fertilisation 
(reviewed in Snow and Tam 1980).
Observation has also shown that an obvious feature of normal 
embryological development is that cell types appear in a fixed sequence 
in which differentiated cells are successively thrown off from a 
multipotent stem cell population (Graham 1977). An example of what 
is meant by this is shown in figure 1, which illustrates early events 
in mouse embryogenesis . The initial differentiation event in mouse 
embryogenesis is the production of the trophectoderm from the outer 
cells of the morula ; the remaining multipotent stem cells even though 
they generate the embryonic ectoderm, endoderm and mesoderm, are not 
completely totipotent since they are unable to produce trophectoderm 
(Rossant 1977, Johnson e£ al_. 1977).
It is not yet clear if subsequent foetal development depends 
upon an initial orderly sequence of developmental events. Little 
information is available from embryonic material itself but observ­
ation of teratocarcinoma cell differentiation has shown that 
differentiated cells representative of the three embryo germ layers 
can arise without an initial orderly developmental sequence. For 
example, testicular teratocarcinoma which are composed of stem and 
differentiated cells ran be induced to form directly from primordial 
germ cells (see review in Rossant 1977). '
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FIGURE 1. The early events in mouse cmbryogenesis.
(taken from Hogan 1977, Rossant and Papiaoanou 1977).
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Differentiation of phenotypically altered cell types is marked 
by changes in cell morphology, synthesis of specific proteins and 
changes in cell behaviour; all of which can be used as markers of cell 
differentiation. However before these changes are manifest the cell 
is thought to be covertly committed to its subsequent development 
fate cello in this condition are said to be determined (Rossant and 
Papiaoannou 1977). Determination can be seen as a stage during which 
the developmental potential of a multipotent cell becomes restricted 
with no overt change in phenotype. It can be envisaged as a single 
cellular event (Levenson and Houseman 1961), or as a labile 
determinative period in which cells arc gradually biased towards a 
particular fate (Johnson et^  a_l. 1977). Determination may or msy not 
be detectable in all differcntiative processes, and it may well be that 
with increasing sensitivity in assay techniques, that determination and 
differentiation may be seen to arise together. However within the 
confines of the present state of knowledge, a state of determination 
defined as above can be detected during some stages of embryogenesio.
The study of differentiation has been advanced with the discovery 
of cell specific biochemical markers and of sensitive assay techniques 
for them (3ode and Dziadek 1979, Dziadek and Adamson 1978, Adamson 1976, 
Strickland and Sherman 1976 and Burke £t al_. 1978); and also by the 
development of antibodies, including monoclonal antibodies, to specific 
stages of embryogenesis (Gooi et_ jj1_ 1981, Kemler et^  jrl. 1979, Soltcr 
and Knowles, 1978, Brulet et (1980).
Activation of the interferon system appears to be associated with 
the establishment of the differentiated cell typo in teratocarcinoma 
cello (Burke et_ al. 1978); and it is one of the aims of this study to 
see if this observation can be confirmed in the mouse embryo.
\The gestation period in mice is complete in approximately 
19 - 21 days, copulation results in a visible plug which marks day 
one of embryogenesis. The developmental age of the embryo is taken 
to begin on midnight, of the night before the day, on which the 
plug was found. The main stages of mouse embryogenesis are complets 
by the first half of gestation; these stages involve the establis­
hment of the extra-embryonic membranes, the embryonic germ layers 
and the organ rudiments. Embryogenesis in the mouse ( and in other 
related animals, the rat, guinea pig and rabbit ) differs from 
that of other mammals, in that the initial arrangement of the three 
embryonic germ layers is reversed. The embryonic endoderm forms 
outside the embryonic ectoderm initially, but this inversion of 
germ layers is corrected when the embryo undergoes a complex rot­
ation at approximately the tenth day of development (Snell 1941, 
Balinski 1975, Hogan 1977 and Green 1960).
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Cleavage stage embryos: determination and differentiation
For the first four days of development the embryo is free 
in the reproductive tract and isolated by a jelly coat, called 
the Zona Pellucida. The single fertilised cell cleaves to two 
four and eight cells which initially aggregate loosely; however 
at the eight to sixteen cell stage, compaction occurs and cell 
boundaries become less obvious. The embryonic genome is active 
early (Johnson et £l_ 1977), the four cell embryo shows rRNA, 
tRNA and mRNA synthesis as well as qualitative changes in protein 
synthesis (Van-Blerkom and Brockway 1975, Izquierdo 1977 and 
Barlow et al 1972).
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It has recently been shown by Johnson and Ziomek (1981) that 
the sixteen cell embryo contains two morphologically distinct cell 
populations, which differ with respect to the distribution of surface 
microvilli. At the eight cell stage all cells show a polar distrib­
ution of these microvilli, but by the sixteen cell stage the cells 
have either a polar or even distribution of microvilli. This latter 
stage coincides with the enclosure of some cells within the aggregate 
which are thus no longer exposed to the external milieu. Johnson 
and Ziomek (1981), propose that the 'decision' of cells to be 
enclosed may depend on the absence of a polar distribution of 
surface microvilli. Thus it is suggested that the cells of the eight 
cell cleavage embryo may possibly be committed to produce either 
enclosed or exterior cells, whose subsequent fate is restricted by 
assuming these positions.
However experiments involving the reaggregation of cells 
from four or eight cell cleavage embryos have shown that the 
developmental fate of these cells i3 not restricted at this stage. 
Each of the cells from these early embryos is able to colonise either 
the trophectoderm or the inner cell mass of the later blastocyst. 
(Wilson and Stern 1975, Rossant 1977, reviewed in Graham 1977 and 
Ro3sant and Papiaoannou 1977); and therefore the cells from the 
four or eight cell embryo cannot be regarded as determined as 
defined above.
Blastocyst: determination and differentiation
Cleavage occurs until the cell aggregate, now called the morula
43
\
reaches approximately 32 - 64 cello, and by this stage the external 
cells of the morula have become morphologically differentiated. These 
altered external cells begin to pump fluid from the external environ­
ment into the centre of the morula. This action mechanically displaces 
the central cells to one pole of the embryo, producing a cavity 
called the blaotocoele. Thi3 stage is now called the blastocyst, the 
outer cells are termed the trophectoderm and the enclosed cells are 
termed the inner cell mass (ICM)(see figure 2a).
The behaviour of these two cell populations are different, the 
cells of the ICM synthesise DNA more rapidly and have a faster doub­
ling time than those of the trophectoderm (Barlow e£ £l 1972). 
Trophectoderm vesicles can invoke a decidual response in the uterus 
and, in contrast to the cells in the ICM, cannot replicate in vitro 
(Gardner 1972).
The ability of the cells of the early morula to form either 
trophectoderm or ICM cells has been shown to be dependent on the 
position of these cells in the morula. The positional hypothesis 
considers that the blastomeres enclosed in the morula become ICM, 
whilst those on the outside, in contact with the uterine secretions 
become trophectoderm. This was originally proposed by Tarkowski and 
Wroblewska (1967), and has been confirmed through reaggregation 
experiments using four or eight cell embryos by the work of Hillman 
et^  al (1972), and is also supported by the work of Johnson et al 
(1977), Herbert and Graham (1974), V/ilson and Stern (1975);
Development of the extra-embryonic membranes and the placenta
At the late blastocyst stage, approximately 4 - 4^ day3 
development, a third morphologically different tissue forms
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(Taken from Bode and Pziadek 1979, Snell 1941, 
Herbert and Graham 1974 and Martin 1978.)
FIGURE 2. STARCS OF EARLY HOUSE EMBRYOGENESIS.
A. Early blastocyst (3hdys age)
inner cell mass' 
primitive endoderm
trophectoderm-
E. Post-implantation, early 
egg cylinder (6-7dys age)
ectoplacental cone 
extra-embryonic ectoderm
trophoblast- 
parietal endoderm
embryonic ectoderm
FIGURE 2. (continued) STAGES OF EARLY MOUSE EMDRYOGENFSIS.
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FIGURE 2. (continued) STAGES OF EARLY MOUSE EMDRYOGENESIS.
G. The arrangement of the embryo 
and the three extra-embryonic 
membranes at mid-term.
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from the cells of the ICM exposed to the blastocoele fluid. This 
single layer of cells is called the primitive endoderm and the ultra- 
structure of these cells differs from that of the remaining ICM cells 
(which are now called primitive embryonic ectoderm). The cells of 
the primitive endoderm are marked by prominent rough endoplasmic 
reticulum, intracellular vesicles and surface microvilli (Hogan 1977). 
Formation of primitive endoderm is not thought to arise from pre­
determined cells in the ICM because isolated ICMs have the ability to 
form a single layer of endoderm over the entire surface (Rossant and 
Papiaoannou 1977).
The primitive endoderm is not thought to contribute substantially 
to the embryo itself, instead it produces two types of extra-embryonic 
endoderm during the next few days of development. These are the 
parietal endoderm which grows adjacent to the trophectoderm and the 
visceral endoderm which grows adjacent to the primitive ectoderm 
(Hogan 1977), this stage is illustrated in figure 2b.
At approximately days the zona pellucida is lost and
the embryo implants into the wall of the uterus, the presence
of the embryo inducing a decidual swelling in the uterine stroma.
After the development of the primitive endoderm several changes 
occur both in this tissue and in the trophectoderm. The trophectoderm 
can be divided into two populations of cells which are morphologically 
distinct, these are termed because of their positions, mural and polar 
trophectoderm (see figure 2b). The inner surface of the mural 
trophectoderm i3 initially in contact with the blastocoele fluid, these 
cells soon cease cell division but continue DNA replication eventually 
producing primary giant trophoblast cells. The polar trophectoderm 
overlies the primitive ectoderm, these cells replicate normally and are 
the source of the remaining trophoblast tissue in the embryo (Hogan 1977).
The further differentiation of the polar trophectoderm is regulated 
by contact with the primitive ectoderm (Gardner and Papiaoannou 1975, 
Johnson 1972 appendix, Gardner 1972).
The polar trophectoderm at the exterior surface differentiates 
into cells of the ectoplacental cone (EPC), which are capable of 
producing secondary giant trophoblast cells. The interior surface 
differentiates into the extra-embryonic ectoderm (ex.emb.ect.). The 
formation of these new tissues displaces the primitive embryonic 
ectoderm producing an elongation of the embryo, the whole embryo 
because of this elongation is now called the embryonic egg cylinder 
(see figure 2c).
Confirmation that the EPC, the secondary giant trophoblast cell 
and the ex.emb.ect. do arise from the polar trophectoderm has been 
obtained from the work of Gardner and Papiaoannou (1975). These 
workers produced chimaeric embryos via injections of the ICMs' of 
one mouse strain into the blastocyst of another strain or species. 
Chimaerism in the tissues was examined by karyotype analysis or 
isozymal variants, and showed that the EPC, secondary giant tropho­
blast cells and the ex.emb.ect. was never of ICM origin. In addition 
Johnson and Rossant (1981) demonstrated that these three tissues 
could produce similar two-dimensional gel profiles.
The embryo at this stage (see figure 2c) is thus enclosed by 
one extra embryonic membrane, which consists of an outer layer of 
trophoblast cells and an inner layer of parietal endoderm cells, 
separated from each other by a layer of inert basement membrane mate­
rial termed Reicherts' membrane ( the latter is specific to rodents). 
This outer membrane is only a temporary structure and 
begins to atrophy at approximately days 14 - 15 of development.
Formaticn_of_the three embryonic germ layers
The next stage of development involves the production of the 
embryonic mesoderm and endoderm from the primitive embryonic ectoderm. 
The ability of the primitive embryonic ectoderm to produce all three 
embryonic germ layers has been demonstrated by Diwan and Stevens (1976). 
These workers transplanted primitive embryonic ectoderm from early 
egg cylinder stages, to ectopic sites (e.g. under the kidney capsule) 
and showed that these cells produced derivatives of all three germ 
layers.
Primitive streak formation occurs at approximately 8^-9 days, 
and results initially in the formation of the extra-embryonic mesoderm 
(ex.emb.meso) and the embryonic mesoderm (emb.meso), (see figure 2d).
The primitive streak defines the posterior axis of the embryo, since 
the head fold develops opposite to this area, while the embryonic 
endoderm (einb.end) is thought to originate from the head fold region 
(Hogan 1977, Gardner and Papiaoannou 1975, Rossant 1977).
The body cavity and the organ rudiments are then established; 
neurulation and rotation of the embryo occurring at approximately day 
18-11 . This rotation of the embryo, and other differentiative
events occurring at this time leads to the establishment of two further 
extra-embryonic membranes, thi3 process is illustrated in figures 2e to 
2g. The innermost membrane adjacent to the embryo is of èx.èmb.mesoderm 
plus emb.ect. origin and is termed the amnion; the layer in between 
the amnion and the outer trophoblast and parietal endoderm i3 colled 
the visceral yolk sac. This latter membrane is composed of visceral 
extra-embryonic endoderm and ex.emb.meso and has many functions; it 
forms the outermost embryonic membrane during late'development and'
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Formation of the three embryonic germ layers
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embryonic mesoderm and endoderm from the primitive embryonic ectoderm. 
The ability of the primitive embryonic ectoderm to produce all three 
embryonic germ layers has been demonstrated by Diwan and Stevens (1976). 
These workers transplanted primitive embryonic ectoderm from early 
egg cylinder stages, to ectopic sites (e.g. under the kidney capsule) 
and showed that these cells produced derivatives of all three germ 
layers.
Primitive streak formation occurs at approximately 8^-9 days, 
and results initially in the formation of the extra-embryonic mesoderm 
(ex.emb.meso) and the embryonic mesoderm (emb.meso), (see figure 2d).
The primitive streak defines the posterior axis of the embryo, since 
the head fold develops opposite to this area, while the embryonic 
endoderm (einb.end) is thought to originate from the head fold region 
(Hogan 1977, Gardner and Papiaoannou 1975, Rossant 1977).
The body cavity and the organ rudiments are then established; 
neurulation and rotation of the embryo occurring at approximately day 
18-11 . This rotation of the embryo, and other differentiative
events occurring at this time leads to the establishment of two further 
extra-embryonic membranes, this process is illustrated in figures 2e to 
2g. The innermost membrane adjacent to the embryo is of èx.ëmb.mesoderm 
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is then able to absorb material from the maternal circulation for 
foetal use, in addition the mesodermal layer generates foetal haemo- 
poetic stem cells in areas called blood islands, and at least some of 
these cells later go on to populate the foetal liver and bone marrow.
Thus the embryo at mid-gestation is surrounded by three membranes. 
These membranes function as mechanical barriers and isolate the embryo 
from potential pathogens. A further aim of this study was to determine 
whether or not these membranes could function as a means to protect 
the embryo from virus attack, this protection would pccur if the 
membranes were able to produce interferon and be sensitive to its 
effects before the interferon system was operative in the embryo 
itself.
Ontogeny of_the immune response
Since it is proposed to assess the relative role of the interferon 
system in conferring protection to the foetus from viral pathogens, 
it is necessary to briefly consider the ontogeny of the immune system. 
(A review of the immune system can be found in Roitt 1977 and Wood, 
Weissman and Hood 1978.)
There is a known association between some virus infections which 
occur during the early gestation period and foetal deaths and mal­
formations; a classical example of this i3 Rubella virus, infection 
with which can cause malformations and even abortions arid stillbirths 
(Mims 1977, 1968). It therefore becomes important to discover whether
immaturity of the interferon system, similar to that seen in un­
differentiated teratocnrcinoma cells.
s
foetus to some virus infections is due to an
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The development of the immune response (i.e. cell mediated and 
humoral actions of lymphocytes) parallels the development of the 
lymphoreticular system in the foetus (Ritter 1975). The elements of 
thir system comprise the haemopc^tic stem cells, liver, bone marrow 
and lymphoid tissue., The immune response is mediated via lymphocytes; 
either T lymphocytes (T represents thymus derived lymphocytes which are 
involved in cell mediated immunity (CHI)),or B lymphocytes (Bursa 
equivalent derived lymphocytes involved in humoral mediated immunity).
The foetus initially produces haemopdptic stem cells in the blnod 
islands of the viseral yolk sac, (at approximately 10-11 days). These 
stem cells migrate primarily to the foetal liver which takes:over'the 
role of haemoptysis, and then secondarily during later foetal develop­
ment to the bone marrow cells. Only the cells of the bone marrow retain 
this function during the final stages of foetal development (Ritter 
1975, Tyler 1971). The foetal lymphocytes do not become immuno­
competent until they have undergone a period of differentiation in 
either the liver or the thymus; lymphocytes can be detected in the 
thymus from approximately day 15 . (Roitt 1977, Ritter 1975) and the
presence of IgG and IgM bearing lymphocytes can be detected in in vitro 
cultures of liver from approximately day 14., (Owen et al. 1974).Wolfe 
J-t j*I (1957) and Silverstein (1963) similarly failed to elicit significant 
antibody titres in early chick embryos and foetal lambs.
The lack of immunocompetant cells, and the lack of demonstrable 
immune function both suggest that the foetus is unable to mount an immune 
response for the first halTof the gestation period. In addition the 
immune response is thought to be depressed in most species in the 
neonate, in humans for example, the production of antibody titreo does 
not reach adult levels until the child is approximately five years of 
age (Mims 1977).
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Early experiments by Isaacs and Baron (1960) demonstrated that 
interferon production and anti-viral sensitivity was reduced in early 
mouse and chick embryos. These workers were the first to propose that 
this depression of the interferon system in early embryogenesis might 
be responsible for the sij^eptibility of the foetus to agents such as 
Rubella virus. These results have been supported by Mendelson et al 
(1970) who demonstrated that interferon production was absent in 12 day 
rat embryos in utero but was present in 19 day embryos. Drasner et al 
(1979) in addition, demonstrated that the growth inhibitory effect of 
interferon could only be seen in in vitro cultures taken from post­
implantation mouse embryos, and not in in vitro cultures of pre- 
implantation stages.
Some interesting work has been done on the role of interferon 
during Rubella virus infections ijo utero, which suggest that the early 
embryo does not produce interferon during infection, despite the fact 
that Rubella virus is capable of inducing interferon production in 
in vitro cultures of amnion cells (Neva and Weller 1964). Desmyter 
et al (1967) and Rawls and Melnick (1966) both failed to detect 
interferon production either in the serum and urine from an infected 
foetus or from cultured explants taken from an infected foetus.
The literature concerning the ontogeny of both the immune response 
and the interferon system in mammals suggest that these phenomena are 
absent or severely depressed in early embryogenesis; thus the embryo 
appears to be unprotected from pathogens during a crucial period 
of development. However, in reality this is not so, not only does the 
foetus passively receive maternal immunoglobulins via the placenta and 
the visceral yolk sac, but the maternal immune response would he 
activated in the advent of a foetal infection. In addition the anatomy
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of the sites of foetal-maternal interaction (at which foetal and
«
maternal circulations are not in direct contact) make it unlikely that 
the majority of maternal born pathogens will reach the foetus.
There have been some reports that the maternal immune response 
is slightly depressed during gestation (Billington and Wild 1979,
Mims 1977), and this may increase the potential hazard to the foetus.
The maternal interferon system has not yet been investigated and reports 
vary as to whether or not maternal interferon can cross the placenta. 
Overall and Glasgow (1970) and fowler et al. (1980) have presented 
evidence that interferon cannot cross the placental barrier, but 
Williams and Reed (1981) found levels of interferon induced 2'5' oligo . 
A synthetase in mononuclear cells from cord blood samples in proportion 
to circulating maternal levels (the former experiments were performed 
on sheep and mice, and the latter on human term placentas, and may 
reflect a species variation).
Because of the known lock and inhibition of the classical immune 
response during early embryogenesis, it becomes interesting and 
relevant to define the role and relative importance of the foetal and 
maternal interferon systems during viral infection of the foetus, this 
will be discussed in section three.
\
TERATOCARCINOMA, AND THEIR USE AS IN VITRO ANALOGUES OF DEVLOPEMENT
The term teratocarcinoma describes a tumour containing undifferen­
tiated multipotent stem cells and a variety of differentiated cell 
types.
The undifferentiated multipotent stem cells are called embryonal 
carcinoma or ec cells and are malignant iri vivo and can be established 
as cell lines in vitro; the differentiated cell types are generally 
benign jji vivo and since they divide relatively little _in vitro, cannot 
be established as cell lines (Adamson and Graham 1979). The ec cell 
gives rise to the variety of differentiated cell types seen in a 
teratocarcinoma This was definitively shown by Kleinsmith and Pierce 
(1964), who transplanted a single ec cell under the skin of histo- 
compatible mice and obtained tumours containing ec cells plus a variety 
of differentiated cell types; these latter were representative of 
tissues derived from the three embryonic germ layers, ectoderm, endoderm 
and mesoderm.
The ability of the ec cell to differentiate into the full range 
of differentiated cell types does vary between different teratocarcinoma 
cell lines. The ec cell component of a teratocarcinoma can be pluri- 
potent; that is, capable of giving rise to a variety of cell types, or 
they can show a more restricted differentiation or even show no 
spontaneous differentiation at all, the latter are termed "nullipotent".
Teratocarcinoma were originally observed and studied as solid 
tumour, a typical teratocarcinoma is illustrated in the review by 
Illmensee and Stevens (1979), and can consist of ec cells plus 
ectodermal tissue (c.g. neural cell), endodermal tissue (e.g. glandular 
epithelium) and mesodermal tissue (e.g. bone and cartilage). It is
a characteristic of such teratocarcinoma that these differentiated cell 
types arc found in small groups distributed throughout the tumour in 
a manner which might at first seem chaotic. However, particular cell 
types can be seen to grow in locally organised arrangements such that 
nerves can be attached to muscle, cartilage is characteristically next 
to bone and bone tissue may contain nucleated erythrocytes within it 
(Graham 1977).
The name teratoma can also be applied to these tumours which has 
led to a slight confusion over terminology ; a teratoma is defined 
(Sherman and Solter 1975) as a benign tumour containing one or more 
differentiated cell types but not containing ec cells, it is not usually, 
transplantable nor can it be passaged in vitro.
Reviews concerning the behaviour, and the use of teratocarcinoma 
as experimental models can be found in, Illmensee and Stevens (1979), 
Martin (1975, 1978), Graham (1977), Hogan (1977) and in Sherman and 
Solter (1975).
Teratocarcinoma are used as experimental models in both tumouri- 
genesis and developmental studies. The ec cells of a teratocarcinoma 
are malignant and can be thought of as normal embryonic cells which 
behave abnormally because they have escaped the usual maternal, or other 
influences, which induce appropriate differentiation. The use of 
teratocarcinoma as a model system for tumourigenesis is reviewed in 
Martin (1975), Strickland (1981), Manes (and others 1976) and Pierce 
(1967). The ec cell, although malignant, resembles certain multipotent 
stem cells of the early embryo, and their behaviour in vitro can provide 
an analogue for some developmental events which occur in embryogenesis. 
The use of tcratocarcinoma have an advantage over the use of the mouse 
(or other mammalian embryo) in the provision of larger amounts of
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material and the ease with which certain differentiation events can 
be both controlled and observed jm vitro.
Factors influencing the formation of spontaneous_or experimentally 
induced teratocarcinoma and teratomas
V
Spontaneous teratocarcinoma are very rare in most strains of
on
mouse and appear to be a species limited phenomer^ unique to inbred 
strains. This suggests that the development of these tumours is under 
genetic control. However the incidence of spontaneous teratocarcinoma 
does not appear to be correlated with the tendency to develop other 
spontaneous tumours, e.g. hepatomas, mammary gland tumours or even 
testicular (non-teratocarcinoma) tumours; in addition although this 
appears to be influenced by the genetic constitution of the animal, 
there is no correlation with particular major histocompatibility 
antigens (Solter et al. 1979).
Some strains of mouse have been observed which have an abnormally
high incidence of spontaneous teratocarcinoma; a sub-line of strain 129
has been bred which have an incidence of up to thirty percent of
testicular teratocarcinoma, and strain LT has a reduced but still high
incidence of ovarian teratocarcinoma (reviewed by Stevens 1979). 
s
The su|:eptibility of mice to experimentally induced teratocarcinoma 
is dependent on strain and in a few cases on the sex of the animal 
host. Solter £t _al. (1979) observed the ratio of malignant terato­
carcinoma to that of benign teratoma formation after transplantation 
of early embryos to ectopic sites, using a wide range of host species. 
These workers found that some mouse strains, e.g. A/J and BalbC/J had 
a high incidence of teratocarcinomn, whilst others, e.g. C57B1/CJ had 
a low incidence of the malignant form. In addition in some strains the
57
incidence of teratocarcinoma was sex controlled, indicating some 
hormonal influence on the development of these tumours, e.g. 129J males 
had a high incidence compared to 129J females. In addition to all this, 
it should be noted that mice in general are more susceptible to 
experimentally induced teratocarcinoma than are other species, e.g. only 
benign teratoma can be experimentally induced in rats and hamsters.
£sli~?E_2Ei2iD5 of_teratocarcinoma and teratoma
Teratocarcinomas and teratomas can either arise spontaneously'in 
the male or female gonads; or be experimentally induced in mice following 
transplantation to an ectopic site; of early embryos (3-9 days old) 
or of genital ridges taken from later embryos (12-16 days old). Analysis 
of the origin of these various tumours has suggested that in vivo 
teratocarcinogenesis has more than one origin. In addition to the 
above, Evans and Kaufman (1981) have demonstrated that undifferentiated, 
but pluripotent cells can be established in vitro directly from the embryo.
Spontaneous testicular teratocarcinoma are thought to arise from 
the primordial germ cells. Stevens (1962) observed the development of 
this form of the tumour in embryos of strain 129J, and found that they 
were clearly detectable within the seminiferous tubules of the 15 day 
embryo; these tubules contain only Sertoli cells and the primordial 
germ cells, and the ec cells of the tumour were thought to more closely 
resemble the primordial germ cells. Stevens has provided further 
evidence for the direct involvement of primordial germ cells (Stevens 
1967), by demonstrating that genital ridges token from mice homozygous 
for the mutation "steel" (/.lack most of their primordial germ cells), 
could not induce teratocarcinomo formation upon transplanation to an
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ectopic site. This' led to the suggestion that the primordial germ cells 
Wete the precursor of teratocarcinoma, and it was proposed that 
teratocarcinoma derived from transplantations of the early embryo 
generated primordial germ cells before producing the tumour.
Female primordial germ cells from genital ridges of similar aged 
embryos (12-16 days old) do not form teratocarcinoma or teratoma after 
similar procedures. One reason for this difference may be that female 
primordial germ cells begin neiosis at approximately day 12-13 , .
whilst the male cells do not begin meiosis until after birth of the 
foetus.
Spontaneous teratocarcinoma of ovarian origin does not arise from . 
the primoridal germ cells; a histological examination of these tumours 
shows numerous embryos at various stages of development (e.g. morulae, 
blastocysts and egg cylinders can be seen) and it is proposed that 
ovarian tumours arise from parthenogenetic activation of oocytes 
(Stevens 1979).
Teratocarcinoma and teratoma can be induced to form by transplant­
ation of early embryos to extra-uterine sites. The incidence of tumour 
formation by this method reaches a maximum at eight days post-gestation 
(reviewed in Graham 1977 and in Illmensee and Stevens 1979). It is not 
yet clear why the incidence of tumour formation from transplantation 
follows this pattern although this may be related to the ability of 
the multipotent cello of the embryo to survive the necessary manipulation 
procedures (Graham 1977). The formation of teratocarcinoma have been 
correlated with the presence of the embryonic ectoderm in the egg 
cylinder stager. (Diwan and Stevens 1976), and thus may be related to 
the presence of multipotent stem cells. The suggestion that embryo 
derived tumours initially generate primordial germ cells is not
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generally supported mainly because of the differences which exist
between teratocarcinoma of primordial germ cell and embryo origin.
The former only have a male karyotype whilst the latter can have either
male or female karyotype, thus the former differ in that they arise from
cells which have not undergone meiosis. In addition many mouse strains 
0
do not produce tumours of primordial germ cell origin, but will form 
tumours from transplantation of early mouse embryo, thus the tumours 
have different survival ability in the same host (Graham 1977).
Further support for a non primordial germ cell origin of 
teratocarcinoma derived from early embryo comes from the work of Mintz 
et_sil_. (1978). These workers showed embryo derived teratocarcinoma 
could be obtained from transplantation of early embryos which were 
homozygous for "steel" (see above),and also from embryos of the W/W 
sterile genotype, neither of which can produce primordiol germ cells.
There are thus considered to be four sources of teratocarcinoma.
(1) Primordial germ cell origin, spontaneously arising in the testis or 
via transplantation of the male genital ridge of 12-16 day post­
gestation embryos, to extra-uterine sites.
(2) Parthenogenctic activation and development of oocytes,which occurs 
spontaneously in the ovary.
(3) Embryonic somatic cell origin, via transplants to extra-uterine 
sites, of embryos of 2-9 days development.
(4) vitro cultivation of early embryos.
Maintenance of teratocarcinoma
Both spontaneous and experimentally induced tumours con be 
maintained by transplantation into an histocompitable host, providing
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that embryonal carcinoma cells are present. Teratocarcinoma are 
passaged in vivo in two ways:
1. 3y subdermal injection of ec cells, this develops into a solid 
tumour of the type described above.
2. By injection of a suspension of ec cells into the peritoneal 
cavity of mice. These cells stimulate the secretion of ascites 
fluid from the peritoneal cells and grow in suspension in this 
fluid forming aggregates of cells which are called embryoid bodies.I
Two types of embryoid body can form, the type and size being 
influenced by both the strain of the tumour and of the host (Stevens 
1979). Simple embryoid bodies consist of an inner core of ec cells 
surrounded by a layer of endoderm like cells (Pierce and Dixon 1959); 
the teratocarcinoma can be passaged indefinitely as simple embryoid 
bodies, and yet the ec cells will still retain their full pluripotentcy 
when placed in a suitable environment. Illmensee and Mintz (1976) 
used ec cells from these forms, which had been in passage for eight 
years, to produce chimaeric mice. A single ec cell was injected amongst 
the inner cell mass cells of a preimplantation mouse blastocyst which 
was then grown to term in a pseudopregnant host mouse; examination of 
the chimttric offspring showed that the ec cell had contributed to a 
wide range of tissues, even to the germ line. The second type of 
embryoid body which can form i3 termed a cystic embryoid body, this 
comprises ec cells, a fluid filled cyst and a variety of differentiated 
cell types, and more closely resembles the solid tumour form.
Teratocarcinoma can also be maintained in tissue culture, but 
generally only after several passages have been undertaken 
in vivo. This adaption to tissue culture can be done by ijn vitro
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cultivation of embryoid bodies using adherent dishes; or via "nursing" 
ec cells from solid tumours on a layer of non-dividing fibroblast 
cells. The fact that in vitro cultures cannot usually be established 
directly from in vivo tumours and also the fact that cell lines can 
only be established from ec cells and not from differentiated cells; 
suggests that the process of establishing a teratocarcinoma cell line 
is selective; first for cells which can withstand iji vivo passage and 
second for cells which do not differentiate readily in culture 
(Graham 1977).
Teratocarcinoma cells can be maintained in vitro as simple embryoi'd 
bodies, by culturing a suspension of ec cells on non adherent dishes, 
or maintained as monolayer culture on normal tissue culture plates. 
Pluripotent teratocarcinoma cell lines which differentiate spontaneously,
appropriate culture techniques, usually involving frequent subculture 
(Burke £t al. 1978). Teratocarcinoma cell lines which undergo little 
or no spontaneous differentiation (called nullipotent cells) are thus 
more easily maintained, and have the advantage in that they can be 
cloned to genetic homogeneity (Berstine £t al. 1973, Evans and Martin 
1975, Adamson £t jal. 1977, Lehman at al_. 1975 and Nicolas et al. 1976).
Ec cells from cloned tissue culture cell lines which have been 
maintained as a homogenous ec culture, hove also been shown to retain 
full pluripotentcy. McBurney (1976) and Martin and Evans (1975) have 
both demonstrated that single ec cells from such cultures, ccn produce 
a well differentiated tumour upon sub-dermal injection into a hinto- 
compatible host. In addition Papiaoannou et al. (1975) have shown that 
ec cello from such lines retain full genetic totipotency , by being able 
to contribute to a wide variety of tissues in a chimaeric mouse, created 
by the technique described above (Illmenoee and llintz 1976).
can be maintained as relatively cultures of ec cells by
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Comparison of the_properties of embryonic stem cells and of ec cells
The process of differentiation occurring in teratocarcinoma, in 
which varied differentiated cell types are generated from a single 
stem cell, has been proposed as a model system to study embryogenic 
differentiation. Ec cells do have many features in common with 
embryogenic multipotent cells (i.e. primitive embryonic ectoderm of 
pre, and post-implantation embryo). These include:
(1) Ultrastructure: in common with primordial germ cells, ec and 
embryonic stem cells, have little condensed chromatin apart from 
nucleoli, the cytoplasm is rich in ribosomes, but lacks prominent golgi . 
or rough endoplasmic reticulum (Pierce and Beale 1964, Damjanov and 
Solter 1975).
(2) X chromosome inactivation: female mouse embryos show condensation 
of sex chromatin beginning at approximately six days development, similar 
X chromatin is seen in some but not all ec cell lines which are XX 
(McBurney and Adamson 1976).It has been proposed that this suggests 
that different ec cell lines represent different embryological devel­
opment stages (McBurney and Strutt 1980).
(3) Cell surface antigens: many workers have raised antibodies to the 
cell surface of ec cello and demonstrated that these are present at 
specific stages of mouse embryogenesis (reviewed by Kemler £t al. 1979, 
and see later). Antibodies have been produced from different ec cell 
lines which react to different stages of embryogenesis, which supports 
the view that different ec cell lines represent different embryological 
development stages.
(4) Biochemical markers: ec and embryonic stem cells can be identified 
by the presence and behaviour upon differentiation, of many biochemical
\
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markers; such as the production of enzymes, and secretory and matrix 
proteins; all of which can be used to qualitate and quantify the process 
of differentiation (see later).
The homology in structure and behaviour between the stem cell 
population of the mouse embryo and of teratocarcinoma, should not 
mask their obvious differences. Ec and embryonic stem cells are not 
the same, ec cells are malignant and kill their host, embryo cells do 
not (Graham 1977); the two stem cell populations are also temporally 
disparate, in that ec cells are obtained from tumours which can have 
been in passage for up to ten years whilst embryonic stem cells result 
from events five to seven days old, and occurring in very different 
culture conditions. Thus although homologies exist between the two 
cell populations sufficient for ec cells to provide an _in vitro model 
for some stages of development, differences between these cell types 
must also be expected.
Differentiation of teratocsrcinoma cells
\
Cultured ec cells, which are induced to differentiate, can
provide a system to study gene expression under defined conditions,
away from maternal end other influences. All teratocarcinoma cell lines
so far studied have been shown to differentiate in culture (this
includes those teratocarcinoma lines previously classed as nullipotent),
the range and extent of differentiation may however vary with the
strain of the tumour and with culture conditons. The full extent of
teratocarcinoma differentiation is at present only seen when ec cello
interact with normal embryo cells. Such experiments have shown that ec
cells can become the stem cells of the embryo. The ec cells and their
I
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differentiated progeny participate fully in developmental interactions 
with normal embryo cells demonstrating that ec cells possess full 
genetic totipotency (Illmensee and Hintz 1976, Papiaoannou et al. 1975, 
197B).
Methods have been developed to synchronise differentiation of 
teratocarcinoma lines in culture. These methods vary with different 
cell lines. Pluripotent cell lines which will undergo spontaneous 
differentiation can be synchronised by being plated as a monolayer 
culture at low density (Burke £t £l_. 1978, Adamson et^  £l. 1979), other 
lines can be caused to differentiate via aggregation of the cells either 
by culture at high denisty or by allowing the formation of embryoid 
bodies by culture in non adherent di3he3 (Martin 1975, Hyafil et al. 
1980). Cells previously thought to be nullipotent in vivo and in vitro 
have now been shown to undergo limited differentiation by culture in 
physiological amounts of retinoic acid (Strickland and Mahdavi 1978).
"Gyi2iE2^5Di"_t£I§tocarcinoma_cell lines: differentiation_in retinoic 
acid
The cell lines used in thi3 study are those which were previously 
thought to be nullipotent, i.e. to undergo no differentiation. These 
have now been shown to undergo limited differentiation when treated 
with retinoic acid, to an endoderm like cell.
Retinoic acid is the acid of Retinol, known as vitamin A, the 
structures of these two molecules is shown below (Pawson 1981):
Retinoic acid
C00H (replaced by CH20H 
in vitamin A)
6 5
Most, but not all of the acid analogues of vitamin A have biological 
activity (Jetten and Jetten 1979), and the biological activity of the 
molecule appears to reside within the carboxyl group, since modification 
of the cyclohexenyl ring does not affect activity (Strickland and 
Sawey 1900).
The mechanism of action of retinoic acid in inducing differentiatin 
in ec cells is not yet clear. It has long been known, from observation 
of vitamin A deficiency diseases, that this vitamin has many important 
biological roles. These affect visual processes and the normal growth 
and differentiation of many, but particularly epithelial tissues 
(reviewed in Pawson 1981). In addition to its effect on nullipotent 
teratocarcinoma cell lines, retinoic acid will accelerate the 
differentiation of pluripotent lines (Jetten and Jetten 1979), and has 
also been shown to alter the growth and morphology of "normal" mouse 
fibroblast cell lines (Jetten et ¿1. 1979).
It has also been suggested that retinoic acid exerts its effects 
in a manner analogous to that of the steroid hormones. Jetten and 
Jetten (1979) and Schindler £t_ _al_. (1981) have both identified a 
retinoic acid binding protein (RDP) in the cytosol of cells which are 
sensitive to the effects of retinoic acid. This RBP interacts with 
retinoic acid in the cytosol, and after this retinoic acid can be found 
in the nucleus of the cell; it is therefore suggested by the above 
authors that retinoic acid may act to directly modify gene transcription.
There have been some reports of cells which are insensitive to the 
effects of retinoic acid, and which have also been shown to lock RBP 
activity. Schindler e_t _nl_. (1981) have isolated ec cells from mutagenised 
stocks which are resistant to the differentiative effects of retinoic 
acid and which lock RBP. Jetten e_t o K  (1979) have shown that 5V40 
virus transformed fibroblasts are insensitive to retinoic acid and
\
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possess the RBP in the absence of the transforming virus.
There is some evidence that retinoic acid as well as influencing 
transcription events, can also have direct effects upon the cells 
biochemistry and behaviour. J. D.. Pitts (personal communication) has 
shown that Retinoic acid at high concentrations can rapidly block 
junctional communications between cells, and Jetten et al. (1981) have 
shown that similar levels of retinoic acid can increase the fluidity of 
cell membranes irrespective of the biological activity of the molecule. 
Retinoic acid is also known to be directly involved in glycosylation 
events within the cell probably forming an intermediate retinyl- 
phosphate carrier molecule (Prehm 1980, Shidaji et al 1981)
Thus retinoic acid may act to influence cell differentiation by 
affecting both transcription, biochemical and cell interaction events. 
However, since many pluripotent stem cells are able to differentiate 
spontaneously simply by manipulation of culture conditions, it is 
difficult at present, to place retinoic acid a3 a general differentiative 
agent; although it is possible that cell lines which spontaneously 
differentiate have enhanced sensitivity to trace amounts of retinoic 
acid which are present in normal growth media.
The production of endoderm-like cells from ec cells
Endoderm-like cells are commonly the first cell type to appear 
as teratocarcinoma cello differentiate. However they ore not always 
observed in the differentiated cell types from all pluripotent strains 
of teratocarcinoma, and therefore may not be a necessary preliminary 
to further differentiation (Graham 1977). In some differentiating 
systems, e.g. simple eb bodies cultured in vivo or in vitro, and in
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"nullipotent" ec cells exposed to retinoic acid, endoderm-like 
cells are the only differentiated cell type to appear. These 
differentiating systems will produce endoderm-like cells which 
can have characteristics of either of the types of extra embryonic 
endoderm (ex.emb.endo) produced during mouse embryogenesis (i.e. 
primitive, parietal and visceral). Pluripotent cell lines can 
produce more than one form of1 endoderm upon differentiation as 
well as mesoderm and ectoderm tissue.
The differentiation of teratocarcinoma ec cells into endoderm- 
like cells is thought to represent the similar transition of multi- 
potent em^onic stem cells (the primitive ectoderm of the pre, and 
post implantation embryo) to endoderm which occurs in early embryo- 
genesis.
The transition of ec to endoderm-like cell (and also of 
embryonic ectoderm to endoderm), is marked by characteristic gains 
and losses in the production of specific products, e.g. matrix and 
other secretory proteins, enzymes and cell surface antigens and 
receptors. In vitro culture conditions have been shown not to inhibit 
the production of biochemical products characteristic of endoderm 
(Graham 1977). Some of these products can be used to distinguish 
between the viseral and parietal forms of ex.emb.endo, others are 
found to be equally present in both forms of endoderm.
Biochemical products characteristic of endoderm and which are 
also seen in the endoderm-like colls produced in differentiating 
teratocarcinoma cultures are listed below.
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MOLECULE (Mwt) PARIETAL
ENDODERM
VISCERAL
ENDODERM
Secretory and 
other proteins
Interferon (23-35K)
Plasminogen Activator (79K) 
Alphafetoprotein (70K)
Alkaline Phosphatase (80K units)
?
+
+
?
+
+
+
extracellular 
matrix proteins
Fibronectin (265K) 
Glycoprotein (350K) 
(250K)
Laminin (150-450K) 
Collagen Type IV
+
+
+
+
(160K)
+
ND
type I (95K)
Cell surface 
antigens and 
receptors
EGF receptors (185K) 
Cell surface antigens
ND
+
+
+
Secretory_and other proteins
INTERFERON: The interferon system (which has been described above) 
has been shown to be inhibited in the ec cell of pluripotent cell lines, 
and then to become active as these cells differentiate by culture at 
low density (Burke et ol. 1978). The production of induced gene 
products is necessary for the operation of the interferon system and 
the transcription of these genes is inhibited in the ec cell. It is 
not clear if this inhibition is specific to the interferon system or, 
if it is true of all inducible genes or, merely representative of the 
region of the chromosomes which contains the interferon genes. The 
interferon system, because it is an inducible gene system, provides 
a model to examine control of gene expression; the elucidation of the 
block on interferon production and sensitivity in ec cells will provide 
an insight into the mechanisms which regulate gene expression in 
multipotent stem cells. This study examines the appearance and 
kinetics of the interferon system in "nullipotent" ec cello caused to 
differentiate to endôderm-like cells by culture in retinoic acid, witti
69
the aim of examining its role as a marker of differentiation in this 
system.
PLASMINOGEN ACTIVATOR: This molecule is thought to have a biological 
role in tissue remodelling and cell migration during embryogenesis.
An increase in plasminogen activator synthesis can be detected as ec 
cells differentiate to endoderm-like cells (Linney and Levinson 1977), 
and also during endoderm formation during embryogenesis (Strickland 
Hi* 1976). It has been found to have equal activity in both the 
visceral and parietal endoderm of the foetus (Bode and Dziadek 1979). 
The increase in plasminogen activator activity seen during endoderm 
formation can be greatly enhanced by treatment of the cells with cAIIP 
(Strickland and Mahdavi 197B), unlike the retinoic acid elevated 
plasminogen activator activity seen in normal chick fibroblast cells 
(Wilson and Reich 1978).
ALPHAFETOPROTEIN: This is an alpha globulin synthesised by the foetus 
(and also by the adult, but only under certain pathological conditions 
and in some tissue culture cells (Graham 1977)) The biological role 
is unclear, it ha3 a high sffinity for oestrogen and may function as 
a specific or general carrier protein. Its synthesis is restricted 
in the early embryo to the visceral endoderm, but in the later embryo 
synthesis is seen in the foetal liver (Dziadek and Adamson 1978). 
Alphafetoprotein synthesis can thus provide a marker which can 
distinguish between visceral and parietal endoderm, but because it can 
be found in other differentiated tissues, it cannot be used as a 
marker indicative of visceral endoderm itself.
ALKALINE PHOSPI'ATASE: This enzyme is present in high levels in both 
ec and in embryo stem cells (Damjonov and Solter 1975), differentiation
V
t
70
of both these stem cells results in a fall in enzyme activity 
(Bernstine et^  o D  1973). Ec cells contain many isoenzyme variants 
of alkaline phosphotase including one unique to ec cells (Wada et al. 
1976).
Extra_cellular_matrix proteins
GLYCOPROTEINS: Parietal endoderm synthesises and secretes two glyco­
proteins of Mwt 350 and 250Kd (Hogan 1980). Both are secreted by a 
differentiated parietal endoderm cell line (PYS) and by the parietal 
endoderm of the mid-term mouse embryo. Only trace amounts of one of 
these glycoproteins (350Kd) is secreted by a differentiated visceral 
endoderm cell line (PSA 5E), and neither can be detected in visceral 
endoderm of the mid-term embryo. In addition, they are not synthesised 
in the endoderm-like cells produced by treatment of the teratocarcinoma 
cell line PCD clone 5 with Retinoic acid which is considered to 
produce ceils characteristic of visceral endoderm (Hogan 1980).
LAMININ: This protein has been shown to be secreted by the treatment 
of the teratocarcinoma cell line F9 with retinoic acid, which is 
considered to produce cells characteristic of parietal endoderm 
(Cooper et td. 1981).
COLLAGEN: Adamson et al. (1979) has shown that in differentiating ec 
cells which produce cells characteristic of visceral endoderm (e.g.
P C D  clone 5) that collagen synthesis undergoes a shift from pre­
dominantly type IV to predominantly type I; this does not happen in 
cultures of ec cell3 which produce cells characteristic of parietal 
endoderm (e.g. F9) Adamson and Ayers (1979) have shown this phenomenon
71
also occurs in post implantation mouse embryo; parietal endoderm 
produces predominantly type IV, and visceral endoderm produces pre­
dominantly type I collagen.
FIBRONECTIN: Fibronectin is thought to have a biological role in 
morphogenesis and is found in extracellular matrix material of both 
the foetus and the adult. Ec cells have little intra or extra cellular 
fibronectin whereas endoderm-like cells of a pluripotent teratocarcinoma 
cell line are found to have increased surface fibronectin (Wartiovaara 
et al. 1978a,b).
CELL SURFACE ANTIGENS AND RECEPTORS
Recent advances in techniques have allowed the development of 
monoclonal antibodies which can identify antigens present on the surface 
of both ec cells and embryonic cells. Solter and Knowles (1978) describe 
such an antibody, raised to the F9 ec cell which can identify surface 
antigens on the eight cell stage embryo. This antigen is transiently 
expressed by trophectoderm cells and is finally confined to cells of 
the inner cell mass of the embryo. This antigen, termed SSEA-1 is present 
on both human and mouse embryonic cells, and is shown to dissapear from 
the cell surface as F9 ec cells are caused to differentiate into endoderm 
like cells.The SSEA-1 antigen is one of the few antigens shown to undergo 
stage-specific expression which have also been identified. Gooi et al 
(1981) have identified the antigenic determinant recognised by the 
monoclonal antibody raised to the SSEA-1 antigen, as being formed by 
the fucosylation of the blood group antigen la.
Ree3 et al (1979) have demonstrated an increase in the number of
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EGF (epidermal growth factor) receptors during the differentiation of 
the cell line PC13 clone 5 (which produces cells characteristic of 
visceral endoderm), the differentiated cells are also able to respond 
to the mitogenic action of EGF. Retinoic acid can also enhance the 
number of EGF receptors on cells not undergoing differentiation, e.g. 
fibroblast and epithelial cells treated with retinoic acid show an 
increased number of EGF receptors (Jetten 1980).
The variety of changes associated with the differentiation of 
both ec and embryonic stem cells into endoderm includes many which 
appear to mark the differentiation of cells in general, and although 
some can be used to distinguish between different forms of endoderm 
(e.g. glycoprotein synthesis and alphafetoprotein production) none are 
unique to endoderm itself. Interferon production and sensitivity is 
thought to be a characteristic of all differentiated cell types (see 
above) and thus, activation of the interferon system will not be 
expected to be specific to one form of endoderm or to endoderm itself 
(although it may show varied kinetics of activiation in different cell 
types). The activation of the interferon system might be found to 
coincide with endoderm production but only because this is one of the 
earliest differentiated cell types to form in both embryogenesis and 
teratocarcinoma cell differentiation.
\
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AIMS or THIS STUDY
The aims of this study are twofold:
1. The examination of the appearance and kinetics of the interferon 
system in "nullipotent" embryonal carcinoma cells undergoing the 
transition from multipotent stem cell to a differentiated cell 
type; with the aim of evaluating the use of the interferon system 
as a marker for the differentiation of endoderm in both terato- 
carcinoma cells and mouse embryos.
2. The examination of the ontogeny of the interferon system in the 
developing mouse embryo with the aims of relating the onset of 
interferon production to the appearance of differentiated cell 
types in the embryo; and also of determining the relative 
importance of the interferon system compared to the other foetal 
anti-viral defences.
The results and discussion resulting from the above investigations 
are in fact divided into three sections. This is because much of the 
work relied upon a single cell assay technique for measuring interferon 
production from single or small groups of cells; it is therefore necessary 
to describe and characterise the features of this assay.
Thus the next three sections will contain results and discussions
from:
1. The characterisation of a single cell assay for the production of 
interferon.
2. The interferon system in differentiating teratocarcinomn cells.
3. The interferon system in the developing mouse embryo.

MOUSE EMBRYOS
These were obtained from the progeny of a mating between strain 129J 
females and strain F^C57B1/CBA males, maintained in a breeding colony 
in the animal house at the Department of Zoology, Oxford University, 
by B. Randle of that department.
MOUSE_CELL_LINES
L929 —  A clone derived from Strain L, established from the connective 
tissue of C3H/An mouse, and maintained in this laboratory in 
continious culture for approximately fourteen years. The 
original clone is available from the American Type Culture 
Collection through Gibco Bio-cult Ltd, Paisley, Scotland.
The cell line maintained in this laboratory was cultured in 
medium different to that recommended by the ATCC and is there­
fore considered a derivative or subline of L929, the karyotype 
has not recently been observed.
C3H/10T% —  A continious line of mouse embryo fibroblasts, which are 
aneuploid and capable of indefinite growth _in vitro, but are 
maintained in culture for a limited number of passages 
only because their growth properties and ability to support 
virus growth is known to change with increasing time in culture. 
This cell line was originaly described by Reznikoff CA, Brandow 
DW and Heidelberger C,t-Cancer Research 21 , pp 3231-3230. 1973. 
PSA 5E —  A differentiated teratocarcinoma cell line which has visceral 
endoderm-like characteristics, derived from a pluripotent terat­
ocarcinoma cell line PSA 5 (Adamson et al 1977).
PYS —  A parietal yolk sac carcinoma cell line isolated from a terat­
ocarcinoma which has parietal endoderm-like characteristics 
(Lehman et al 1974).
7 5  ( c o n t )
F9 Cl 9 —  A differentiated teratocarcinoma cell line which has parietal 
endoderm-like characteristics, cloned from a culture of F9 
embryonal carcinoma cells which had been caused to differen­
tiate in vitro. (Solter et ¿1 1979b)
PC13 Cl 5 —  A "nullipotent" teratocarcinoma cell line, passaged as 
embryonal carcinoma cells which do not undergo spontaneous 
differentiation in vitro but will differentiate into a variety 
of cell types in vivo (Bernstine et jal 1973 and Hooper and 
Slack 1977), and into a visceral endoderm-like cell after 
treatment with retinoic acid (Rees ^1 1979). PC13 was 
originally established from outgrowths of cultured embryoid 
bodies from the tumour 0TT6050B (the latter established 
by Dr. L. Stevens) by Bernstine et^  (1973). PC13 Cl 5 
-c was isolated from PC13 by Dr. S. Gaunt (Zoology Dept, Oxford 
University). This clone was recieved at passage five and was 
not used beyond a total of twenty passages.
F9 —  A "nullipotent" teratocarcinoma cell line, passaged as embryonal 
carcinoma cells which undergo little or no spontaneous diff­
erentiation in vitro. F9 was originally established from 
outgrowths of embryoid bodies of the tumour OTT6050970 
(the latter established by Dr. L. Stevens ) which were cult­
ured on an agar substratum.by Bernstine £t al^  (1973). F9 
was able to produce well differentiated tumours in vivo at 
the time of isolation but the range of tissues generated 
was reduced with increasing passage (Bernstine et al 1973), 
and the pluripotency of this cell line in vivo has not 
recently been demonstrated. Monolayers of F9embryonal carc­
inoma cells treated with retinoic acid will differentiate into 
o parietal endoderm-like cell (Strickland £t. ¿1 1978), and it 
has been recently shown by Hogan et-al (1981) that aggregates 
of F9 ec cells similarly treated will differentiate into
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cells resembling visceral endoderm.
NULLI 2A —  A "nullipotent" teratocarcinoma cell line, passaged as 
embryonal carcinoma cells which undergo little or no spon­
taneous differentiation in vitro, but which will differentiate 
into an endoderm like cell when treated with retinoic acid.
Nulli 2A was established from a spontaneous teratocarcinoma 
(LS 402C 1684 established by Dr. L. Stevens). Various cloned 
embryonal cell cultures were established from this line, as 
described in Martin and Evans (1975), including Nulli 2A. This 
cell line was obtained from Dr. P. Stern (Zoology Dept, Oxford 
University),and has not been recently recloned.
All teratocarcinoma cell lines (except Nulli 2A) were gifts from Dr.
C.F. Graham of the Zoology Department, Oxford University.
The establishment of the original teratocarcinomas from which the above 
cell lines were obtained is described in Stevens (1970). All "nullipotent" 
teratocarcinoma cell lines were not used beyond twenty passages, the 
karyotype of these cells is thought to be normal for this period.
However Papiaoannou et al (1979) have shown that the G-banding pattern 
is abnormal in some embryonal carcinoma cell lines which have a normal 
karyotype, this suggests that these cell lines are in some manner 
"abnormal".
\
STORAGE OF CELLS
A large stock of all cell types was prepared at the begining of 
this study. Confluent cell monolayers were trypsinised to a sus­
pension of single cells, washed once with maintenance media and 
resuspended at a concentration of 1 x 10^/ml in media containing 
50% foetal calf serum plus 10% dimethylsulphoxide (DMSO). One ml 
aliquots were placed in plastic screw capped vials and placed at 
-70°C for five hours contained inside a 2cm thick polystyrene 
box. The cells were then transferred to liquid nitrogen for perm- 
are nt storage.
Cells retrieved from liquid nitrogen were thawed rapidly in a 37°C 
water bath and then spun at 1 000 rpm for five minutes to pellet 
the cells. The supernatant was removed and the cells gently resus­
pended in five ml of growth media and placed in a suitable culture 
flask. All cells were passaged at least twice after removal from 
liquid nitrogen before being used because it was noticed that 
the growth of the embryonal cells differed during the period when 
the culture established itself from frozen storage.
DMSO was obtained from BDH chemicals, Atherstone, Warwickshire.
MYCOPLASMA TESTING
All cell lines used in this study were examined for the presence of 
mycoplasma using the technique described by Russell et al 1975), 
which visualises these organisms through the use of a stain which 
identifies the presence of mycoplasma DNA in the cytoplasm of 
infected cello. Cells were seeded sparsley onto glass coverslips 
and 3tained with A'-6-Diamidino-2-phenylindole (DAPI) and examined 
under ultra violet illumination using the Reichert Zetopan flour- 
escence microscope.
DAPI wa3 obtained from Flourochem Ltd, Glossop, Derbyshire.
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CELLMEDIA
nb: 'growth media ' were supplemented with 10?i serum and 'maintenance- 
media ' with 2?» serum.
L929 and C3H cells were grown in the Glasgow modification of Eagles'
medium containing 10?i new born calf serum, and supplemented with
glutamine (200mM) and antibiotics (benzylpenicillin 50 units per ml
and streptomycin 50 ng per ml). L929 cells were grown routinely in
2one litre glass culture bottles and C3H cells were grown in 250cm 
plastic culture bottles.
All teratocarcinoma cells were grown in alpha modification of Eagles' 
medium containing 10* foetal calf serum, and supplemented with glutamine 
(200mM) and antibiotics as described above, plus additional nucleosides 
(adenosine 30yM, cytidine 30yM, guanosine 30jjM, thymidine 10uM and 
uridine 3Q»jM) as described in Rees et al (1979). The differentiated 
teratocarcinoma lines were cultured in plastic dishes and the undiff­
erentiated embryonal carcinoma lines were cultured on gelatinised 
plastic dishes. Gelatinised dishes were prepared by coating plastic 
culture dishes with 0.5% solution (w/v) of gelatin for two hours at 
4°C. The gelatin was then removed and the dishes inverted and left to 
dry inside a laminar flow tissue culture hood. The plates were then 
taped together and could be stored indefinitely in a sealed container. 
Alpha MEM, GMEM, glutamine, foetal calf and new born serum were all 
obtained from Flow Laboratories Ltd, Irvine, Ayrshire.
Penicillin and streptomy'cim were obtained from Glaxo Laboratories 
Ltd, Greenford, Middlesex.
Gelatin and nucleosides were obtained from Sigma Chemicals Ltd,
Poole, Dorset.
Plastic culture dishes were obtained from Gibco-Biocult Ltd, Paisley, 
Scotland, and one litre glass culture bottles from Gibco, Europe.
\
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Cell number was determined using the 'improved Neubauer' counting 
chamber,with cells suitably diluted with maintainance media and 
mixed with an equal volume of PBS containing \% trypan blue. Only 
cells excluding this dye were considered viable and counted (how­
ever non-trypan blue excluding cells were not often seen).
Trypan blue was obtained from BDH chemicals, Atherstone, Warwickshire.
?ASSAGE_OF_CELL_LINES
All cell lines were passaged using a trypsin/versene mixture. L929,
C3H and the differentiated teratocarcinoma cell lines were passaged 
using trypsin at a concentration of 80.Qug per ml for 3 - 4 minutes at
37°C'for 3 - 4  minutes. All embryonal carcinoma cell lines were passaged
/
using Trypsin at a concentration of 8.0pg per ml for 30 - 60 seconds at 
37 C. Cell monolayers were washed with PBS then incubated with suff­
icient trypsin/versene to cover the cell sheet for two to three 
minutes at 37°C. The trypsin/versene mixture was neutralised with 
two volumes of growth media and the cell monolayer disrupted to a 
suspension of single cells by vigorous pipetting All cell lines 
were passed when confluent and reseeded to reach confluency in 
approximately seven to ten days.
A stock solution of fifty times concentrated trypsin/versene was 
prepared (ethylenediaminetetra acetate - 4mgs/ml, NaCl - 7.6mgs 
/ml, KC1 - 0.224mgs/ml, glucose - 0.18mgs/ml, Na^HPO^ - o.l42mgs 
/ml, trypsin - 4mgs/ml, adjusted to pH 7.2 with 1M NaOH) and
diluted to a one times solution prior to use.
\  «
All chemicals were obtained from Sigma Chemicals Ltd, Poole, Dorset.
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DIFFERENJIATION_OF_EMBRYONAL CARCINOMA CELLS
Embryonal carcinoma cells from PC13 Cl 5, F9 and Nulli 2A cell 
lines were seeded at a density of 3 000 cells per cm^ onto three 
cm gelatinised plastic culture dishes, into growth media contain­
ing 3 x 10 6II retinoic acid. The cells were cultured over a period 
of twenty days and the media changed every two days; retinoic acid 
containing media was removed and the cell sheet washed with PBS 
prior to interferon induction.
Retinoic acid (all trans) was dissolved in DMS0 at a concentration 
of Amgs per ml and 25jj1 of this stock solution added per lOOmls of 
growth media. Retinoic acid was obtained from Sigma Chemicals Ltd, 
Poole, Dorset.
£§§^S_r0R_INIERFER0N
A) INAS ASSAY --  Inhibition of viral Nucleic Acid Synthesis
(Atkins et el 1974). L929 cells were routinely used to assay 
all mouse interferon samples, 2 x 10^ colls were seeded into 
2" x V  flat bottomed glass vials in one ml of growth media 
and left for twenty four hours. The media was then removed and 
replaced with maintenance ' media containing different amounts 
of interferon. After approximately twenty hours the interferon- 
containing medium was removed and replaced with 0.2ml of main­
tenance media containing 3pg per ml octinomyocin-D and Semliki 
Forest virus (1/15 dilution of stock virus). After 2.5 hours 
incubation at 37°C an additional 0.2ml of media containing 
actinomycin-D plus 2uCi/ml ^H-uridine, were added to each 
vial. After five hours of virus growth the media was removed 
from each vial and the cell sheets washed twice with ice-cold
trichloroacetic acid (TCA) and once with ethanol. The cell- 
sheets were then dried and solubilised in 0.2ml3 of Soluene
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(dissolved 1:2 in toluene). A further 2.0 mis of acidified 
scintillant was added to each vial and each sample counted 
in an LKB Rackbeta liquid scintillation counter. The titre 
of each sample of interferon is the reciprocal of the dilution 
found to inhibit the synthesis of viral nucleic acid by 50?o.
This 50”o level is obtained from the difference between virus 
and cell control vials which are always included with each 
assay. These vial3 are not exposed’to interferon and are 
either infected with virus or not infected. One unit of inter­
feron in the L929 INAS assay is equivalant to one international 
reference unit of interferon (see introduction).
Preparation of interferon containing samples: A dilution 
series was prepared from each interferon containing sample to 
be placed in the INAS assay. Interferon titres were seldom 
expected to exceed 10^ units/ml, therefore a dilution series 
extending from 0.5 to 4.5 logs^g was used routinely. Ten 
vials were used for each sample, each dilution being placed on 
duplicate vials.
Preparation of Semliki Forest virus: Primary stocks were prep­
ared from iri vivo infections of brains of suckling mice (as 
described in Walters jal_ 1967). These primary stocks were 
used to prepare secondary stocks from infection of either baby 
hamster kidney or chick embryo fibroblast cells (as described 
in Kennedy end Burke 1972). The secondary stock was diluted 1/15 
for use in the assay and was not used to grow further stocks 
of virus. The titre of the secondary stock on BHK cells was 
10 plaque forming units (pfu) per ml.
Glass assay vials were obtained from Regina Industries Ltd, 
Stoke-on-Trent. ^
■^H-uridine (activity )25 - 30 ¿iCi per ml) was obtained from
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Radiochemical Centre, Amersham, Buckinghamshire.
TCA was obtained from BDH Chemicals, Atherstone, Warwickshire. 
Soluene was obtained from the Packard Instrument Co, Caversham, 
Berkshire.
Acidified scintillant was prepared from 5gin 2,5, diphenyloxazole 
and one ml acetic acid per litre of toluene. (Chemicals obtained 
from Fisons Ltd, Loughborough, Leicestershire.
B) DETECTION OF INTERFERON PRODUCTION FROM SINGLE CELLS: this assay 
is a modification of that described by Kronenberg (1977) and is 
illustrated in figure 3.
The indicator monolayer is prepared by seeding 1 xJ10b L929 cells 
onto a gelatinised five cm plastic culture dish for twenty-four 
hours. The cells under test are induced to produce interferon 
whilst still in a monolayer. The test cells were infected with 
100 HAU of NDV-F for one hour at 37°C, washed three times with 
PBS and then incubated for a further hour with media containing 
antiserum raised to NDV-F. The test cells were then trypsinised 
to a suspension of single cells; the number of trypan-blue exc­
luding cells counted and the cell suspension diluted to contain 
100 cells per 0.2mls (this concentration varied with different 
experiments). The media was removed from the indicator monolayers 
and o.2mls of the cell suspension added per dish. Immediately 
1.5mls of agar-media (warmed to 37°C) was added and the di3h 
agitated to disperse the single cells evenly. The agar was 
allowed to gel at room temperature before the assay plates were 
returned to 37°C. After 16 - 20hr3 •> culture the agar and single
cells were removed from the indicator monolayers by tapping the
\ o
dishes sharply whilst held at an angle of 45 . The monolayers
FIGURE 3. A modified assay to detect interferon production 
from single cells.
Test cells are infected 
with virus for one hour
Test cells are washed then 
incubated with antiserum 
to the inducing virus for 
a further hour, and tryps- 
inised to a suspension of 
single cells.
A known number of single 
cells are suspended in agar 
above an indicator monolayer 
of similar cells.
Interferon produced by the 
single cells diffuses across 
to the indicator monolayer.
The agar and single cells 
ore removed and the mono- 
layer infected with a 
cytopathic virus.
Staining of the monolayer 
reveals foci of interferon 
protected cells amongst a 
background of dead cells.
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were then washed with PBS to remove particles of agar and then 
infected with 4 pfu Encephalomyocarditis (EMC) virus per cell. 
After one hour excess virus was removed and the cells refed with 
5m 1 of maintenance media then incubated at 37°C for 12 hours.
The media was then removed from all dishes and the cell sheet 
fixed by the addition of methanol for one minute and then stained 
with 0.1S crystal violet for fifteen minutes.
Staining reveals foci of interferon protected cells,of various 
sizes,in the indicator monolayer amongst a backgroud of dead cells 
each foci representing the area underneath an interferon producing 
single cell. Each single cell assay contained a control plate 
which differed only in that it did not contain induced single 
cells. This plate will therefore indicate the presence of any 
spontaneously occurring foci produced by the indicator monolayer 
cells; all such control plates were negative throughout use of 
this assay.
Photographs of the stained assay plates were taken using a yellow 
filter (Asahi Pentax Y2) on Tri-X Pan 35mm film, with the plates 
illuminated by a fluorescent light box.
952yib_2C_yi5u§ES
A) NEWCASTLE DISEASE VIRUS, STRAIN F (NDV-F), was grown in 11 
day embryonated chicken eggs. 0.1ml of a 10"5 dilution of a stock 
solution (previously titred at 10^ haemagglutinin units (HAU) 
per ml) was injected into the allantoic cavity of each egg.
The egg3 were incubated at 37°C for 60 hours then at 4°C for 
24 hours, the shell tops were then removed and the allantoic
fluids harvested. The virus containing fluids were then spun at
\
3 000 rpm for 30 minutes to remove the heavier allantoic proteins, 
and then dispensed into 0.25ml aliquots and snap frozen. The
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virus was stored at -70^C and was not refrozen once thawed. The 
concentration of virus determined by haemagglutinin assay (as 
described by Borland and Mahy 1968) was 10^ HAD‘per ml.
B) ENCEPHALOMYOCARDITIS VIRUS was grown in L929 cells. The media 
was removed from one litre culture bottles containing conflu­
ent monolayers of L929 cells and replaced with 2ml of low 
passage virus stock. After one hour at 37°C the surplus virus 
was removed and the cells refed with twenty ml of maintainance 
media. At twenty hours post-infection (when cell lysis was 
evident) the supernatant is harvested and spun at 5 000 rpm 
for five minutes to remove cell debri3. The virus was dispensed 
into 0.25 aliquots, snap frozen and stored at -70°C, and was 
not refrozen once thawed. The concentration of virus determined 
using a standard plaque assay technique (on L929 cells) was
g
2 x 10 pfu per ml. ,
PREPARATION OF ANTISERUM TO NDV-F: A 100ml sample of NDV-F, prepared 
as above, was purified as described by Avery and Niven (1979). 
Briefly, the virus was pelleted from the allantoic fluid by centr­
ifugation at 21 000 rpm for three hours and then resuspended in a 
minimal amount of buffer. The concentrated virus was then banded 
on a sucrose density gradient and finally pelleted through a sucrose 
velocity gradient, before being resuspended in a small volume of 
tris/EDTA/NaCl buffer. The protein content of the purified virus 
sample was estimated using the technique described by Lowry et al 
(1951), and the sample diluted to 1.5mg protein per ml. The immun­
isation programme consisted of an initial injection compooed of 
an emulsion of one ml virus plus one ml Freunds Complete adjuvant. 
This was followed at two weekly intervals by injections composed
of an emulsion between one ml virus plus one ml Freunds Incomplete
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adjuvant. Two "half lop" rabbits (obtained from Hylyne Ltd, Marston) 
were used to produce antibody, and the titre of antibody obtained 
by means of a haemagglutinin inhibition assay . The titre is expr­
essed a3 the reciprocal of the dilution of antibody required to 
prevent agglutination of erythrocytes by 4 HAU of NCV-F. The stock 
antiserum had a titre of 640 units and was diluted 1 in 10 for 
all experiments.
Freunds Complete and Incomplete adjuvants were obtained from Gibco 
Biocult, Paisley, Scotland.
PREPARATION OF AGAR MEDIA: Fifty ml of agar-media (0.3?o agar) 
were prepared thus; 9.7ml of 1.8?i agar ( Difco Laboratories, East 
Molesey, Surrey), 5ml of foetal calf serum, 3mls of 0.85M NaHCO-j, 
0.1ml of antibiotics, 5mJ of ten times concentrated GMEM (Flow 
Laboratories, Irvine,Ayrshire), 0.5ml of 200mM Glutamine and 
26.7ml distilled water. All fluids except the agar were mixed 
and maintained at 37°C, the agar was liquified by boiling and left 
at 45 C ; when required the agar was added to the other fluids and 
the whole mixture left to reach 37°C before use.
I^2y£ii2^_9t_iyi§?t§52N_SYNTHESIS BY VIRUS INFECTION
Cells were routinely grown in 3cm culture dishes prior to interferon
induction. lOQul of media containing 100 HAU of NDV-F was added to
each monolayer for one hour at 37°C.and the cells then washed three
times with PBS before being refed with 2ml maintenance medium.
After incubation for a total of 20 hours post-infection at 37°C
the supernatants were harvested and the cell number counted. The
supernatants were dialysed at 4°C for five hours in a pH 2 solution
(6.5mls of two molar HCL pus 43.5mls of two molar KCL were made
.  \
up to one litre with distilled water). Each sample was then dialysed 
for one day in PBS to restore the pH to 7.4. All samples were 3tored
8 7
Purified mouse interferon was a gift from Dr. A.G. Morris (of this 
laboratory), this interferon had a specific activity in excess of 
10^ units per mg protein, and was used in section two (figure 30) 
to examine the antiproliferative effects of interferon upon terato- 
carcinoma cells.
Interferon antiserum, used in section one (figure 12), was similarly 
a gift from Dr. A.G. Morris. This antiserum had a titre of 10^’  ^
against four units of interferon.
a t  - 2 0 ° C  u n t i l  a s s a y  a n d  r e s u l t s  a r e  p r e s e n t e d  a s  i n t e r f e r o n  u n i t s
p e r  c e l l  i n  c u l t u r e .
POkYACRYLAMIDEGELELECIROPHORESiSOrCELL LYSATES
20 x 20 cm polyacrylamide gradient (10 - 2Q%) slab gels containing 
sodium dodecyl sulphate, were prepared using the tris/glycine buffer 
system (as described in Laemmli 1970). Samples containing an equal 
number of acid precipitable counts were loaded onto each track; gels 
were fixed in 45?o methanol plus 10?j acetic acid and dried under 
suction onto filter paper, then exposed to Fuji X-ray film (Fuji 
Photo Co Ltd, London) for approximately one week.
Preparation of cell lysates: Cell cultures were labelled with ^ S  
methionine (activity 740 Ci/mMol) as described in figure 34a , washed 
three times with ice cold PBS then harvested using a rubber bung into 
a tris/sodium dodecyl sulphate/mercaptoethanol buffer (pH 9). An equal 
volume of this lysate was then mixed with an equal volume of "blue 
buffer" , boiled for three minutes and then spun for four minutes in 
a microfuge. The number of acid precipitable counts wer? then courted 
and an equal number of counts per lysate loaded on to the gel.
"Blue buffer" : 10 mis of this solution was prepared from l.ml methionine
ea
0.5 ml of O.lfS Bromophenyl blue and B.5 mis of 'extra strong buffer' 
(ie: 2.5mls 0.5M tris-HCL pH 6,fl, 2g sodium docdecyl sulphate, 2mls 
mercaptoethanol, 12mls glycerol, 3.3mls distilled H20; diluted to 
two volumes with o.5M tris-HCL pH 6.8)
Counting of cell lysate samples: 5jj1 of the cell lysate (previously
mixed with 'blue buffer' and boiled for three minutes) were spotted 
2
onto 1 cm of filter paper and dried under an infra-red lamp. The 
filter paper squares were then boiled for ten minutes in 5.0!S TCA 
then washed twice in ice-cold TCA, once in ice-cold ethanol and 
dried under an infra red lamp. The squares were then placed in a 
scintillation mixture (toluene plus 5.0?i 2,5, diphenyloxazole) 
and counted in a LKB Rackbeta liquid scintillation counter.
EXTRACTION OF CELLULAR RNA AND QUANTITATION OF INTERFERON mRNA 
PRODUCED IN VIRUS INFECTED CELLS.
Cellular RNA was extracted from virus infected cells using two 
methods.
A) Total cellular RNA:
Intact cells were harvested at six hours post virus infection 
and lysed in Guanidine thiocyanate (4t1) the total cell RNA was 
obtained by centrifugation of this lysate (at 40 000 rpm for 16hrs) 
through 5.7M caesium chloride. The pellet was solubilised and RNA 
extracted using butanol/chloroform, this method i3 described in 
Morser £t jjI (1979).
\
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E) Cytoplasmic cellular RNA:
Intact cells were harvested at six hours post-virus infection 
into ice-cold isotonic buffer and then washed and resuspended 
into ice-cold hypotonic buffer. After addition of a non-ionic 
detergent the cells were gently homogenised using a Dounce 
glass homogeniser, until all cells were shown to be non-trypan 
blue excluding. Nucleii and other cell debris were removed by 
centrifugation for ten minutes at 10 000 rpm, RNA was then 
obtained from the remaining supernatant by phenol/chloroform 
extraction.
The RNA obtained from both these methods v/as precipitated three 
times under ethanol before being used in subsequent experiments.
XENOPUS OOCYTE INJECTIONS: RNA at a concentration of 5mg/ml was 
injected into both the nucleus and cytoplasm of the Xenopus oocyte 
by Dr. A Colman (of this department). It has been previously shown 
(Colman and Morser 1979) that the oocyte will secrete interferon 
manufactured from injected messenger RNA. Thirty injected oocytes 
were placed in 200ul medium which was assayed (by INAS assay) 
at 24 and 48 hours post-injection. Similar levels of interferon 
were found to be produced at both these times.
RABBIT RETICULOCYTE SYSTEM:An mRNA dependent reticulocyte lysate 
protein synthesising system as devised by Pelham and Jackson (1976) 
was used by Dr. J Morser to assess the activity of all extracted 
RNA samples. »
\
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AGAROSE FORMAMIDE GEL ELECTROPHORESIS: The RNA samples which 
were injected into the oocytes were also examined in anagarose- 
formamide gel system using a 1.05» agarose gel and a tris/EDTA/ 
NaH2P0^ buffer (Dr. J Norton, this department, personal commun­
ication). Gels were stained in ethidium bromide (1.0 pg/ml) and 
examined under ultra violet illumination for the presence of 
ribosomal RNA bands.
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SECTION ONE ---  RESULTS
THE PUBLISHED SINGLE CELL ASSAY IS INACCURATE:
The single cell assay used throughout this study is fully 
described in the Methods; however, although it is similar, it does 
differ significantly from published descriptions of such assays 
(Osborn and Walker 1969, Kronenberg 1977). Because of this, section 
one will describe the reasons why changes to the published assays 
were thought necessary, provide a characterisation of the modified 
assay and also explore the use of this assay in the examination of 
interferon production from single cells.
A single cell assay which could qualitatively detect interferon 
production was first described by Osborn and Walker (1969), who used 
it to examine the behaviour of individual spleen cells taken from 
mice previously innoculated with virus. More recently, Kronenberg 
(1977) described a similar assay which was able to detect interferon 
production from individual culture cells previously infected with 
virus, or treated with dsRNA. The main features of these two assays 
are similar, and the assay described by Kronenberg is illustrated in 
figure 4.
This assay is analogous to the infectious centre assay for virus 
production, wherein virus yielding cells are detected by plaque 
formation in an indicator monolayer of cells. The difference between 
the single cell assay for interferon production and the infectious 
centre assay for virus production is that in the former, foci of live 
cells are seen amongst a background of dead cells in the indicator 
monolayer cells, whereas in the latter the reverse is true, plaques of
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FIGURE It. A SINGLE CELL ASSAY FOR INTERFERON (KRONENBERG 1977).
Test cells are infected 
with virus, and then 
trypsinised to a suspension 
of single cells.
r 0 0 0 o o 0
A known number of 
single cells are 
suspended above a 
monolayer of similar 
cells.
Interferon produced by 
individual cells diffuses 
across to monolayer.
I
The agar and single cells 
are removed and the 
monolayer infected 
with cytopathic virus.
Staining of monolayer 
reveals foci of protected, 
live cells, amongst a 
background of dead cells.
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dead cells form amongst a background of live cells in the indicator 
monolayer cells.
Each of the foci produced in the single cell assay for interferon 
represents production from a single cell which has been suspended in 
agar above that area of the indicator monolayer. The number of foci 
counted, divided by the number of single test cells added to that 
assay dish, gives the percentage of cells in a culture able to produce 
interferon, under the inducing conditions used. Figure 5 shows 
photographs of the indicator cell monolayer after the single cell 
assay has been completed: foci of varying diameters (0.5 to 5.0mm) and 
also of varying intensity can be seen. Data obtained from four 
separate single cell assays are provided in figure 6 . This data shows 
that there is a linear relationship between the number of single test 
cells added to each assay plate, and the number of foci produced at 
the completion of the assay. Figure 6 shows two further features of 
the results obtained from early use of this assay; these were that 
consistently more foci were counted than the number of single cells 
added per assay dish, and also, that a wide variation was seen in the 
percentage of single cells found to be producing interferon (this 
varied from ninety-five to one hundred and fifty percent for a 
population of L929 cells infected with NDV-F virus).
Such results may suggest errors in the addition of test cells to 
the assay plates; for in order to obtain appropriate cell numbers for 
use in the assay, a cell suspension of initially 500 000 cells per 
ml i3 diluted to approximately 500 cells per ml, and dilution errors 
are possible. However, such errors were not considered the most likely 
explanation, mainly because although the assay wa3 repeated many times, 
the error wa3 never negative. There were always the same, or more foci 
produced on completion of the assay, than the number of test cells
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FIGURE 5 . Appearance of assay plates at the completion of the 
single cell assay for interferon production.
(Method as Kronnenberg 1977)
N° of cells 
added per 
assay dish.
74.0
N° of foci 
counted at 
end of assay.
106.0
37.0 53.0
19.0 30.0
The method for the sinnle cell assay for interferon production is 
illustrated in figure 4., the above cell monolayers were fixed in 
100?i methanol for one minute and stained with 0.1* crystal violet 
for ten minutes.
9 6
F I G U R E  6  .  S i n g l e  c e l l  a s s a y  d a t a  ( m e t h o d  a s  K r o n e n b e r ç  1 9 7 7 )
Number of 
single cell 
interferon 
producers.
1 2  3 4
Experiment number.
Monolayers of L929 cells were induced to produce interferon by 
infection with NDV-F virus, washed three times with PBS and then 
trypsinised to single cells. Cell numbers from 20 - 100 were 
placed in the single cell assay as described in the text; the 
results from four separate experiments are illustrated. Each bar 
represents the mean of four dishes, ( H  ) the number of cells 
added per assay dish, ( E3 ) the number of foci counted per dish 
at completion of the assay.
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originally added. This suggested that a second factor could be 
present in the assay system which was responsible for the production 
of foci similar to those caused by interferon production from single 
cells. It was possible that the virus used to induce the single test
t
cells to produce interferon was being carried over, with the single 
cells, into the assay system and producing foci in the indicator 
cell monolayer (despite washing of the cells, trypsinisation and a 
one thousand fold dilution).
Thus the single cell assay for interferon production as described 
by Osbourn and Walker (1969) and Kronenberg (1977) appears to contain 
a systematic error, possibly due to virus eluting from the test cells.
Can_NDV-F_directly cause the production of foci within the confines 
of the single cell assay system?
It has been shown by Brown £t^  _al. (1980) that a plaque forming 
strain of NDV, when added directly to a monolayer of L929 cells, can 
produce foci similar to that seen in the single cell assay. Figure 7 
shows this to be true for NDV-E (a non-plaque forming strain of NDV); 
discrete foci could be seen when 10“ ■* to 10"4 HA units of virus were 
added directly to the indicator monolayer within the single cell assay 
system. The variation seen in diameter and intensity were similar to 
that obtained for the single cell assay as shown in figure 5. At 
amounts greater than 10-  ^HA units discrete foci were not seen and the 
whole monolayer was protected from subsequent CPE by EMC virus; at 
amounts less than or equal to 10 ^ HA units no foci were seen and 
complete cell death occurs. These data show that previous treatment 
of cells with NDV-E can protect cells from subsequent cell death caused 
by a lytic virus. Since NDV-E can induce interferon, and this NDV-E
98
FIGURE 7. Foci produced within the single cell assay system 
by various concentrations of NDV-F.
(a)
Amount of NDV-F. 10"3 HA 10“A
Number of foci. 200.0 30.0
(b)
Foci produced by various concentrations of NDV-F.
Amount of NDV-F 
per assay plate.
Description of monolayer 
at completion of assay.
10.0 HA Complete protection
1.0 HA Complete protection
0.1 HA Complete protection
0.01 HA Complete protection
0.001 HA 149 - 200 foci
0.0001 HA 29 - 36 foci
0.00001 HA 2 - 3  foci
0.000001 HA 0
0.0000001 HA 0
100 ul of PBS containing various concentrations of NDV-F were added 
to 5 cm monolayers of L929 cells for one hour, the cells were then 
washed three times with PBS and then refed with 1.5 mis of agar-media. 
The proceedure then followed that of the single cell assay described 
in figure 4., (a), shows photographs of typical foci obtained with 
this method and (b), shows the data obtained with different dilutions 
of virus.
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associated viral interference is probably due primarily to interferon 
production in the protected cells. These data also show that approxim­
ately 2.5 x 10"’ virus interfering (or possibly interferon-inducing) 
particles are present in one HA unit of NDV-F.
NDV-F is a large virus (approximately 500 x 106 MW), and it 
might be expected that the virus is relatively immobile within the 
assay. Therefore the ability of the virus to diffuse through the 
agar-media used in the single cell assay was examined. Figure 8 shows 
that NDV-F can diffuse through a one millimetre barrier of 0.3?o agar 
during the period of time that the single test cells are suspended 
in the assay, and can induce protection in the underlying indicator 
monolayer cells. Since 1.25 x 10^ viral interference particles were 
added to each dish (ie: 0.5 HA units) and complete protection was not 
seen (compare with figure 7), these data do show that 0.3?o agar can 
inhibit the movement of NDV-F to a limited extent.
Does_NDV-F replicate in, or_denorb from L929 cells?
NDV-F is an avirulent strain of NDV (an avian paramyxovirus), it 
does not plaque, nor does it have a significant cytopathic effect in 
chick embryo fibroblasts or have a pathogenic action in young chickens. 
This is in contrast to the mesogenic and velogenic strains of NDV 
(Lomniczi et al. 1971). NDV-F does replicate and produce infectious 
virions in embryonated chick eggs (see methods) and the growth profile 
of NDV-F in such eggs is similar to that of the other strains which 
are grown in chick embryo fibroblasts (Lomniczi et al. 1971). None of 
the strains of NDV-F produce infectious virions when used to infect 
mouse cells, however, the velogenic strains can produce inhibitory effects 
on host cell synthesis and can also produce the major viral proteins
\
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FIGURE 8. The effect of an agar barrier on the ability
> of NDV-F virus to infect an cell monolayer.
\
Volume of Description of
agar barrier. L929 monolayer.
1.0ml 50?ó cell death
no clear foci.
0.5ml 50?¿ cell death
no clear foci.
0.0ml complete protection
0.5ml - 1.0ml of agar-media (0.3!o) was added to 5cm 
monolayers of confluent L929 cells, and allowed to gel. 
0.5HA NDV-F in 5Q^ il volume were added' to the top of 
the gelled agar and the volume of agar-media made up to 
1.5mls in total, the method of the single cell assay 
described in Figured was then followed.
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(ie: the haemaglutinin, neuraminidase) (Gandhi et al. 1971). In contrast 
NDV-F does not depress host cell RNA synthesis (as shown Lay incorpor­
ation of Uridine into infected cells) or host cell protein synthesis 
(as shown by polyacrylamide gel’ electrophoresis of infected cells), 
neither can viral proteins be detected (data not given). Because 
of the data presented in figures 7 and 8, it was of interest to examine 
the behaviour of NDV-F in L929 cells; this could not be done by 
conventional means, but since it was known that NDV-F could interfere 
with the growth of a second virus within the single cell assay, the 
behaviour of L929 cells infected with NDV-F was followed by measuring 
the levels of viral interference. Viral interference was assayed in 
the standard INAS assay (see methods) where the titre of viral inter­
ference of a solution is the reciprocal of the dilution which produced 
a fifty percent inhibition of SFV nucleic acid synthesis. This assay 
is also used to quantify interferon yields from samples in which virus 
has been inactivated (eg: by pH2 treatment). Since NDV-F will also 
induce interferon in the cells under study it is necessary when using 
this method to inactivate or remove any interferon present in the sample. 
Interferon was removed from the samples by spinning infected cell 
supernatants at AO 000 rpm for two hours, the molecular weights of 
mouse interferon range from 22 to 35 Kd and therefore remain in the 
supernatant. The resultant pellet was washed with PBS and resolubilised 
in media, and then assayed for viral interference. The percentage 
recovery of virus using this method is approximately 20?o (data not given) 
and is sufficient to monitor the system. An analysis, using this method,
of a culture of L929 cells infected with NDV-F is presented in figure 9.*
These data show the behaviour of virus infected L929 cells during the 
time course of the single cell assay; a base line reading (b) was 
taken immediately after the virus was washed off the cells, and can be
\
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FIGURE 9 . The desorbtion of NiDV-F virus from L929 cells.
Duplicate monolayers of L929 cells were infected with 10 HAU K'DV-F for 
one hour at 37nC, then washed three time with PBS and refed with main­
tenance medium. The media was immediately resampled to obtain the first 
sample and the cello refed. Thereafter the supernatant was harvested 
at intervals, the cells being washed three times with PBS after each 
harvest. Samples were spun at 60 000 rpm for two hours and the super­
natant discarded, the pellet was solubilised overnight in one ml of 
media. All samples were then assayed for interference using the ItvAS 
assay described in methods.
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seen to contain a high titre of viral interference. This interference 
can be seen to increase up to 5 hrs post-infection, and then decrease 
to reach a plateau during the remainder of the experiment. Thus 
these data show that NDV-F infected L929 cells release particles 
capable of viral interference during the period of the assay.
t:£yi£§ii®5ii2D_2r_v^ra^-in^er^erence groduced_by NDV-F infected 
cells_by antiserum raised to partially purified NDV-F
It has been shown in figure 5, that NDV-F grown in embryonated 
chick eggs can directly induce foci within the single cell assay.
Since it has been shown in figure 9, that NDV-F infected L929 cells 
can release viral-interference into the supernatant during the course 
of the assay, it is necessary to check firstly that this viral inter­
ference can produce foci within the single cell assay, and secondly 
that such foci are due to NDV-F.
Figure 10 shows the result of such an analysis, in which three 
parameters were measured from supernatant harvested from NDV-F 
infected L929 cells. These data show that the viral interference 
which is released into the cell supernatant could be 99.9% removed by 
treatment with antiserum raised to partially purified NDV-F. In 
addition, this viral interference, at a suitable dilution, was capable 
of producing foci of similar diameter and intensities to those 
described above; furthermore these foci could be completely removed 
by prior incubation with antiserum raised to NDV-F. The third parameter 
of interferon yield was measured to ensure that both the virus and 
the cells were behaving as expected.
FIGURE 1C. Neutralisation of interference produced by NPV-f 
virus infected cells, by antiserum (AS) raised to 
partially purified NPV-F.
TIME POST-INFECTION WITH NDV-F VIRUS.
1.5hrs 19hrs
nil AS +AS nil AS +AS
*
Virus interference 2.5 NO 
titre (log units) 
produced in INAS 
assay.
3.5 0.4
(.99.9% reduction)
Virus interference 
the number of foci 
produced in single 
cell assay.
-- 10'3 dilution
— 10~4 dilution
Interferon yield 
titre (log units) 
produced in INAS 
assay
ND ND
*#
CP 20-30
ND ND 160-175 0
0.0 ND 3.9 ND
A confluent monolayer of L929 cells were infected with 500HA NDV-F 
for 1.5hrs at 37°C, washed three^times with PBS, then refed with 5mls 
of maintenance media which was immediately sampled for the 1.5hr time 
point. The cells were then refed and the supernatant harvested at 19hrs 
post-infection.Each 5ml sample was divided into two; one half provided 
material for assay of virus interference and for use in the single 
cell assay, and was prepared as described in figure 9 . The remainder 
was used to provide material to assay the interferon yield; this 
material was dialysed at pH 2 for five days to inactivate virus and 
then at pH 7 for one day to readjust the pH, before being used in 
the assay. Neutralisations were performed by incubating samples with 
antisera for one hour at 37°C.
Both virus interference and interferon yield were assayed in the 
INAS assay (see methods), the single cell assay system used has been 
described in figure 6.
ND = not done, CP = complete protection, foci not discernable.
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Production of_foci within the_single cell assay by NDV-F infected 
cells^ which cannot produce interferon active upon L929 cells.
Interferon produced by virus infected cells can be species 
specific in action (see Introduction). Thus it is known that some 
species of interferon will not cross-react, ie: produce anti-viral or 
other effects, upon cells of another species. For example mouse L929 
cell interferon induced by NDV-F will not induce anti-viral protection 
in chick embryo fibroblasts (CEF) or in human fibroblasts as measured 
by the INAS assay. It is also known that some cells are unable to 
produce interferon, for example embryonal carcinoma cells (see Introduction) 
do not produce interferon when infected by virus (Burke et al_. 1978).
Thus if either heterologous cells, or cells that do not produce 
interferon are infected with NDV-F and placed in the single cell assay 
performed as illustrated in figure A, then no foci will be expected.
Figure 11, shows the data obtained from such an experiment, these data 
show that NDV-F infected CEF, human fibroblasts and mouse ec cells 
did not produce interferon when assayed upon L929 cells in the INAS 
assay. But, all these cell types produced foci within the single 
cell assay when L929 cells formed the indicator monolayer! furthermore 
all these foci could be removed by prior treatment of the infected cells 
with antiserum raised to NDV-F.
Thus these data support the proposal that virus used to induce 
interferon in the test cells is carried over and probably desorbs from 
the single cells during the course of the assay, resulting in the 
production of foci which are similar to that caused by interferon 
production from single cells.
\
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FIGURE IT. Production of foci within the single cell assay by 
virus infected cells; which either cannot produce 
interferon, or produce interferon which is inactive 
on the cells forming the indicator monolayer.
SINGLE TEST CELLS.
The number of 
foci produced 
in the SCA*
Chick embryo
fibroblasts
(CEF)
Human
fibroblasts 
( MG63 )
Embryonal 
carcinoma 
(PC13 cl 5)
-- control sera: 32-54 (129) 65-80 (140) 39-43 (100)
— antisera: 0 " 0 0 "
Interferon yield 
titre (log units) 
produced in INAS 
assay.
0.0 0.0 0.0
The single test cells were grown os monolayers and infected with 
500HA NDV-E for one hour at 37°C, washed three times with PBS and 
then either incubated with media containing antiserum raised to 
NDV-F, or with media containing control sera, for one hour at 37 C. 
The cells were then washed with PBS and trypsinised to a suspension 
of single cells, a small aliquot was diluted further to be used 
in the SCA; the remainder were returned to the culture dish for 
approximately 20hrs and the cell supernatant harvested for inter­
feron yield.
The single cell assay data represents the range obtained from five 
plates, the number in brackets refers to the number of single cells 
added to each dish. The indicator monolayer of the single cell 
assay and the cells used in the INAS assay were mouse L^g cells.
SCA = single cell assay.
i 07
A_fnodiried_single cell assay for interferon
Using the information presented above a modified single cell 
assay was designed, which is fully illustrated in methods and differs 
from the assay illustrated in figure 4 in one feature. Test single 
cells are infected with virus for one hour at 37°C, then washed 
three times with PBS, as described previously. The modified assay 
differs in that the test cells are then incubated for a further hour 
with media containing antiserum raised to the inducing virus, before 
being trypsinised to single cells and placed in the assay. The data 
from figure 11 shows that this procedure is capable of preventing 
foci production from virus carried over with the single cells.
The foci produced at completion of the modified single cell 
assay were examined to ensure that they formed as a result only of 
interferon production by the single cells used in the assay. Figure 
12 shows that single cells treated as for the modified assay, will not 
produce foci within the single cell assay if they are suspended in 
agar containing antiserum to mouse interferon. Thus all of the foci 
produced in the modified single cell assay are due to interferon 
production, and none are due to the direct actions of the inducing virus.
The percentage of an L929 cell population able to produce 
interferon upon infection by NDV-F, using the modified assay, was 
found to be approximately 30%, which is in contrast to the results 
obtained in figure 6 using the assay as described by Osborn and Walker 
(1969) and Kronenberg (1977). This figure of approximately 30°!, was 
however, found to be constant for relatively short periods of time 
only. Figure 13 shows that over the period of two years in which the 
assay was in routine use, the percentage of single cell interferon 
producers using this cell/inducer system, was found to vary between
\
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FIGURE 12. Demonstration that all foci, produced in the modified 
single cell assay, are due to interferon production 
from the single cells used in the assay.
A B
N° of cells/dish. 94 94
N° of foci. 36 0
A monolayer of L929 cells were infected with 100 HA NDV-F for one 
hour, washed three times with PBS, and then incubated with media 
containing antiserum raised to NDV-F for a further hour. The cells 
werethen trypsinised to a suspension of single cells, a small 
aliquot of which was diluted furhter to provide cells for use in the 
single cell assay (performed as described in methods). Plate A shows 
the result of a single cell assay with single cells suspended in 
normal agar-media. Plate B shows the result of a single cell assay 
with cell suspended in agar-media containing antiserum raised to 
mouse interferon.
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FIGURE 13. Variation in the percentage of single cell interferon- 
producers in a population of L929 cells infected with 
NDV-F virus.
Date Percentage of single cell
interferon producers.
March i9eo 34
April tl 49
May It 40
June II 24
July II 35
March 1901 36
April It 45
May II 43
June II 24
July II 33
The above data was obtained from examination of NDV-F infected 
single cells using the modified single cell assay as described 
in methods, and span a period of eighteen months. The L929 cells 
used were from the came batch of cells maintained in liquid 
nitrogen, and the virus (NDV-F) was from a batch grown in May 
1979 and maintained at -70°C (the virus was not refrozen once 
thawed).
Each figure represents the average from at least four separate 
experiments occurring throughout the month, and each individual 
experimental result represents the mean from five dishes.
n o
22?ô to 49?£, the figures remaining constant only for a period of 1 - 2 
months.
OPTIMISATION OF THE MODIFIED SINGLE CELL ASSAY.
The results of the modified single cell assay using NDV-F 
infected L929 cells shows that less than half of the cell population 
can produce interferon; it is therefore necessary to assess whether 
or not this is a reflection of this particular inducer-cell
system, or whether it reflects the limitations of the assay. By the 
latter is meant that the assay may for example, only be sufficiently 
sensitive to detect 30X of the interferon producers, or that the 
method of inducing and placing the cells in the assay does not allow 
the maximum number of cells to produce interferon. Following this, 
the various stages involved in the modified single cell assay were 
examined to assess their role in influencing the outcome of the assay.
a: Interaction between_the_test_cells and the inducing_virus.
Ttie production of interferon at the population and the single 
cell level was measured in cultures of L929 cells infected with 
increasing amounts of NDV-F. These data are presented in figure 14, 
and show that both interferon yield per culture, and the percentage 
of single cell interferon producers, increased when more virus was 
applied to the culture. This increase reached a maximum for both 
parameters at approximately 10 HA units NDV-F per 10 cells. Therefore 
to ensure maximum interferon yields, interferon was induced in cell 
cultures using a ratio of 100 HA units per 106 cells throughout this study.
Ill
FIGURE 14 . The production of interferon at the population and the 
single cell level in cultures of L929 cells infected 
with increasing amounts of NDV-F.
Percent
single
cell
IFN
producers.
( 0 )
Duplicate monolayers of L929 cells were infected with different 
concentrations of NDV-F for one hour at 37 C, then washed three 
times with PBS. The cells were incubated for a further hour with 
media containing antiserum raised to NDV-F, then trypsinised to 
a suspension of single cells. A small aliquot of which was used 
to provide cells for the single cell assay (performed as descri- 
-bed in methods), the remaining cells were returned to the 
culture dish. Media from the culture dish was harvested at 20 hrs 
post-infection, treated to inactivate virus and then assayed for 
interferon yield by INAS assay (as described in methods).
* = not done.
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• The percentage of single cell producers was reduced with a 
concentration of 500 HA NDV-F per 10^ cells. This may have been due 
to cell death. As mentioned above, NDV-F is a lentogenic strain of 
an avian paramyxovirus which does not replicate significantly in 
mouse cells, however at high concentrations it can be toxic to some 
but not all mouse cell lines (my observation). If the virus is toxic 
at the concentration used to induce interferon in the single cell 
assay, then this could reduce the number of cells able to produce 
interferon. The viability of cells infected with different concentra­
tions of NDV-F was examined (Figure 15). Two cell lines L929 and a 
teratocarcinoma cell line F9 ec were infected with increasing amounts 
of NDV-F. The viability of the two cell lines was not reduced by 
eight hours post-infection and was only slightly reduced by 20 hours 
post-infection. Interferon production is maximal in L929 cells at 
10-12 hours post-infection and in ec cells at 5-6 hours post-infection 
(see later); thus it can be assumed that interferon production is not 
affected by the slight reduction in cell viability which occurs late 
in infection.
The influence of the density of the cells at the time of addition 
of virus, on subsequent interferon production, was also examined. 
Figure 16 shows that interferon production at the population and the 
single cell level is not influenced by the density of the cells at the 
time of infection. Cultures seeded at 0.9 x 10^ per 3cm dish were 
approximately 75?i confluent whilst those seeded at 3 x 106 per 3cm 
dish were overconfluent, rounded and poorly attached to the substrate. 
From this information test single cells were routinely seeded to a 
density of 1 x 10^ per 3cm dish, before being used in the single cell
\
assay.
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FIGURE 15. The viability of cells infected with NDV-F virus.
8 hrs post 20 hrs post
infection. infection.
Triplicate monolayers of L929 and F9 ec cells were infected 
with five ( □  ), fifty ( Ë) ) or one hundred ( D  ) HA NDV-F 
for one hour at 37°C. The cells were then washed three times 
with PBS then refed with maintenance media. At eight and twenty 
hours post-infection the cell number from each plate was counted, 
only trypan blue excluding cells were included, and the results 
are expressed as a percentage of control culture coll numbers.
FIGURE 16. The effect of cell density upon interferon production 
at the level of the population and the single cell.
CELL NUMBER PER 3cm DISH.
0.9 106cells 3.0 106cells
IFN yield per culture 2.0 - 3.0 2.8 - 3.8
cell (units/cell).
Percent single cell 33 - 4 4  31 - 37
producers of IFN.
Triplicate 3cm di«hes were seeded at two cell densities overnight, 
infected with 100 HA NDV-F for one hour at 37°C, washed three 
times with PBS and then incubated with media containing antiserum 
raised to NDV-F for a further hour. The cells were then washed and 
trypsinised to a suspension of single cells, a small aliquot of 
this was used to provide cells for the single cell assay (perfor­
med as described in methods), the remainder were returned to the 
culture dish. At 20 hours post-infection cell supernatants were 
harvested and the cell number counted; the supernatants were then 
treated to inactivate virus and then assayed for interferon in an 
INAS assay (this proceedure is described in methods).
The results show the range of results obtained from three dishes.
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b: I□teraction_between_virijs infected test cells and antiserum 
raised_t°_the inducing virus.
Test cells in the modified single cell assay are infected with 
virus for one hour, washed three times with PBS to remove surplus 
virus and then incubated with media containing antiserum raised to 
the inducing virus. This period of incubation is sufficient (see 
figure 10) to prevent virus desorbtion from the single cells during 
the period of the assay. As mentioned in the Introduction, it is 
not fully clear what comprises the actual interferon inducer in virus 
infected cells, although there is evidence that interferon production 
may be invoked by formation of dsRNA (Morser and Burke 1979). Therefore, 
it is necessary to check whether or not the period of incubation with 
antiserum raised to the inducing virus, can influence the production 
of interferon in virus infected cells. Figure 17 shows the interferon 
yield obtained from cultures of virus infected L929 cells treated 
either with control sera or with antiserum raised to the inducing virus. 
These data show that treatment with antiserum does not inhibit the 
production of interferon from virus infected cells.
c: The accuracy with which small cell numbers can be dispensed.
The result of a single cell assay is expressed as the percentage 
of cells able to produce interferon under the inducing conditions 
chosen. This figure is a ratio between the number of foci counted 
at completion of the assay and the number of cells originally added 
to each assay plate. The former can readily be counted macroscopically 
when the assay plates are stained, the latter are obtained from 
counting cells at a high concentration and then diluting a sample of
\
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this suspension by approximately 1 000 fold. Thus the accuracy of 
the result of the assay depends primarily on the accuracy with which 
such dilutions can be made. Figure 18 shows data obtained from 
dilutions of cell suspensions originally at different 
concentrations. These data show that dilutions of cell suspensions 
to small cell numbers can be made with a repeatable and high degree 
of accuracy. An additional check on the accuracy with which small 
cell numbers can be dispensed can be made by performing single cell 
assays on more than one culture of test cells simultaneously. Separate 
L929 cell cultures induced to produce interferon by the same means, 
should when trypsinised and diluted into the single cell assay, 
produce the same percentage of cells able to produce interferon.
Figure 19 shows the result of single cell assays using three cultures 
of L929 cells, the single cells from each test plate being added to 
four assay plates. These data show that the mean percentage of cells 
able to produce interferon from all three cultures varied from 22?£ 
to 25?«; thus confirming that small cell numbers can be dispensed with 
accuracy.
d: The timing of events within the single cell assa^.
The test single cells, during the single cell assay, are suspended 
above the indicator monolayer for a period of approximately 18 hours. 
Because induction and other preparations of the test cells occupies two 
hours, the test cells are included in the assay only for 20 hours post­
infection. This period in the assay wa3 determined by following the 
kinetics of interferon production in virus infected cells.' Figure 20 
shows the rate of interferon production in virus infected L929 cell 
cultures which were either left in situ after addition of virus; or
FIGURE IB. Accuracy and repeatability of pipetting small 
cell numbers.
1 000
Aliquot dispensed. lui
Expected cell N°. 1.0
N° of drops counted. 96.0
Range of cell N° 
counted in all drops.
0 -
Mean cell number 
per drop.
0.6
CELL NUMBER PER MILLILITRE.
000 20 000
5ul 5ul
50.0 100.0
16.0 11.0
AO - 79 85 - 112
56.0 100.0
A monolayer of L929 cells was trypsinised to a suspension of 
single cells and cell numbers counted using a haemocytometer, 
the suspension was then diluted using a Gilson Pipetman ' to 
1000, 10 000 and 20 000 cells per ml into separate containers. 
These containers were then agitated and dispensed as indicated 
above into one or five microlitre drops.on to the base of plastic 
culture dishes. Each drop was then scanned, using a light micro- 
-scope with a grid incorporated into an eyepiece, and the cell 
number per drop counted.
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FIGURE 19. Repeatability of results obtained from the single 
cell assay for interferon.
Culture dish Number of cells 
added per SCA*
N° of foci per 
5CA ( 4 dishes)
Mean 
foci N°
A 95 25,23,20,31. 25
B 95 26,20,25,22. 23
C 95 22,23,30,14. 22
Three separate cultures (A,B and C.) of L929 were infected with 
NDV-F (100 HA) for one hour at 37°C, washed with PBS three times 
and incubated with media containing antiserum to NDV-F, for a 
further hour. Each culture dish was then separately assayed in 
the single cell assay (see methods for description).
* SCA = single cell assay
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F I G U R E  2 0 . The rate of interferon production in a population 
of L929 cells infected with NDV-F virus.
Interferon yield 
per 10^ cells 
(log units).
Four monolayers of L929 cells were infected with 100 HA NDV-F 
for one hour at 37®C, then washed three times with PBS. Half 
the plates were refed with maintenance media, the remainder 
were trypsinised to a suspension of single cells and replaced 
in the culture dish with maintenance media. From both the 
trypsinised and reseeded cultures ( A ), and the control 
infected cultures ( •  ), supernatants were removed at various 
intervals. These samples wore treated to inactivate virus and 
then assayed for interferon yield as described in methods.
Each point represents the mean of two determinations.
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trypsinised to a suspension of single cells and returned to the 
same culture dish. These data show that interferon production in both 
cultures began four hours post-infection and was maximal 10-12 hours 
post-infection. Trypsinisation of the infected cell monolayer did not 
effect the kinetics of production but did effect the yield. This 
reduction in yield was marked in the early hours post-infection 
(approximately 60?<O but had recovered in the later hours following 
infection (approximately 20?o reduction).
e: The role of the cells in the indicator monolayer and the
cytolytic virus_used to reveal the interferon-protected foci.
The role of the indicator monolayer cells is to detect interferon 
production from the single cells suspended above in agar. The presence 
of interferon-protected foci is indicated by a stain (0.1?o crystal 
violet) which can clearly differentiate between foci of healthy cells 
amongst a background of dead cells.
It is thought that ageing (the length of time undisturbed in 
culture) and cell density can influence the sensitivity of some human 
cell lines to anti-viral action of interferon when used in the INAS 
assay (Carver and Marcus 1967). Ageing does not increase the sensi­
tivity of L929 cells to the anti-viral action of interferon (data not 
given), possibly because the growth of L929 cells, unlike that of the 
human lines which do show the ageing phenomena, is not density dependent; 
L929 cells left for a period in culture will become over-confluent 
and then show reduced sensitivity to the action of interferon.
Figure 21 shows the anti-viral action of different concentrations 
of interferon, on cells seeded at different densities per surface area; 
all cell densities were infected with the same multiplicity of cytolytic
\
FIGURE 21. Effect of cell density on the sensitivity of cells 
to the antiviral effects of interferon.
CELL DENSITY PER CM2.
25 000 50 000 250 000 500 000
O.lu IFN/ml! - ++ ++
l.Ou II ++ ++ ++
5.0 ft - + ++ ++ ++
10.0 II
*#
++ ++ ++ ++
50.0 II
#*
++ ++ ++ ++
A monolayer of L929 cells was trypsinised to a suspension of 
cells to add the above cell densities into wells on a "micro- 
titer" plate. The cells were left overnight to attach, the 
growth media removed and maintenance media containing interferon 
at the concentrations indicated, was added per well for a further 
24 hr period. The interferon containing media was then replaced 
with EMC virus at a multiplicity of 4 pfu per cell, for a final 
period of 12 hrs. All cells were then fixed using 100!o methanol 
for one minute and then stained with O.lfi Crystal Violet.
The cell in each well were then observed macroscopically and 
scored ( - ) no protection, ( -+ ) partial protection, ( ++ )
complete protection.
* u IFN/ml = units interferon per ml.
##
++ = macroscopically complete protection, but microscopically 
some cell death seen.
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virus (iipfu EMC per cell). The data shows that cells seeded at a
o
density of 25 000 per cm (no cell/cell contact) have reduced 
sensitivity to the action of interferon compared to cells seeded at 
higher densities. Although cell death could not be detected in cultures 
seeded at very high densities and treated with 0.1 units interferon, 
this was probably due not to interferon protection but to the inability 
of cell death to be detected in such cultures. The areas of cell 
death in the indicator monolayer at the completion of the assay, which 
contrasts with the foci of live cells, comprise 50-60?o dead cells 
only, these cells round up leaving wide spaces between neighbouring 
cells, producing a pale background when the monolayer is stained, thus 
foci can be observed macroscopically. When cells are used at a high 
density, the live cells are rounded and with poor cell/cell contact 
and cell death cannot be clearly observed macroscopically even in virus 
infected cell cultures not previously treated with interferon. Foci 
produced in the single cell assay are most readily visualised by 
staining if cells in the indicator monolayer are just confluent; such 
cells are flattened, in close cell/cell contact and upon infection with 
a cytolytic virus such cultures round up leaving obvious areas of cell 
death. Therefore, because cell death cannot be accurately determined 
macroscopically in dense cell cultures, the indicator monolayer used
2
throughout this study was seeded at a concentration of 50 000 cell/cm . 
This cell concentration (figure 21) can be protected from a multiplicity 
of 4 pfu EMC per cell by a concentration of 1.0 unit/ml interferon; 
these cells are not protected by 0.1 units/ml interferon.
The optimum multiplicity of EMC to reveal the interferon-protected 
foci in this assay was found to be 4 pfu per cell, the virus wa3 left 
on the monolayer for a period of 12 hours.
\
THE OPTIMUM CONDITIONS FOR THE SINGLE CELL ASSAY
These conditions, based on information gathered from the above 
data, are fully described in methods and were used to obtain the single 
cell assay data presented in the remainder of this study. These data 
also show none of the manipulations involved in the assay inhibit the 
maximum possible production of interferon in NDV-F infected cells.
~Düi£i^i£y_9f_î:t!5_Ëin2ie ceH  §ssay to interferon.
Previous results (above) suggest that the procedures involved 
in the single cell assay do not inhibit interferon production from 
the single cells used in the assay. It is possible then that the 
reason why less than half the cell number in a virus infected culture 
produce interferon which is detectable in the single cell assay is 
that; the assay is only sensitive enough to detect cells which produce 
a sufficient quantity of interferon.
The amount of interferon produced by four cultures of L929 cells 
infected with NDV-F, is shown in figure 22. These data also relate 
the interferon yield per culture to the number of cells in the induced 
population. This assumes that all cells in the culture are producing 
equal amounts of interferon; if only a small percentage of the population 
were capable of producing interferon then the amount per producer cell 
would be larger. However the range of interferon production related 
to each culture cell can be seen to vary from 0.25 to 1.3 units per 
cultured cell.
The sensitivity of the single cell assay is illustrated in 
figure 23. This shows photographs of a dish which had received 
interferon ranging from 0.5 to 50.0 units in one microlitre drops. The
125
FIGURE 22. The amount of interferon produced by cell populations 
infected with an interferon-inducing virus.
EXPERIMENT NUMBER.
1 2 3 4
Total N° of cells 1 700 000 700 000 270 000 100 000
infected by NDV-F.
Total interferon 2 000 000 630 000 63 000 130 000
yield (units)
Interferon yield 1.2 0.9 0.25 1.3
per culture cell 
(units).
Various monolayers^of L929 cells were infected with 100 HA NDV-F 
for one hour at 37 C, then washed three times with PBS and refed 
with maintenance media. Cell supernatants were harvested and cell 
numbers counted at 20 hr3 post-infection; supernatants were treated 
to inactivate virus and assayed for interferon yield by INAS assay 
as described in methods.
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FIGURE 23. The limits of sensitivity to interferon seen in 
the single cell assay.
1.5 mis of agar-media were added to a 5cm monolayer of L929 cells, 
the plates were transferred to 4°C for ten minutes to allow the 
agar to gel and harden. Using a ' Hamilton syringe ' ( 1 - 1 0  ul 
capacity) one microlitre aliquots of media, containing various 
amounts of mouse interferon, were injected into the agar into 
the four areas indicated in the above photograph. The plates 
were incubated for 20 hrs then the agar-media (plus interferon) 
was removed, the cell sheet washed three times with PBS, and 
infected with a cytopathic virus (EMC) for 12 hrs. Subsequent 
fixing and staining of the cell monolayer revealed areas of 
protected cells underneath the agar which contained the interferon 
sample.
a; 0.5 units IFN, b; 2.5 units IFN, c; 5.0 units IFN, d; 50.0 
units IFN.
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ability of these amounts of interferon to confer protection upon the 
indicator monolayer is shown by the areas of protected cells produced 
by each drop. The results show that amounts as low as 0.5 units can 
produce detectable foci within the assay, thus the sensitivity of 
the assay is within the range of yields as shown in figure 22. This 
data also shows that the size and the intensity of the foci are in 
proportion to the concentration of interferon applied. This latter 
point suggests that the foci produced in the single cell assay vary in 
area and intensity because the single cells used in the assay were each 
producing different amounts of interferon. If this suggestion is 
correct, ie: that interferon production is unequal amongst the cell 
population then it remains possible that some cells are producing 
amounts of interferon too low to be detected in the assay.
This point can be further clarified by examining the range of foci 
that are produced in an assay plate. Since it seems likely from the 
variation in area and intensity of the foci, that sub-population3 of cells 
exist amongst a cell culture which each produce different amounts of 
interferon; the distribution of these sub-populations can be examined 
by measurement of the area of these foci. Figure 24 shows such an 
analysis. The variation in diameter of foci wa3 examined in assay 
plates produced from four separate L929 cell assays, and the foci were 
grouped into one millimetre size groups. These data show that three 
out of four assay plates contain these size groups in an approximately 
normal distribution, while one assay plate shows a slightly skewed 
distribution. If the single cell assay was only sensitive encught to 
detect cells producing a minimum amount of interferon then the skewed 
distribution seen in one out of the four plates will have been expected 
in all assay dishes. However since three out of four plates show an 
approximately normal distribution then it seems more probable that
M  i l
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ability of these amounts of interferon to confer protection upon the 
indicator monolayer is shown by the areas of protected cells produced 
by each drop. The results show that amounts as low as 0.5 units can 
produce detectable foci within the assay, thus the sensitivity of 
the assay is within the range of yields as shown in figure 22. This 
data also shows that the size and the intensity of the foci are in 
proportion to the concentration of interferon applied. This latter 
point suggests that the foci produced in the single cell assay vary in 
area and intensity because the single cells used in the assay were each 
producing different amounts of interferon. If this suggestion is 
correct, ie: that interferon production is unequal amongst the cell 
population then it remains possible that some cells are producing 
amounts of interferon too low to be detected in the assay.
This point can be further clarified by examining the range of foci 
that are produced in an assay plate. Since it seems likely from the 
variation in area and intensity of the foci, that sub-populations of cells 
exist amongst a cell culture which each produce different amounts of 
interferon; the distribution of these sub-populations can be examined 
by measurement of the area of these foci. Figure 24 shows such an 
analysis. The variation in diameter of foci wa3 examined in assay 
plates produced from four separate L929 cell assays, and the foci were 
grouped into one millimetre size groups. These data show that three 
out of four assay plates contain these size groups in an approximately 
normal distribution, while one assay plate shows a slightly skewed 
distribution. If the single cell assay was only sensitive enought to 
detect cells producing a minimum amount of interferon then the skewed 
distribution seen in one out of the four plates will have been expected 
in all assay dishes. However since three out of four plates show an 
approximately normal distribution then it seems more probable that
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FIGURE 24. Variation of the size of foci seen in the single 
cell assay.
-15
Number of foci -10 \ ■
in each size
group. -5
15
-10
-5
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0.5-0 .9  IjO-1.9 ZO-2.9 3.0-3.9 4.0-45 5.0-5.9
Diameter (mm) of foci.
Single cell assay plates from four separate assays ( using NDV-F 
infected L929 cells; see methods for details ), were examined 
for the number and size of foci.
i
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this assay is capable of detecting all of the cells which are producing 
interferon. This does not rule out the possible existence of a 
sub-population of cells which produce a range of very low amounts of 
interferon.
One further point which tends to support the argument that the 
assay can detect all the cells producing interferon is that if virus- 
infected L929 cells are placed in a single cell assay using indicator 
monolayer cells which are known to have greater sensitivity to 
interferon, (eg: C3H cells) then a larger number of foci are not seen 
(data not given). C3H cells frequently show an increase in sensitivity 
to the anti-viral action of interferon of approximately 0.5 log units 
(my observation); however these cells were not suitable for routine use 
as the indicator monolayer cells because their sensitivity to the 
cytolytic virus altered considerably with increasing passage.
Thus observations on the sensitivity of the single cell assay 
does suggest that the assay is capable of detecting all the cells capable 
of producing interferon in the NDV-F/L929 interferon-inducing system.
Can the percentage of virus_infected cells able_to produce interferon 
be_increased_?
It has been shown that when L929 cells are infected with an 
optimum amount of NDV-F only a small percentage of cells produce 
interferon (figure 14), and furthermore, that this percentage of cells 
probably produces unequal amounts of interferon. It was therefore of 
interest to see if the interferon production at the population and the 
single cell level could in any way be increased. This was done for 
two reasons; firstly, the question of why all the cells in a population 
do not produce interferon is by itself interesting, and secondly, the
\
main aim of this study was to exarrnt interferon production in differen­
tiating cells which initially did not produce interferon. Therefore, 
to accurately observe the latter it is necessary to use interferon 
inducing conditions that optimised interferon production in 100?£ of 
the cells in the cell culture under study.
Figures 25 and 26 illustrate two attempts to increase the 
interferon yield in L929 cells. Figure 25 shows the variation in 
interferon production per culture in cell cultures which had been pre­
treated with small amounts of interferon prior to being exposed to an 
interferon inducer (this is termed priming and has been described in 
the introduction). Cell cultures were primed with 3-12 units per ml 
of interferon and then induced with either virus or with dsRNA, the 
subsequent interferon yields showed that priming did not enhance 
production, therefore interferon production was not examined at the 
single cell level.
Figure 25, shows the effect of pretreatment of L929 cells with 
sodium butyrate. The interferon yield can be seen to increase by 
approximately six fold, but the single cell assay data show that this 
increase is not duo to an increase in the number of cells able to 
produce interferon and therefore must be a result of an increased 
output per existing producer cell.
These results show that the L929 cell population can be induced 
to produce larger amounts of interferon by appropriate pretreatment, 
however, in the case of butyrate, this pretreatment does not alter the 
number of cello able to produce interferon.
Why cannot one hundred percent of culture cells produce _interferon?
Two possibilities suggested themselves as to why all culture cello
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FIGURE 25. The effect of pretreatment of cells with small
amounts of interferon, on the yield of interferon 
obtained following subsequent induction.
Interferon Amount of IFN used to pretreat cells (u/ml).
inducers
0.0 3.0 6.0 12.1
NDV-F virus 
(100 HA)
*
4.6 4.7
##
4.6 4.6
Sendai virus 
( 10 HA)
5.4 ND 4.8 4.9
Synthetic ds- 5.4 ND 5.4 5.5
RNA, Poly rI:rC. 
(lOug + lOOpg 
DEAE dextran)
Confluent monolayers of L929 cells (containing approximately 10 
cells) were incubated with maintenance media,containing interf- 
-eron at various concentrations, for a period of six hours. The 
cells were then washed with PBS and virus or dsRNA added as ind- 
-icated for a further hour. The cells were again washed three 
times with PBS and refed with maintenance media. At approximately 
20 hours post-infection the cell supernatants were harvested and 
cell numbers counted; the supernatants were treated to inactivate 
virus (see methods) and to inactivate dsRNA ( by addition of 
ribonucleases) and assayed for yield of interferon by INAS 
assay (as described in methods.). Triplicate monolayers yielded 
similar results.
* = Interferon yield expressed in log units.
** = Not done.
FIGURE 26. The effect of pretreatment of cells with Butyrate, 
on interferon yield per population and on the 
single cell production of interferon.
Interferon yield 
per cell population 
(units/cell).
percentage of 
single cells 
producing 
interferon.
Expt. 1 Expt. 2.
Four monolayers of L929 cells were seeded at a density of 5«105 
per 3cm dish; two dishes were refed with growth media, the rem- 
-ainder with growth media containing one millimolar Sodium 
Butyrate. After 48 hours the cells were washed and infected with 
100 HA NDV-F for one hour at 37°C, the cells were again washed 
three times with PBS and then trypsinised to a suspension of 
single cells. A small aliquot of this suspension was used to 
provide cells for the single cell assay? the remainder were 
returned to the culture dish for approximately 20 hours. The 
supernatants were harvested and the cell numbers per culture dish 
counted; the supernatants were treated to inactivate virus (see 
methods) and then assayed for interferon yield by INAS assay 
as described in methods.
( (¡3 ), Control cultures. ( O  ), Butyrate treated cultures.
* single cell assay is described in methods.
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could not produce interferon upon virus infection.
(a) The ability to produce interferon is dependent upon the stage 
of the cell cycle of the individual cell, this will vary 
between different cell lines.
(b) The cell population are heteroger^bus in their ability to 
produce interferon, any cell line will contain multiple 
sub-populations of cells which differ slightly in their 
genetic constitution, which may influence interferon production.
Figure 27 shows the interferon production over a period of 
52 hours, in cell cultures synchronised with respect to cell cycle.
The interferon per culture can be seen to increase by approximately 
15 fold at approximately 30 hours post-seeding, but no such increase 
was seen in interferon production at the single cell level. The 
interferon yields of the cell culture were reduced compared to control 
levels whereas the percentage of single cell producers did not differ 
from that seen in control cultures.
Figure 28 shows the results obtained from examination of interferon 
production at the single cell level in L929 cell populations which 
had been cloned from single cells. Fifty-four cloned colonies were 
obtained, the percentage of single cells able to produce interferon was 
examined in 24 of these (all contained approximately 50 000 cells). A 
variation was seen amongst these colonies in the percentage of single 
cells able to produce interferon, however, no colonies showed a greater 
percentage of single cell interferon producers than that seen in control 
cultures; but several of the colonies showed a reduction in the 
percentage of single cell interferon producers. These data suggest 
that the cell population is heterogenous in its ability to produce 
interferon but, this heterogeneity does not explain the inability of 
some cells in the population to produce interferon.
\
FIGURE 27, Interferon production at the population and the single 
\ cell level in L929 cells synchronised with respect to 
cell cycle.
134
L929 cells synchronised with respect to cell cycle, were obtained by 
gentle agitation of a recently confluent monolayer of cells. The 
suspended cells were sedimented by centrifugation at 2 000 rpm for 
five minutes and resuspended in fresh growth media at a density of 
1«105 per ml, then seeded into 3cm dishes. Control cell cultures were 
obtained by trypsinisation of similar monolayers, these were seeded at 
the same density. At various intervals post-seeding duplicate cell 
cultures were induced to produce interferon by infection with 100 HA 
NDV-F for one hour. All cultures were then treated with antiserum 
raised to NDV-F for a further hour then trypsinised to a suspension 
of single cells; a small aliquot of which were used in the single 
cell assay (performed as described in methods), the remainder being 
returned to the culture dish to provide samples for assay of interf­
eron yield (cell supernatents were treated to inactivate virus then 
assayed by INAS assay as described in methods).
(----) = mean values obtained from control cultures.
( □  ) = cells synchronised with respect to cell cycle.
135
FIGURE 28. The percentage of single cell interferon producers 
in L929 cell populations cloned from single cells.
A monolayer of L929 cells were trypsinised to a suspension of 
single cells, this was diluted to a concentration of 1 000 cells 
per ml, and lpl of this dilution added to separate wells in two 
"raicrotiter" plates. The wells were examined under light micro­
scope and only those containing one cell were cultured in growth 
media. A random selection of cloned cell populations was examined 
in the single cell assay for interferon ( a 3  described in methods). 
The above histogram shows the variation in the percentage of single 
cells able to produce interferon; os the cloned cell populations 
are passaged. Three cloned populations are illustrated ( □  ) C3,
( {3 ) C5, ( □  ) C6; in addition results are shown from a popul­
ation of non-cloned 1.929 cells ( B  ), which were assayed simul- 
-taneously.Each bar represents the results from triplicate cultu­
res which were tightJy grouped around the mean. *
* Passage number since cloning.
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■ Interferon production at the single cell level was examined in 
three cloned populations during five subsequent passages and compared 
to control cultures (figure 28). The behaviour of the control cultures 
altered during the period of the experiment (this phenomenon has 
already been referred to in figure 13). However, these data do show 
that the cloned cell populations differ from the control cultures only 
for the first two passages, thereafter the cloned cell populations 
behave similarly to the control cultures.
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SECTION ONE ---- DISCUSSION
The data presented above has shown that results from an assay 
capable of detecting interferon production from single cells as 
described by Osborn and Walker (1969) and Kronenberg (1977), was 
complicated by the presence of the interferon-inducing virus used 
initially to infect the test single cells (see figure 11). Cells 
infected with NDV-F produced material capable of producing foci within 
the single cell assay, and the production of these foci could be 
completely prevented by prior incubation with antiserum raised to 
NOV-F. during the time course of the assay, the virus infected cells 
released NDV-F particles capable of directly inducing interferon in the 
indicator monolayer cells, the diffusion of these particles was only 
slightly inhibited by the agar used to suspend the single test cells.
Thus the assay as described by Osborn and Walker (1969) and Kronenberg 
(1977) was in reality capable of detecting two events, firstly, interferon 
production from the virus infected single cells suspended in agar and 
secondly, the ability of the cells in the indicator monolayer to respond 
to the virus which desorbed from these single cells.
A modified single cell assay was designed (and is fully described 
in Methods) which incorporates a stage wherein the interferon-inducing 
virus is neutralised by specific antiserum. This neutralisation stage 
involved treatment of the test cell monolayer immediately following the 
one hour infection period and prior to the trypsinisation of the test 
cells, and was sufficient to completely remove any foci caused by the 
inducing virus alone (see figures 10 and 11). The resultant foci 
seen in the modified single cell assay can be shown to be solely due
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to interferon production from the single test cells. Incorporation of 
antiserum to mouse interferon completely removed all the foci produced 
in the modified assay by virus infected cells.
The modified single cell assay contains five main stages, and 
each stage was examined to assess its role in influencing the result 
obtained with the assay.
NDV is known to be a good inducer in mouse cells (Meager and 
Burke 1972, Wagner and Huang 1966, Fleischman and Simon 1974), and 
NDV-F is used routinely to induce interferon production in many different 
mouse cell types. In addition this strain has no pathenogenic effects 
and has less cytolytic effects on cells in culture than the other 
mesogenic and velogenic strains of NDV. The data presented above 
(figure 14) has shown that cultures of L929 cells infected with NDV-F 
produce a maximum interferon yield per culture at a particular virus/ 
cell ratio, and that increasing the amount of virus does not increase 
the interferon yield per culture. Examination of the behaviour of 
single cells in this system, shows that only approximately one third 
of the cell population are producing interferon; this suggests that 
the majority of cells are not capable of producing interferon in 
response to infection by NDV-F. There are two possible reasons for 
this, either these non-producer cells are not infected by this virus 
(or the formation of the actual interferon inducer molecule does not 
occur) or, these cells do not produce interferon in response to infection 
by this virus (alternatively these cells could produce amounts of 
interferon too low to be detected by the assay). The first possibility 
(ie: that the virus does not infect the majority of cells) is unlikely, 
since Brown et^  al. (1980) have shown that one hundred percent of L929 
cells can be infected by infectious NDV. In addition Fleischman and 
Simon (1973) have shown that one hundred percent of L929 cells can be
. V
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infected by Mengovirus. Thus it seems improbably that a large sub­
population of culture cells cannot be infected by virus, which suggests 
that a large sub-population of cells are unable to produce interferon 
in response to virus infection. The finding of phenotypic variation 
amongst individual cells in a cell culture is not unexpected even in 
recently cloned cultures. The individual cell genotype can become 
abnormal in passage resulting in the existence of discrete sub­
populations of cells which each respond differently to the same 
stimulus; the sum of the behaviour of these discrete sub-population3 
comprising the "normal" response shown by the cell population.
The modification made to the original single cell assay involves 
treatment of virus-infected cells with antiserum raised to the inducing 
virus. Treatment of virus infected cells prevented the desorbtion of 
virus from infected cells during the course of the assay (figure 11).
It is not clear exactly how antisera is involved in the neutralisation 
of virus at the cellular level, nor is it known how or if neutralisation 
of virus at the cellular level affects subsequent interferon yield. 
Treatment of infected cells does act to prevent NDV-F from the single 
cells from reaching the indicator cells below; this might be because 
the antiserum acts to prevent the desorbtion of the virus or to 
neutralise the free virus. The results presented above do however 
show that treatment of virus infected cells with specific antiserum at 
one hour post-infection does not inhibit subsequent interferon yields. 
This latter point is relevant since it is proposed that the formation 
of dsRNA, on initial step in the replication of this virus, may 
constitute the actual interferon inducer (Horser and Burke 1979) and 
interference with this step by the neutralising antibody may have 
affected interferon yields.
\
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It has also been shown above that it is possible to dispense cells 
into the assay with a reasonable degree of accuracy. The degree of 
inaccuracy increases with cell numbers of fifty, or less, but as shown 
in figure 18 cell numbers of one hundred can be dispensed with an 
error of ± 15?ó. The result of the assay relates the number of cells 
added to each assay plate, to the number of foci counted at the 
completion of each assay. The number of foci seen will depend on the 
sensitivity of the assay, and data presented above has shown that the 
assay can detect interferon amounts as low as 0.5 units per microlitré. 
The sensitivity of the conventional interferon assays (see Introduction 
and Methods) depends on the cells and the system in use and with a 
sufficiently sensitive system It"is theoretically possible to detect 
one international reference research unit of interferon. Thus the two 
types of assay have a similar but not directly comparable sensitivity. 
Examination of the foci produced within the assay (figure 24) suggests 
that all of the interferon producer cells in a cell culture can be 
detected by the assay; although it still remains possible that cells 
producing vastly reduced amounts of interferon do exist but cannot be 
detected by the assay.
The timing of events within the assay are the same as those used 
by Kronenberg (1977); virus infected cells are left in the assay for 
approximately 18 hours. If this period of incubation is greatly 
extended then the foci become larger in area and less distinguishable 
from each other. However this period of 18 hours is not rigid; because 
similar results are obtained when the single cells are removed any 
time from 14-20 hours post-infection. The substitution of agarose for 
agar was not found to influence the result of the assay.
The monolayer used throughout the results presented in this study 
was composed of L929 cells and the condition of the monolayer was of
\
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great importance in producing clear, easily discernable foci. The 
parameters which affected the behaviour of the monolayer were the cell 
density, the even distribution of cells across the dish and the 
attachment of cells to the substrate. The effect of cell density on 
the sensitivity of the cells to EMC has been described and this 
remained unchanged throughout use of the assay; the adhesive behaviour 
of the L929 cells was however, found to fluctuate.. The assay involves 
a stage whereby the agar and single cells are removed, the monolayer 
washed and then infected with a cytolytic virus; this procedure 
periodically resulted in the partial or complete removal of the cell 
monolayer. To prevent this, the culture plates used for the single 
cell assay were coated with 0.1?o gelatin, and the plates were air 
dried before use (see methods). The plates were further incubated 
with growth media for one hour at 37°C before the indicator monolayer 
cells were added. This ensured a more even distribution of these cells, 
and in particular prevented the central clumping of cells which always 
occurred without this pretreatment process. If the cells in the 
indicator monolayer were not evenly distributed, the cells tended to 
form clumps and swirls which obliterated much of the foci produced 
in the assay.
A variety of stains (Trypan Blue, Crystal Violet, Neutral Red,
Giemsa ) were used to identify the foci formed in the monolayer, and a 
O.lfi solution of Crystal Violet was found to give optimum results.
Thus the modified single cell assay (as described in Methods) 
can detect interferon production from single cells without detecting 
the virus used to induce interferon in the test cells. In addition 
the procedures involved in this assay do not hinder interferon production 
from the single test cells. The assay can be used for a variety of
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cell types (human and mouse cell types have been assayed successfully) 
and for a variety of interferon inducers providing it can be ensured 
that the inducer does not directly affect the indicator cells. The 
procedures involved are straightforward, relatively simple and take an 
average total of approximately four hours to complete.
Interferon induction and production are usually examined in terms 
of the average response of a large population of cells. Data obtained 
from single cell studies can more suitably answer questions concerning 
these processes. For example, do procedures such as priming, super- 
induction and pretreatment with certain chemicals like butyrate, which 
increase the interferon yield; result from an increased output per 
cell or from an increase in the number of cells able to produce 
interferon? Such information can more accurately evaluate 'good' and 
'poor' interferon inducers and may help to isolate cells which are 
high producers of interferon. In addition, the single cell assay can 
be used to identify interferon production in cell populations too 
small to produce amounts of interferon which could be assayed in the 
conventional assay systems, eg: cell populations which make up the 
early mouse embryo. Because of the lack of a suitable assay the 
previous work on interferon production in the mouse embryo has been 
performed uoing tissue explant3 taken from embryonic tissues, instead 
of performing direct analysis on the embryonic tissues themselves.
Using the modified single cell assay to examine interferon 
production in NDV-F infected L929 cells it has been shown (figure 13) 
that between 22% and 49?i of cells can produce interferon. The percentage 
of cells able to produce interferon remained constant for periods of 
one to two months only and was found to oscillate between the two above 
extreme values during the course of this study. The source of this 
variation is not clear. The cells were obtained from stocks maintained
in liquid nitrogen, and further stocks were prepared from these cells 
and similarly maintained and used throughout this study. In addition 
a large quantity of NDV-F was also prepared at the begining of this 
study (see Methods), dispensed into 0.25 ml aliquots which were kept 
at -70°C, the virus was not used once thawed and was sufficient for use 
throughout this study. The variations seen in interferon production 
at the single cell level also did not correlate with new batches of 
either media or of serum.
The fluctuations seen in the percentage of cells able to produce 
interferon using apparently constant inducing and assay conditions, 
may indicate that results obtained from different laboratories are 
difficult to compare directly; no clear pattern of the behavior of 
single cells in populations induced to produce interferon has yet 
emerged. The majority of the single cell assay data whether of the 
type described by Kronenberg (1977) or whether involving the examination 
of isolated single cells (Fleischman and Simon 1974) are all complicated 
by the fact that the virus used to induce interferon may also directly 
effect the indicatory cells. Brown £t al. (1980) and Fleischman and 
Simon (1974) have shown that 100% of L929 cells infected by a plaque- 
forming unit of NDV will produce interferon, while Kronenberg (1977) 
using the assay illustrated in figure 4 has shown that only 33-41% of 
L929 cells will produce interferon when infected with excess amounts 
of NDV.
From the results presented above it can be seen that if the single 
cell assay method as published by Kronenberq (1977) is used with the
cells
L929:NDV cell/inducer system then the results show that between 100-150% ofj^ 
can produce interferon; such results are obviously wrong. Modification 
of the assay by introducing a neutralisation stage reduces these figures 
to 22-49%. It is not clear why the use of different methods (the original
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and the modified assay) should produce such similar results with L929 
cells. Kronenberq (1977) also examined the percentage of single cell 
producers in a population of NDV infected HFF (human foreskin fibro- • 
blast) cells and fbund that 50% of cells could produce interferon when 
infected with virus. When NDV-F infected HFF cells are placed in the 
modified single cell assay only 18% are found to produce interferon 
(data not given) using a variety of cells as the indicator monolayer 
cells including GM2504, a human cell line trisomic for chromosome 21 
and therefore possessing greater sensitivity towards interferon. The 
discrepancy between the results obtained by Kronenberg (1977) and 
those obtained with the modified single cell assay may be due to the 
direct induction of foci in the indicator monolayer by NDV itself.
Interferon production in other mouse cell types infected with 
NDV-F is described in a later section; briefly three differentiated 
teratocarcinoma cell lines (F9C1 9, PYS, PSA 5E) which have endoderm- 
like characteristics, were infected with NDV-F and placed in the 
modified single cell assay. The percentage of single cell interferon 
producers was found to be 18% (F9C1 9), 3% (PYS), 0.4% (PSA 5E), the 
interferon yield per culture was found to correlate with the number of 
cells able to produce interferon (ie: PYS cell cultures produced 
approximately six times more interferon than PSA 5E cultures).
Thus it seems that various differentiated mouse cell types vary 
in their ability to produce interferon in response to NDV-F, and the 
source of this variation resides in the number of single cells which 
are able to produce interferon, and not in the variation in the output 
of interferon per cell.
An attempt was made to increase the interferon yield in L929 cells 
infected with NDV-F, by pretreatment of cells. Priming of cells with
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small amounts of interferon did not increase yields. Although priming 
has been reported in L929 cells (Stewart 1979 p233-238), the lack of 
this effect with the cells under study may be because the cells were 
already producing maximum amounts of interferon. Pretreatment of the 
cells with sodium butyrate did however increase interferon yields by 
approximately six fold in the cell cultures (figure 26), but did not 
alter the number of producer cells. Butyrate has been shown to enhance 
interferon production in cultures of Namalwa cells, a human lympho- 
blastoid cell line (Baker jrt 1979); direct measurements of the 
amount of RNA produced in butyrate treated Namalwa cells has shown 
that the amount of interferon mRNA is increased in butyrate treated 
cells (Morser £t al. 1980). Thus butyrate is thought to increase the 
yield of interferon per culture by increasing the rate of transcription 
of the mRNA. This observation is consistent with the finding in L929 
cells that butyrate increases the output per cell without increasing 
the number of cells able to produce interferon.
Thus a situation exists in L929 and other mouse and human cell 
types wherein only a small proportion of cells will produce interferon 
upon virus infection of the culture. A similar situation can be seen 
with Sendai viru3-infected cells; L929 cultures infected with Sendai 
contain approximately 102S single cell producers, while Namalwa cells 
similarly infected contain approximately 40?o single cell producers 
(data not given). The production of interferon at the single cell 
level (and therefore the population level) in response to one virus 
does vary between cell types, and thus is influenced by the genotype, 
however the output per cell can be influenced in some cases by 
appropriate treatment of the cells.
Why cannot one hundred percent of the cell population produce 
interferon? Two possible reasons were suggested. The inability of the
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major proportion of the cell population to produce interferon may be 
due to the stage of the cell cycle occurring at the time the individual 
cell was exposed to the virus. RNA and protein synthesis in eukaryotic 
cells are continuous except for the actual period of mitosis; nuclear 
RNA synthesis is inhibited completely during this stage and protein 
synthesis much reduced (reviewed in De Robertis et al. 1975). The 
production of interferon occurs by activation of a previously inactive 
gene, transcription and translation follow to produce the interferon 
protein (see Introduction), and this process could be envisaged as 
being delayed in cells undergoing mitosis. However the period of 
mitosis is relatively short compared to the remainder of the cell cycle, 
and the assay conditions are such that test cells in a monolayer are 
infected with virus but not trypsinised to a single cell suspension 
until two hours later; thus the viral interferon inducer will be 
present in the cell after mitosis has been completed and before the 
assay is performed. Cells which had been synchronised with respect 
to cell cycle (figure 27) do show an increase in interferon yield 
after approximately 30 hours seeding, but show no increase in the number 
of cells able to produce interferon. This suggests that the cell cycle 
does not influence the number of single cell producers. However, the 
method used to synchronise the cells was simplistic and the degree of 
synchrony within the culture was not checked by other means; this and 
also the reasons behind the reduced output seen in these cells need to 
be re-examined. It is interesting to note that Martin et al. (1969) 
have reported that the gene for tyrosine amino transferase
cannot be induced in synchronised cell cultures during G2, M and early 
G1; although translation of the mRNA can occur during this period.
The inability of the major proportion of the cell population to 
produce interferon may reflect the phenotypic variation existing within
\
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the cell population. No clear result was obtained from the examination 
of interferon production in colonies cloned from single L929 cells.
A variation in the number of single cell interferon producers, different 
to that of control cultures, was seen in the cloned colonies (figure 28) 
but this variation was only negative, no cloned colonies were identified 
containing more than fifty percent single cell producers. In addition 
the difference between the cloned colonies and the control cultures 
decreased with increasing passage.
This experiment suggests that phenotypic variation amongst L929 
cells does influence the number of single cells producing interferon 
upon virus infection, but only to a limited degree. The fact that even 
first passage cloned colonies did not contain some which were capable 
of one hundred percent single cell interferon production may suggest 
that production of interferon at the single cell level is controlled, 
not by one, but multiple factors; only some of which are controlled 
by the genome. De Haeyer and De Maeyer-Guignard (reviewed in De Maeyer 
and De Maeyer-Guignard 1979) have identified the presence of autosomal 
loci (which are not the structural genes for interferon) but which can 
influence the levels of circulating interferon in BalbC and C57D16 mice. 
Four loci have been identified so far each with two alleles regulating 
a higti or low interferon response to a virus inducer. These four 
loci control the circulating interferon response to three viruses, NDV, 
Sendai and mouse mammary tumour virus (Sendai induced interferon 
production is controlled by two loci). In addition these two strains 
of mice, do not contain loci controlling interferon production in 
response to infection by Influenza or Sindbis virus. The alleles con­
trolling circulating interferon levels have been shown to be expressed 
only in cell originating from the bone marrow stem cells, their effects
\
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are not seen in mouse embryo fibroblasts established from these two 
strains are examined.
Thus interferon production is controlled not just by the presence 
of structural genes, but by genes which control the final yield of 
interferon in response to specific inducers, and it would be of interest 
to examine the number of single cell interferon producers present 
in macrophage cultures taken from high and low producer animals.
However, similar genes controlling final interferon yields have not been 
identified in non-bone marrow cells although it is possible that they 
may exist.
The existence of such genes and also of the effects on interferon 
production by the cell cycle discussed above, might explain a feature 
seen in all the single cell assays performed. In all assays the foci 
produced varied in size and intensity, the diameter of the foci varied 
ten fold on average; this, is has been suggested, is due to differential 
production of interferon by the test single cells, and it is this feature 
rather than the number of cells able to produce interferon, which may 
be regulated by the cell cycle and any postulated genes which could 
influence interferon yields.
\
SUMMARY
A modified single cell assay has been designed which can detect 
only interferon production from single cells, this assay is probably 
sensitive enough to detect all cells capable of producing interferon 
within a given cell population. The question of why one hundred percent 
of cells do not prpduce interferon has been explored, but as yet no
clear answer is forthcoming. However the analysis of the NDV/L929 
inducer/cell system has shown that alteration of the treatment of the 
cells in the assay does not alter the result of the assay; this 
therefore suggests that the assay can be used with confidence to 
analyse interferon production in the differentiated cell systems 
(described in the Introduction) which initially lack an interferon 
system.
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SECTION TWO ---- RESULTS
sensitivity in differentiating
teratocarcinoma cells
The status of the interferon system in three 'nullipotent' 
teratocarcinoma cell lines was examined; 'nullipotent' cell lines are. 
those which maintain an embryonal carcinoma cell morphology and phenotype 
when cultured in routine tissue culture media. Figure 29 shows the 
ability of teratocarcinoma cells, cultured with and without retinoic 
acid, to produce interferon in response to a virus inducer and also 
to develop an antiviral state in response to interferon treatment.
These data show that the embryonal carcinoma (ec) cells of two of the 
three cell lines examined do not produce interferon and are not 
sensitive to its antiviral action. The ec cells of the third cell 
line (Nulli ?A) did show low levels of interferon inducibility and 
antiviral sensitivity which were found to increase considerably as the 
cells were caused to differentiate.
If the results from the three differentiated cell cultures are 
compared, it can be seen that the interferon system is most active 
in the Nulli 2A cells and least active in the F9 cells. All three 
cultures appear to contain 100?£ differentiated cells (see later), but 
are each capable of producing varied amounts of interferon. It has 
already been shown in section one that the interferon yield per cells 
from differentiated cell cultures varies considerably, this variation 
is also shown by the differentiating cultures in figure 29. The 
existence of this variation suggests that the absolute extent of the
FIGURE 29. The status of the interferon system in differentiated 
and undifferentiated teratocarcinoma cells.
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PC13 F9 \2A
Three teratocarcinoma cell lines (PC13 C15, F9 and \ulli 2A), were 
cultured for eight days either in growth media, or in growth media 
containing 3*10"6 molar retinoic acid.Cell cultures were then assa­
yed for interferon production following virus induction (as descri­
bed in methods); and also for sensitivity to the antiviral action 
of interferon. The latter was obtained by assaying a sample of IFN 
of known titrc simultaneously upon the teratocarcinoma cells and 
upon control L929 cells, the difference in IFN titre between these 
cello indicates the sensitivity of the teratocarcinoma cells towards 
interferon.
( D  ) cells cultured in growth media
( □  ) cells cultured in media containing 3xl0"bmolar retinoic acid. 
( Q  ) results obtained using control L929 cells, 
jr = zero result obtdindfj.
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production is not related to the extent of differentiation shown by 
the cells in the culture.
The sensitivity of teratocarcinoma cells to the anti-proliferative 
effects of interferon is illustrated in figure 30; PC13 Cl 5 embryonal 
carcinoma cells were cultured over a period of ten days in media 
supplemented with combinations of retinoic acid and interferon, or with 
neither. Ec cells cultured in normal growth media showed a sigmoid­
shaped growth curve and a doubling time of approximately sixteen hours 
under the culture conditions used, and the growth curve of ec cells 
cultured in media containing interferon remained unchanged. Ec cells 
cultured in media containing retinoic acid showed both a reduced 
rate of growth and also a reduction in the density of the culture at 
completion of the experiment, when compared to control cultures.
If ec cells cultured in media containing retinoic acid were treated 
with interferon, the initial rate of growth remained unchanged, but the 
final density of the culture can be seen to be slightly reduced, 
compared to cultures treated only with retinoic acid.
Thus the data from these two figures show that the ec cells of 
the 'nullipotent' cell lines PC13 cl 5 and F9 do not produce interferon 
and are not sensitive to its action. The differentiated cell type 
generated in these cultures by treatment with retinoic acid could 
produce interferon and were sensitive to the anti-viral action of 
interferon, and were probably marginally sensitive to the anti­
proliferative action of interferon. The ec cells of the third cell line 
examined (Nulli 2A) produced small amounts of interferon in response 
to virus infection and showed slight sensitivity to the anti-viral 
action of interferon. Both these aspects of the interferon system 
increased greatly as the cells were caused to differentiate by treatment
with retinoic acid.
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riCUJRE 30. The sensitivity of teratocarcinoma cells to the
anti-proliferative action of interferon.
Time (days) in culture.
A teratocarcinoma cell line (PC13 C15) was seeded at a density of 
2X10^ per 3cm dish at day zero. Cultures were refed at day zero 
with growth media containing either 3xl0"^retinoic acid plus If4 
units per ml interferon (*-0‘")> or with 3xl(]-6retinoic scid 
(— O — )» or with 10 units per ml interferon or with none of
these (— # — ). Cell numbers from triplicate dishes from each of 
the culture coitions were counted at the times indicated.(only trypan 
blue excluding cells were counted). All cultures wore refed every 
two days.
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Why is_the interferon system inoperative in ec cells?
The interferon system has two components, these are production 
of the interferon molecule itself and the sensitivity of the cell to 
the pleiotropic actions of interferon. These two phenomena are distinct 
and separate cellular events, and, although they are usually present 
together in normal cells, they can be separately present or absent 
in some cells (see Introduction). The inhibition of the interferon 
system in ec cells may be due to one or more factors operating within 
the cell and an investigation of the nature of the block inhibiting one 
part of the interferon system may shed light on the degree of 
inhibition of the genome and its activities within the undifferentiated 
cell.
Interferon production is not seen in virus infected primed or 
unprimed ec cells, but it is seen in differentiated endoderm-like cells. 
Since the production of interferon is an inducible event there are two 
main processes which might be involved in the inhibition of interferon 
production in the ec cells. Firstly the molecule comprising the 
actual interferon inducer might be absent or reduced in the undifferentiated 
cell, and therefore the stimulus to activate the interferon gene might 
not be available, and secondly the ec cell may be unable to produce 
and secrete a functional interferon molecule in response to the 
production of the interferon gene inducer molecule.
It is.not knownexactly how the transcription of the interferon 
gene is controlled. Because of the known efficiency to induce high 
yields of interferon, of both negative strand viruses and synthetic 
dsRNA molecules (eg: poly rlsrC); dsRNA itself has been proposed as the 
normal inducer in virus infected cells (Morser and Burke 1979). DsRNA
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is formed in NDV-F infected cells via the action of an RNA polymerese 
and experiments using ultra violet irradiated NDV to induce interferon, 
have shown that loss of the ability to induce the production of interferon 
is associated with a loss in activity of the polymerase in chick 
embryo fibroblast cells (Meager and Burke 1972). However as mentioned 
above the growth of NDV-F in mouse cells cannot be easily measured, 
therefore it is not possible to ascertain whether or not the interferon 
inducer is present to the same degree in both the undifferentiated and 
the differentiated teratocarcinoma cell. However, if it could be 
shown that the virus behaved differently in the ec cell than in the 
differentiated endoderm-like cell then this might indicate that there 
could be differential production of the interferon gene inducer 
molecule between the two different cell types. NDV-F activity cannot be 
simply measured in infected mouse cells, since these cells do not
show either an alteration in host cell synthesis or detectable viral 
synthesis after infections; however it is possible to measure indirectly 
the desorbtion and/or replication of NDV-F from such cells. Figure 31 
shows the desorbtion and/or replication of NDV-F from virus-infected 
teratocarcinoma cells and from control L929 cells. The data presented 
in figure 31 shows that virus desorbtion and/or replication does occur 
for the whole of the 24 hour period following infection of the 
teratocarcinoma cello with NDV-F. The pattern of interference produced 
in the supernatant above the virus infected cells was similar for both 
the undifferentiated ec cell and for the differentiated endoderm-like 
cell. Thus these data show that both the undifferentiated and the 
differentiated teratocarcinoma cells behave similarly at the level of 
binding and release of the virus at the cell surface.
The alternative suggestion is that interferon production is 
inhibited in the ec cell because of a block in transcription or in
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FIGURE 31. The desorbtion of NDV-F from teratocarcinoma cells.
5 cm monolayers of F9 undifferentiated ec cells F9 different­
iated endoderm-like cells (— #-) and L929 cells (--O--) were infected 
with 100 HZ' NHV-F for one hour at 370C. Cultures were then washed 
three times with PBS and referi with maintenance media, this was imm­
ediately harvested to provide the baseline reading ( A ). Cell super­
natants from each culture were harvested at the times indicated, cell 
monolayers were washed after each harvest and refed with maintenance 
media. Samples were spun at 40 000 rpm for two hours, the supernatant 
discarded and the pellet solubilised overnight in four mis media; all 
samples were then assayed for interference using the 1NAS assay as 
described in methods.
in translation of interferon which is removed as the cells different­
iate. This was investigated by a search for interferon mRNA in virus 
infected ec cells. The production of interferon mRNA can be assayed 
by translation of the message in Xenopus oocytes. RNA samples were 
injected into the nucleus and cytoplasm of the oocyte by Dr. A. Colman, 
and additional samples were injected into the oocyte cytoplasm by 
John Shuttleworth of this laboratory. The interferon protein secreted 
by the injected oocyte was assayed in the conventional INAS assay 
described in Methods.
The kinetics of interferon production in virus infected differ­
entiated teratocarcinoma cells was examined to assess the optimum 
time post-infection to extract the induced interferon mRNA. Figure 32 
shows that the synthesis of interferon mRNA or protein cannot be 
detected before 3 hours post-infection, and that the amount of mRNA 
synthesis does not increase beyond that seen at 3 hours post-infection 
although the synthesis of interferon protein from the infected cell 
continues to increase beyond 7 hours post-infection. Therefore it was 
decided to extract the cellular RNA at 6 hours post-infection and assay 
for the presence of interferon mRNA. The result from this experiment 
is shown in figure 33, RNA was extracted from virus infected terato­
carcinoma cells in two ways: (A) extraction of the cytoplasmic RNA and 
(B) extraction of the total cell RNA. The data presented in figure 33 
shows that virus infected ec cells do not produce interferon but the 
virus infected differentiated endoderm-like cell, can produce interferon. 
The RNA extracted from virus infected ec cells did not direct the synth­
esis of interferon when injected into Xenopus oocytes, in contrast to the 
RNA extracted from the virus infected differentiated cell.The RNA extracted 
from virus infected ec cells was injected into the nucleus of the oocyte 
therefore these results suggest that the ec cell is not able to produce 
interferon mRNA (or produces mRNA which cannot be 'matured' in the
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FIGURE 2^. The kinetics of interferon production in differentiated 
teratocarcinoma cells infected with NDV-F.
Time (hours) post-infection with NDV-F.
2
Three 125 cm monolayers of differentiated PC13 cl 5 cells (ie: 
cultured for eight 'days in media containing retinoic acid) were 
infected with 2 000 HA NDV-F for one hour at 37°C. The cultures 
were then washed three times with PBS and refed with maintenance 
media containing 2uci/ml Uridine and incubated at 37°C. At the 
times indicated the cell supernatant was removed, treated to ina­
ctivate the virus and assayed for interferon using the INAS assay 
(as described in methods); the cells were washed three times with 
PBS at 4°C and removed from the culture flasks using the flat area 
of a rubber bung. The total cell RNA was then extracted from these 
cells (see methods for details), samples from this RNA were inj­
ected into the cytoplasm of Xenopus oocytes ( by John Shuttleworth 
from this laboratory). The supernatants bathing the oocytes were 
removed at 24 hours post-injection and assayed for interferon 
yield using the INAS assay.
(“*■©■ *^ interferon yield from supernatant above infected cells.
(— • — ) ". " " " containing oocytes
injected with RNA.
FIGURE 33. The production of interferon mRNA in virus infected 
undifferentiated (EC) and differentiated (END) 
teratocarcinoma cells.
EXTRACTION A EXTRACTION B
EC END EC END
IFN titre (log,0units/ml) 
from infected cell 
supernatant.
0.0 3.6 0.0 3.0
IFN titre (log^units/ml) 
from supernatant bathing 
oocytes injected with RNA 
extracted from infected 
cells
0.0 1.4 0.0 0.85
Activity of extracted RNA 
in rabbit reticulocyte 
system. (?i stimulation 
over blank system)
170 220 140 140
Presence~of bands on 
autoradiograph of poly- 
acrilamide gel of products 
from the RRL system.
++ + ++ +
Presence of ribosomal RNA 
bands in extracted cell 
RNA run on an agarose- 
formamide gel system.
++ ++ ++ ++
Undifferentiated and differentiated teratocarcinoma cells were infected 
with NDV-F for one hour, washed with PBS and then refed with maintenance 
media and incubated at 37°C. At six hours post-infection cell superna­
tants were harvested, treated to inactivate virus and assayed for IFN 
yield using the INAS assay as described in methods. The infected cells 
were washed with PBS at 4°C and removed from culture dishes using the 
flat area of a rubber bung, Cellular RNA was then extracted using two 
methods A, phenol-chloroform extraction of cytosol RNA, and B, Guanid- 
ium Rhodamide extraction of total cell RNA (both methods are described 
in methods). The resultant RNA's were injected into the nucleus of 
Xenopus oocytes by Dr. A Colmnn , the supernatants bathing the oocytes 
were assayed for IFN yield at 24 hours post-injection using the INAS 
assay. The extracted RNA was translated in a rabbit reticulocyte system 
and the products run on a poly-acrylamide gel (see methods)j and also 
examined using an agarose-formamide gel system for the presence of 
ribosomal RNA peaks.
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oocyte nucleus). Figure 33 also includes data collected to ensure 
that the RNA extracted from the ec cell was as capable of directing 
translation a3 was the RNA extracted from the ehdoderm-like cell.
RNA from both undifferentiated and differentiated teratocarcinoma 
cell stimulated protein synthesis in a rabbit reticulocyte system 
(RRL) to the same degree. When the products of the RRL system were 
run out on a poly-acrylamide reducing gel it showed that translation 
of the RNA had occurred, and that the RNA from the ec cell produced
I
considerably more bands on the subsequent autoradiograph than the 
RNA from the endoderm-like cells (all RRL assays were kindly performed 
by Dr. J. Morser). In addition the extracted RNA was also run on 
an agarose-formamide gel system, and the extracted RNA from both cell 
types produced ribosomal RNA peaks of 18s and 28s, with no obvious . 
signs of degradation. Although this observation does not prove that 
the mRNA is intact it does show that obvious degradation of the ribosomal 
RNA bands had not occurred.
Since interferon message cannot be detected in a situation when 
the oocyte would be expected to be able to splice and process immature 
message, it is possible that neither immature nor mature interferon 
message is produced in the embryonal carcinoma cells. Therefore there 
is no need to postulate either processing or translation mechanisms 
in the regulation of interferon production in teratocarcinoma cells.
In vitro differentiation of 'nullipotent' teratocarcinoma cells
'Nullipotent' teratocarcinoma cells can be induced to differentiate 
to an endoderm-like cell by exposure to micromolar amounts of retinoic 
acid. The appearance of differentiation in these cultures can be
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followed by observing changes in morphology and behaviour in the cells 
and also by quantitating changes in the synthesis of certain biochemical 
markers; of which the appearance of interferon inducibility and 
sensitivity is an example. The procedure used to obtain optimum 
differentiation is described in the Methods.
The morphological changes which occur as the undifferentiated 
teratocarcinoma cells are cultured in retinoic acid are illustrated 
in figures 34 a and b which show macroscopic and microscopic views 
of such cultures. The ec cell can be seen to be small in size, 
unevenly spaced and overgrown in some areas, and also poorly attached 
to the substrate (requiring only 30-60 seconds treatment with 8.0 *jg/ml 
trypsin at 37°C to be removed). Because the ec cell is poorly attached 
to the substrate it cannot be passaged in glass culture dishes and 
instead is maintained j_n vitro using gelatinised culture plates 
(see Methods). The differentiating culture is seeded at a low cell 
density into retinoic acid containing media, and after two to three 
days treatment, colonies of morphologically differentiated cells are 
formed (see figure 34a). The differentiated endoderm-like cell is 
usually larger than the undifferentiated ec cell (the exact size 
depends upon the available space) and becomes more firmly attached to 
the substrate (requiring treatment for three to four minutes with 
80.0 ¿ig/ml trypsin at 37°C to be removed). The cells become extremely 
flattened and difficult to see by phase microscopy and form orderly 
arrays within three to four days exposure to retinoic acid. In contrast 
to the ec cell, the growth of the differentiated cell becomes contact 
inhibited, if the cuture remains in retinoic acid containing media, 
resulting in a much reduced cell density.
All three teratocarcinoma cell lines studied (PCD Cl 5, F9 and 
Nulli 2A) showed most of the above changes upon treatment with retinoic
FIGURE 34a. Macroscopic view of embryonal carcinoma cells cultured 
for various periods of time in retinoic acid.
4
2*10 PC13 cl 5 embryonal carcinoma cells were seeded into 3 cm 
gelatinised dishes containing growth media plus 3*l0"^f1 retinoic 
acid, and cultured over a period of twenty days. The media was 
changed every two days, at the intervals indicated on the above 
photograph (ies 5, 10, 13 and 20 days) cultures were washed with 
PBS, fixed with 100SS methanol and stained with Giem3a, before 
being photographed.
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Fir,USE 34b. Microscopic view of embryonal carcinoma cells cultured 
for various periods in media containing retinoic acid.
V  . <*
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The cells were prepared as described in figure 34a; with the exception 
that the ec cello shown in A, were grown for eight days without 
retinoic acid (RA) before being fixed and stained. The cello were 
photograhed using a light microscope and brightfield illumination.
acid, the changes in morphology all occurring after two to three days 
exposure to retinoic acid.
In figures 35 and 36 the changes in the pattern of protein 
synthesis which occur in a differentiating teratocarcinoma culture 
are examined. Both figures show microdensitometer scans of auto­
radiographs made from polyacrylamide gels in which cell lysates had 
been run; these lysates were of methionine-labelled teratocarcinoma 
cells treated for various periods with retinoic acid. Figure 35 shows 
two such scans which result from samples of ec cells grown for eight 
days in culture with and without retinoic acid. Considerable changes 
in protein synthesis profile can be seen. The relative amounts of many 
of the proteins synthesised is altered in the sample taken from differ­
entiated teratocarcinoma cells; and in addition the area under this 
curve is 40?o less than that obtained from samples of ec cells. It can 
be seen from figure 36 that these changes in protein synthesis profile 
are obvious after the ec cell has been treated with retinoic acid 
for two days, and become increasingly more pronouryed the longer the 
time the cells are exposed to this vitamin.
Thus it can be seen that the changes in protein synthesis profile 
become apparent at approximately the same time as changes in the cell3 
morphology and behaviour are observed. The onset of these structural 
changes will be discussed later in relation to the onset of production 
or changes in production of biochemical markers associated with 
differentiation.
The effect of retinoic acid on interferon yield from differentiated_cells
Retinoic acid is used to induce differentiation in ec cells, and 
the ability of ec cells to respond to this vitamin has been correlated
166
FIGURE 35. A microdensitometer recording from an autoradiograph of 
a poly-acrylamide gel containing samples of 35s methio­
nine labelled PC13 El 5 teratocarcinoma cello.
PC13 Cl 5 ec cells were seeded into dishes containing growth media 
or growth media plus retinoic acid, after eight days in culture at 
37°C, the cultures were washed three times with PBS and then refed 
with serum and methionine-free media which contained lOOjjci 35s 
methionine, for 30 minutes at 37°C. The cell monolayers were then 
washed several times with PES kept at 4°C, scraped off the dish using 
the flat area of a rubber bung and solubilised in tri3-SDS (as 
described in mehtods). Samples were then mixed with an equal amount 
'blue buffer' (see methods) boiled for three minutes, spun for five 
minutes using an eppendorf microfuge. Volumes of the samples cont­
aining 100 000 cpm were loaded onto the poly-acrylamide gel 
(see methods for gel preparation). The gels were fixed and dried, 
autoradiographs were prepared and the relative densities of each track 
was scanned using a Joyce-Loebl microdensitometer.
(------) tracing of densitometer scan of samples from PC13 cl 5
cultured in growth media for eight days.
(----- ) tracing of densitometer scan of samples from PC13 cl 5
cultured in growth media containing 3 xlO-^ molar retinoic 
acid, for eight day3.
FIGURE 36. Microdensitometer scan of an autoradiograph of a poly­
acrylamide gel containing samples of teratocarcinoma cells 
cultured for various periods in retinoic acid.
Mlr.'t (xlO?) 17 30 49 77 95H5 stackerI I 1111 9el
PF13 cl 5 ec cells were cultured for 0, 2, 4, 6 and 8 days in retinoic 
acid, before being exposed for a brief period to methionine, cell 
samples were then prepared as described in figure V>, and the subseq­
uent. autoradiograph was scanned ufeing the Joyce-LoebL microdensit­
ometer. The recordings were photoreduced and then traced.
with the presence of a cytosol retinol-binding protein (Jetten and 
Jetten 1979, Schindler et^  al_. 1981) and it is thought that retinoic 
acid may act in a manner analogous to that of the steroid hormones, 
by directly influencing transcription events in the genome. It was 
therefore of interest to see if differentiated cells treated with 
retinoic acid produced an altered yield of interferon. Three differen­
tiated teratocarcinoma cell lines were examined. These are permanent 
cell lines in contrast to the differentiated cells established from 
embryonal carcinoma cells. Figure 37 shows the results obtained 
from three differentiated cell lines PSA 5E, PYS and F9 Cl 9. The 
cells of the former express markers characteristic of visceral 
endoderm. While the latter two lines express markers characteristic 
of parietal endoderm. The data from figure 37 shows three main 
points; firstly culture of these cells in 3 x 10-^ M retinoic acid has 
no significant effect on interferon production from these cells, 
secondly retinoic acid inhibited cell growth in the two parietal endoderm 
cell lines but showed no inhibition of the growth of the visceral 
endoderm cell line, thirdly each of the three cell lines showed a 
wide variation in interferon production at the population and the 
single cell level; in particular the number of cells able to produce 
interferon varied from 0.35& (PSA 3E) to 18?i (F9 cl 9).
The kinctic'sof interferon production in differentiated terato- 
carcinoinn cultures.
Cell differentiation in ec cell cultures treated with retinoic 
acid is marked by morphological and behavioural changes as described 
above, and also by the changes in production of certain biochemical 
markers. The kinetics of interferon production at both the population
168
169
FIGURE- 37. The production of interferon in differentiated terato-
carcinoma cell lines infected with NDV-F.
IFN production after 
8 days in culture.
PSA 5E 
( VE*)
PYS
(PE)
F9 cl 1 
( PE*
a: Population yield 
(xiO 5 units/cell)
0.6 45.0 180.0
b: %age single cell 
IFN producers.
IFN production after 
8dys exposure to 
3xl0-6 molar retinoic 
acid.
0.35% 3.1% 18.0%
a: Population yield 
(xlo3 units/cell
0.4 60.0 169.0
b: % age single cell 
IFN producers.
ND ND ND*
% depression of cell 0.0 70.0 88.0
numbers seen in cul­
tures treated with 
retinoic acid.
Three differentiated teratocarcinoma cell lines PSA 5E, PYS and F9 
cl 9 were seeded at,an initial density of 5*10^ per 3cm dish into 
either growth media or growth media plus 3x10“*’ molar retinoic acid. 
After eight days in culture the cultures were infected with 100 HA 
NDV-F for one hour at 37°C, washed three times with PBS and then 
cultured for a further hour with media containing antiserum raised 
to NDV-F. The cell monolayers were then trypsinised to a suspension 
of single cells, a small aliquot of which was used to provide cells 
for the single cell assay (performed as described in methods) the 
remainder were returned to the culture dish. After approximately 20 
hours post-infection the cell supernatants were harvested and cell 
numbers were counted. The supernatants were treated to inactivate 
residual virus and assayed for interferon yield using the INA5 assay 
as described in methods.
* (VE) cells produce biochemical markers characteristic of visceral 
endoderm.
**(PE) cells produce biochemical markers characteristic of parietal 
endoderm.
** ND not done.
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and the single cell level was followed in the three teratocarcinoma 
cell lines described in figure 29. The results of this series of 
experiments are presented in figures 38 a, b and c. In this figure 
interferon production and cell growth were examined over a 20 day 
period after the ec cells were exposed to retinoic acid. These data 
show three general features; firstly, interferon production both at 
the populationand the single cell level rises from an initial zero 
level (except for Nulli 2A), reaches a peak value and then declines 
rapidly. This decline in production is not due to obvious cell death 
only trypan blue excluding cells were counted (only rarely were non- 
trypan blue excluding cells seen), and in addition the cell number was 
still increasing in two out of the three cell lines after the decline 
in interferon production was seen. Secondly, the maximum percentage 
of single cells able to produce interferon varied between the three 
cell lines from 12% (Nulli 2A) to 1% (PC13 cl 5) and U% (F9), and this 
variation was generally reflected in the population interferon yields. 
Thirdly, if the results from PC13 cl 5 and F9 are compared (which 
differentiate into endoderm-like cells with characteristics of visceral 
and parietal endoderm respectively), it can be seen that there are no 
differences in the kinetics of the development of interferon production. 
The differentiated PC13 cl 5 culture contained approximately twice as 
many single cell interferon producers when compared to the number seen 
in the differentiated F9 culture. In view of the variation seen in the 
differentiated cell lines (figure 37) this may represent an innate 
variation between cell lines rather than a difference between visceral 
and parietal endoderm cells.
Of the three cell lines the growth of F9 was least affected by 
culture in retinoic acid, for these cells reached eight times the 
density of the PC13 cl 5 culture. However the rate of growth of cultures
exposed to retinoic acid is not correlated with the number of single
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FIGURE 3Pa The kinetics of interferon production in differentiating
PC13 cl 5 teratocarcinoma cells.
Cell number 
per 3cm dish 
(X1GA)
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PC13 cl 5
É
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2X10 PC13 cl 5 embryonal carcinoma cells were seeded in 3 cm dishes 
containing growth media plus 3X10"^ molar retinoic acid. At the times 
indicated duplicate cultures were infected with 100 HA NDV-F for one 
hour,the cells were then washed three times with PBS and then incubated 
for a further hour with media containing antiserum raised to NDV-F.
The cells were then trypsinised to a suspension of single cells, a 
small aliquot of this suspension was used to provide cells for the 
single cell assay (performed as described in methods), the remainder 
were returned to the culture dish. At approximately 20 hours post­
infection the cell supernatant was harvested, treated to inactivate 
virus and assayed for interferon yield using the I\AS assay (as desc­
ribed in methods).
( 1 ) assay performed and 7cro result obtoined.
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FIGURE ÎCb. The kinetics of interferon production in differentiating
F9 teratocarcinoma cells.
lxlG F9 embryonal carcinoma cells were seeded into 3cm dishes 
containing growth media plus 3X10“^ molar retinoic acid. 
Interferon production at the population and the single cell level 
was examined in the differentiating cell culture as described in 
figure 36a.
( I ) assay performed and zero result obtained.
.A
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FIGURE 30c. The kinetics of interferon production in differentiating 
Nul.li 2A teratocarc.inoma cells.
5 10 15 20
Time (days)
5x10 Nulli 2A embryonal carcinoma cells were seeded into 3 cm dishes 
containing growth media plus 3x10“^ molar retinoic acid. Interferon 
(IFN) production at the population and the single cell level was 
examined in the differentiating cell culture os described in figure 3fla.
( f ) assay performed and zero result obtained.
FIGURE 3Gc. The kinetics of interferon production in differentiating 
NuJli 2A teratocsrcinoma cells.
5 10 15 20
Time (days)
5x10 Nulli 2A embryonal carcinoma cells were seeded into 3 cm dishes 
containing growth media plus 3xl0*6 molar retinoic acid. Interferon 
(IFN) production at the population and the single cell level was 
examined in the differentiating cell culture os described in figure 30a.
( ^ ) assay performed and zero result obtained.
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cell interferon producers seen in that culture; Nulli 2A differentiated 
cultures contained the highest percentage of single cell interferon 
producers but had a final cell density intermediate between that of 
PC13 cl 5 and F9. If the plates resulting from the single cell assay 
are examined (see figure 39) it can be seen that the size of the foci 
produced as the cells differentiate is not constant. Foci produced 
from cells after five days treatment with retinoic acid are uniformly 
small (approximately 2-3 mm in diameter) whilst those from cells which 
have been in culture 10-15 days show a large variation in size 
(approximately 1-5 mm in diameter). These date suggests that the yield 
of interferon per cell is changing as the cells are treated for 
increasing lengths of time with retinoic acid.
It is possible to enrich the number of single cell interferon 
producers and therefore the population yield in differentiating cultures 
24 hours prior to induction of interferon. The results of such an 
experiment are shown in figure 40. Differentiating teratocarcinoma cells 
were trypsinised (using trypsin of greater concentration than that used 
for ec cells) and reseeded onto non-gelatinised dishes, thus selecting 
for cells with increased adhesiveness. The effect of this procedure 
at all time intervals (except for ec cells not treated with retinoic 
acid) was to enhance the interferon yield at both the single cell and the 
population level. Thus these data suggest that the cell able to produce 
interferon is more able to withstand the trypsinisation procedure and 
to establish themselves on non-gelatinised dishes, than are the 
remaining cells in culture.
The differentiating teratocarcinoma cell lines can be seen to 
produce considerably less interferon (see figure 38) than that produced 
by L929 cells induced under similar conditions (see section one). 
Pretreatment of L929 cells with small amounts of interferon prior to
FIGURE 39. Embryonal carcinoma cells induced to differentiate by 
retinoic acid show an increase in yield of interferon 
per sinqle cell.
Interferon production from single cells was examined in a differ­
entiating population of PE13 cl 5 teratocarcinoma cells as descr­
ibed in figure 38a. The above photograph shows typical single cell 
assay plates obtained from teratocarcinoma cells cultured for five, 
ten and fifteen days in retinoic acid and then induced to produce 
interferon.
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FIGURE 40. Interferon production in populations of differentiating 
teratocarcinoma cells trypsinised and reseeded prior to 
interferon induction.
IFN yield 
(xlO^ units 
per cell)
Percent 
single cell 
IFN producers
Time (days)
PC13 cl 5 embryonal carcinoma cells were seeded at a density of 3 000 
per cm^ into 9cm gelatinised plastic culture dishes into growth media 
containing 3X10-6 molar retinoic acid. 24 hours before the time inter­
vals indicated the cultures were trypsinised ( BO^jg/ml Trypsin) to a 
suspension of single cells and seeded into non-gelatinised 3cm plastic 
dishes at a density of 1x106 per 3 cm. At the times indicated the 
reseeded cultures were infected with 100 HA NDV-F for one hour at 37 C 
washed three times with PCS then cultured for a further hour with media 
containing antiserum raised to NDV-F. Interferon production was then 
examined at the population and the single cell level as described in 
figure
( ♦  ) assay performed and zero result obtained.
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interferon induction (ie: priming) did not increase the subsequent 
yield; it was suggested that this was because the cells v/ere already 
synthesising interferon at maximum levels . Differentiating terato- 
carcinoma cultures do not synthesise maximum levels of interferon until 
approximately 15-20 days after treatment with retinoic acid, and 
therfore it is possible that these cultures could be primed during 
their early exposure to this vitamin. Figure 41 shows the interferon 
yield at both the population and the single cell level in differentiating 
teratocarcinoma cultures primed prior to induction. Since it has been 
show that trypsinisation and reseeding the culture can enhance the 
number of single cell interferon producers, this procedure was used to 
obtain cells with the aim of increasing any result shown by priming.
The data from figure 41 shows that differentiating teratocarcinoma 
can be primed to increase interferon yields but only for a limited 
period following exposure to retinoic acid. An enhancement of yields 
was seen in the period 5-10 days after treatment with retinoic acid 
in all the triplicate plates that were primed, and although some 
difference was seen between the primed and non-primed 15 and 20 day 
cultures, the range of results from these cultures did overlap. The 
single cell assay data shows that where an increase in yield was 
seen after priming, the number of single cells able to produce interferon 
did not increase; thus the action of priming is to increase the amount 
of interferon produced per cell and not the number of cells able to 
produce interferon. It is possible that cultures treated for 15 to 20 
days with retinoic acid could not be primed because such cultures 
were already producing maximum amounts of interferon.
Ec cells cultured in retinoic acid differentiate, and since the 
culture then becomes able to produce interferon upon induction, it was 
of interest to discover the minimum period of exposure to retinoic
FIGURE 41. Priming of teratocarcinoma cells cultured in retinoic 
acid for various periods of time.
0 5 10 15 20
Time (days) in culture.
Cultures of differentiating PC13 cl 5 cells were prepared as des­
cribed in figure 40., six hours prior to the times indicated 
cultures were either primed for six hours with maintenance media 
containing 10/j/ml mouse interferon ( El ), or refed with maintainance 
media only ( E3 )• The cell monolayers were then washed with PBS and 
induced to produce interferon by virus infection. Interferon 
production at both the population and single cell level was examined 
as described in figure . Each bar represents the mean value from 
triplicate culture dishes, values were tightly grouped around the mean.
( 4 ) assay performed and zero result obtained.
acid needed to obtain the maximum production of interferon in such 
cultures. The results of this experiment are shown in figure 42. In 
this experiment two sets of cultures (A and B) were prepared, Culture A 
contained PC13 cl 5 embryonal carcinoma cells seeded into growth media 
containing retinoic acid; at daily intervals up to day 14, these 
cultures were induced to produce interferon by virus infection. Culture 
B, were similarly seeded but at daily intervals the retinoic acid 
containing media was removed and substituted by normal growth media. 
Interferon induction was performed on culture B cells only after a four 
day period in the absence of retinoic acid. Thus culture B represents 
results obtained from a series of dishes treated for periods of one 
to ten days with retinoic acid but then cultured for a period without 
this vitamin.
If the interferon production from cultures A and B are compared, 
for example at day 10, it can be seen that culture A cells (ie: cells 
in culture for ten days and exposed to retinoic acid for ten days) have 
a mean yield of 36 x 10~Vcell, whilst culture B cells (ie: cells in 
culture for ten days but only exposed to retinoic for the first six 
days) have a mean yield of 4.0 x 10-Vcell. The yield seen in culture 
B cells at day ten is similar to the range seen in culture A cells at day 
six, and this suggests that the development of maximum interferon 
yields requires continual exposure to retinoic acid for longer than 
six days. For the first 12 days in culture the results obtained from 
culture B cells are reduced compared to culture A. Thus a period of 
exposure to retinoic acid longer than eight days is required for maximum 
yields. After 12 days in culture the yields from both cultures reach 
a similar order of magnitude.
Thu3 the data from figure 42 shows three main points. Firstly 
exposure to retinoic acid for at least eight days is required for
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FIGURE 42. The relationship between interferon yield in different- 
\ iating teratocarcinoma cells and the length of time the
cells are exposed to retinoic acid.
_____ f\ B
ays in IFN N° of IFN N° of
alture yield* cells** yield cells
0 - 8 r- 8
1 0 - - -
2 0 47 -
3 0.5 - - -
4 0.7 129 - -
5 1.2 - 0.03 -
6 1.2 170 0.6 335
7 11.0 - 3.5 -
8 12.8 160 5.0 275
9 30.0 - 7.1 -
10 36.0 142 4.1 250
11 37.0' - 12.0 -
12 200.0 178 20.0 250
13 281.0 - 225.0 -
14 300.0 186. 225.0 315
%
PC13 cl 5 embryonal carcinoma cells were seeded at a density of 
exlO4 per 3 cm dish into growth media containing 3x10“^ molar 
retinoic acid. The cells in culture A were induced to produce 
interferon on the day in culture indicated , the cells in culture 
B were on the same day transferred to growth media lacking retinoic 
acid after copious washing. Culture B calls were maintained in media 
lacking retinoic acid for a period of four days, the media being 
changed daily, the cells then being induced to produce interferon in 
the same manner as used for culture A.
For interferon induction cell monolayers were infected with 100 HA 
NDV-F for one hour at 37 C then washed three times with PBS before 
being refed with maintenance media. At approximately 20 hours post­
infection the cell supernatants were harvested and the cell numbers 
counted. The cell supernatants were treated to inactivate residual 
virus and then assayed for interferon yield using the INAS assay 
as described in methods. Each result represents the mean from tri­
plicate dishes, values were tightly grouped around the mean.
* IFN yield 10^ units/cell 
**Cell number 10"^ per 3cm dish.
- not done.
maximum interferon yields in teratocarcinoma cultures, secondly, ec 
cells develop a detectable interferon yield after only one days exposure 
to retinoic acid. Thirdly, there are cells which exist even after 
ten days treatment with retinoic acid which show an increased replication 
rate when retinoic acid was removed; the cell densities seen in culture B 
are all greater than that seen in culture A.
It has been shown by Strickland and Mahdavi (1978) that sequential 
treatment of F9 ec cells (with first retinoic acid then diButyrl-cAMP) 
increased the degree of differentiation seen in the resultant culture 
as measured by the expression of the biochemical marker plasminogen 
activator factor. The ec cells from both PC13 cl 5 (which differentiates 
into cells with biochemical characteristics of visceral endoderm) and 
from F9 (which differentiates into cells with biochemical characteristics 
of parietal endoderm) were treated in a manner which followed the 
Strickland and Mahdavi (1978) protocol, and examined for interferon 
production. The results from this experiment are shown in figures A3 
a and b, which described results from six series of cultures. Only four 
sets of data are shown for day three but six sets of data are presented 
for days 3ix and nine. This is because culture series 5 and six are treated 
for a total of six days before being induced to produce interferon. 
Comparison of the results obtained from both cell lines shows that 
while the growth of the two cell lines was differentially effected, 
the ability of the treated cultures to produce interferon was similar.
The control ec cultures and those treated with retinoic acid behaved 
as expected (see figure 38); however diBcAMP produced different effects 
on the replication of the two cell lines. The replication of PC13 cl 5 
was completely inhibited by this chemical whilst the replication of 
F9 wa3 not affected. Activation of the interferon system in diBcAMP 
treated cells wan seen in the F9 cultures but this was minimal (3 000
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FIGURE 43a. Interferon production in PC13 cl 5 embryonal carcinoma 
treated with retinoic acid and dibutryl-cyclic-AMP.
Time (days) in culture.
PC13 cl 3 embryonal carcinoma cells were seeded into six separate 
series of culture dishes at a density of 3x10** per 3cm.
The first series ( 0  ) was refed with growth medio only.
The second series ( O  ) with growth media plus 3xl0“^molar RA.
The third series ( ED ) with growth media plus 10" BiBcAMP.
The fourth seris ( fl ) with growth media plus both 3*10“6i-t RA
and in-3:t DiEcAMP.
The fifth series ( ED ) with growth media plus 3xlG-^M RA for the
first 3 days, cells were washed thoroughly 
and refed with growth media plus 10”3(1 DiBcAMP. 
The sixth series ( Q  ) with growth media plus 10~^ f* DiBcAMP for the
first 3 days, cells were washed thoroughly 
and refnd with growth media plus 3xl0"°M RA.
At days 3, 6 and 9 post-seeding triplicate plates from all six series 
were induced to produce interferon. 100 HA NDV-F wa3 added for one 
hour at 37®c, cultures were washed three times with PBS then refed 
with maintenance media. At 20 hours post-infection cell supernatants 
were harvested and cell numbers counted; the supernatants were treated 
to inactivate residual virus then assayed for interferon yield using 
the INAS assay as described in methods. Each bar represents the mean 
result from triplicate dishes, value's were tightly grouped around the 
roan.
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FIGURE 43b. Interferon production in F9 embryonal carcinoma cells 
treated with retinoic acid and dibutryl-cyclic-AMP.
FIGURE 43b:legend as figure 43a.
i
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fold less than seen in retinoic acid treated cultures) while no 
activation was seen in PC13 cl 5 cultures similarly treated. In neither 
cell type was an enhancement of interferon inducibility seen when 
retinoic scid and diBcAMP were applied to cells either simultaneously 
or sequentially, and the general effect of diBcAMP is to prevent further 
development of interferon inducibility in both cell types and to 
inhibit cell replication in PC13 cl 5 only.
sensitivity in differentiating
^nulligotent' teratocarcinoma cells
It has been shown that interferon production develops over a 
period of time after the exposure of teratocarcinoma cells to retinoic 
acid. Figure 44 examines the development of anti-viral sensitivity 
to interferon in differentiating teratocarcinoma cultures. The 
sensitivity of these cultures to the anti-viral action of interferon 
was determined by assessing the extent of virus replication in the 
differentiating teratocarcinoma cells previously treated with a 
standard amount of interferon (performed as described for the INAS 
assay in Methods). The response of a control sample of L929 cells 
similarly treated was always included in the assay because of the 
known variation shown by this assay. Figure 44 shows that the 
development of interferon anti-viral sensitivity is similar to the 
development of interferon inducibility in the differentiating cultures; 
interferon anti-viral sensitivity increases during exposure to retinoic 
acid, and with PC13 cl 5 cells this can be seen to reach a maximum and 
thento decline. The decline in interferon nnti-viral sensitivity wo3 
not seen in the F9 or the Nulli 2A cultures, although interferon
FIGURE 44. The development of interferon anti-viral sensitivity 
in differentiating teratocarcinoma cells.
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Embryonal carcinoma cells from three teratocarcinoma cell lines 
wore seeded into 9cm dishes at a density of 3 000 cells/cm^ into 
growth media containing retinoic acid. 25 hours prior to the time 
intervals indicated the differentiating cultures were trypsinisod 
(Bug/ml trypsin) and reseeded into 250;j1 'microtitrc' plates which 
had been treated with 0.1ft gelatin (see methods); control 1929 cells 
were also seeded at the same time into the inicrotitre dishes. For 
each time point a sample of interferon of known titre, was assayed 
simultaneously upon both the teratocarcinoma cells and the L929 cells 
using the INAS assay an described in methods.
( ED ) IFN titre upon PC13 cl 5.
( ED ) IFN titre upon F9 cells.
( B  ) IFN titre upon Nulli 2A cells.
( Q )  IFN titre upon control 1929 cells.
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inducibility (see figure 38) had declined in these cultures by day 13 
and day 10 respectively. Thus although the general trend of the 
development of interferon anti-viral sensitivity is similar to the trend 
seen in the development of interferon inducibility, the actual kinetics 
do differ.
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SECTION TWO ---  DISCUSSION
The data presented in figure 29 shows that the embryonal 
carcinoma cells (ec) of PC13 Cl 5 and F9 teratocarcinoma cell lines do 
not produce interferon in response to virus infection and are not 
sensitive to the anti-viral action of interferon. The differentiated 
progeny of these cell lines do show both interferon inducibility and 
sensitivity. The behaviour of the Nulli 2A teratocarcinoma cells 
differed slightly; the ec cells showed slight interferon inducibility 
and sensitivity which increased markedly upon differentiation. PC13 Cl 5 
and F9 are recently recloned "nullipotent" cell lines that undergo little, 
if any spontaneous differentiation in vitro but can be induced to differ­
entiate by treatment with retinoic acid (Rees et al 1979’and Strickland 
and Mahdavi 1978). Nulli 2A is similarly a "nullipotent" cell line 
but it has not been recloned since it was established (Martin and Evans 
1975). The small amount of interferon inducibility and sensitivity seen 
in the ec cells of Nulli 2A suggest that this cell line undergoes some 
degree of spontaneous differentiation whilst in culture, or alternatively 
may suggest that this cell line has become heterogeneous.since it was 
established.Despite this, data from the Nulli 2A cell line is included 
in this study because, firstly, the activity of the interferon system 
does increase greatly upon differentiation and secondly, the different­
iated progeny show a greater level of interferon production and 
sensitivity than that shown by PC13 Cl 5 and F9 endoderm-like cells.
The activation of the interferon system in cultures of differen­
tiated teratocorcinoma cells was first examined by Burke edt _al_ (1978). 
These workers were similarly unable to induce interferon production 
(using a wide range of inducers and conditions ) in undifferentiated
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cells. The cell lines examined were however, multipotent in vitro 
and could be induced to differentiate by culture at low density. The 
data described above confirms that 'nullipotent' embryonal carcinoma 
cells also have an inactive interferon system which develops as these 
cells are caused to differentiate jji vitro to an endoderm-like cell.
The use of such homogeneous cultures capable of only limited differenti­
ation ui vitro makes available a system wherein the development of 
the interferon system can be investigated as only one differentiated 
cell type is generated, and therefore any differences in the development 
of this system as different teratocarcinoma cell lines are caused to 
differentiate can also be compared.
The growth of ec cells in interferon-containing media was 
examined in figure 30 and it was found that cell replication was not 
affected by treatment with 10^ units per ml of interferon. Taylor- 
Papadomitriou (1980) and Hicks et^  j d . (1981) have both shown that 
transformed and normal cells will show an inhibition of growth if 
treated with interferon concentrations of between lO^-lO^ units per ml. 
Ec cells cultured in retinoic acid and interferon simultaneously, did 
not show a reduction in the rate of replication but did show a reduced 
cell density at completion of this experiment ( this effect was not 
noticed when the cells were treated with interferon at 10^ units per ml). 
This minimal effect on the growth of the differentiated cell may be 
due to the fact that the growth of the culture is already markedly 
inhibited by retinoic acid, which would reduce any anti-proliferative 
action of interferon.
It has been reported that interferon production and sensitivity 
in a few cell lines, increases a3 these cells are 'aged' in vitro; 
ie: left undisturbed in culture for a period of eight to ten days 
(Carver and Marcus 1967, Morgan 1976). Since ec cells are cultured 
undisturbed for similar periods of time it is possible that the
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observed increase in activity of the interferon system may be related 
to this ageing phenomenon. However, neither L929 cells nor differ­
entiated ec cells show an increase in interferon production associated 
with ageing. Comparison of interferon yields from a culture of ec cells 
treated with retinoic acid for seven days in undisturbed conditions, 
with a similar culture trypsinised and reseeded onto gelatinised 
plates 24 hours prior to interferon induction, shows that ageing does 
not increase interferon yields (data not given).
The lack of interferon production and sensitivity can be attributable 
to many causes. Both these phenomena require the interaction of an 
inducer with the cell and the subsequent activation of previously 
inactive gene(s). Thus the cause of the inhibition of the interferon 
system in ec cells can lie at the level of cell/inducer interaction or 
at the level of transcription or translation of the induced gene 
product.
The behaviour of (lytic) virus interferon inducers in both ec and 
differentiated cells, is generally held to be similar. SFV (Burke et al. 
1978) and EMC, Sindbis, Vacinnia, VSV (Teich et a_l. 1977) are lytic 
viruses which are all able to replicate equally well in undifferentiated 
and differentiated teratocarcinoma cells. Although the growth of the 
viral interferon inducer used in this study (ie: NDV-F) cannot be 
measured in mouse cells; it can nevertheless be shown (see figure 31) 
that the rate of desorbtion is similar in the ec and the differentiated 
cell during the time course of the assay for interferon production. 
Examination of the activation of the interferon gene in ec cells (by 
assay of the production of IFN mRNA, see figure 32) in response to 
virus infection suggests that transcription of the interferon gene does 
not occur in the ec cell. At the time the experiment was undertaken 
it was not known if the interferon gene contained introns, which would
\
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require post-transcriptional maturation of the message. Because of this 
the RNA extracted from the infected cells was injected into the nucleus 
of the Xenopus oocyte, which is capable of maturation of such message. 
Recent examination of cloned human interferon genes has shown that 
neither the alpha nor the beta classes of interferon contain introns 
(see Introduction); although there are some workers (Sehqal et al. 1981) 
who consider that there exists an additional series of interferon 
genes, which contain intervening sequences, in addition to those already 
identified. The structure of the mouse interferon genes is not clear, 
but there are as yet, no reasons to consider that these sequences 
will differ from the form seen in human cells.
A system analogous to the lack of production of IFN-mRNA in 
induced ec cells, is that seen when these cells ore infected with some 
integrating viruses. Wild-type SV40, Polyoma and ecotropic murine 
C-type (eg: Moloney leukaemia) viruses, which all require splicing of 
mRNA prior to translation, do not replicate in ec cells but will 
replicate in the differentiated cell type (Swartzendruber et al. 1977, 
Teich e^ sd. 1977 and Segal et £l. 1979). The lack of replication 
of these integrating viruses is thought to be due to the absence of a 
factor in the ec cell rather than a positive block on replication.
Gautsch (1980) formed hybrids of ec cells with cells permissive for 
SV40 virus replication, and found that these hybrid cells were able to 
produce infective virus. SV40 virus has been shown to absorb, penetrate, 
uncoat and migrate to the nucleus in infected ec cells (Lehman £t al. 
1975, Swartzendruber £t ^1. 1977 and Segal et al. 1979); thus the 
inhibition of replication of these types of virus in ec cells is 
considered to involve either integration or transcription of the viral 
genome. Swartzendruber et al. (1977) were unable to identify integrated
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provirus in SVAO or Polyoma infected ec cells, but Segal et al_. (1979) 
could identify the presence of non-spliced SVAO viral mRNA in infected 
cells, which was in contrast to the spliced SVAO viral mRNA seen in 
differentiated cells. In addition Knowles et al_. (1980) have 
inserted a cloned single copy of the SVAO genome plus an adjacent 
thymidine kinase gene, into thymidine kinase negative F9 ec cells.
These ec cells show transcription of the thymidine kinase gene in the 
absence of apparent transcription of the SVAO genome, and on differ­
entiation of the ec cell, SVAO viral proteins can be detected. These 
experiments suggested that the ec cell was unable to mature the viral 
transcripts prior to translation. However the story is 
more complex for Kelly and Bocarra (1976) have shown that adenovirus 2 
(a lytic virus requiring splicing of transcripts prior to translation) 
can replicate, albeit to a reduced degree, in ec cells. More recently, 
Katinka et^  jal. (1980 a and b) have shown that mutants of SVAO and 
Polyoma (which have the same in vitro transformation ability and in vivo 
tumourigenesis as the wild type virus) are able to replicate in ec cells. 
The mutation in these variants are thought to affect the area of the 
viral genome associated with the initiation of transcription. Thus it 
seems more probable that an aberration in the initiation of trans­
cription exists in ec cells preventing the replication of these 
integrating viruses. This explanation may also explain the lack of 
production of interferon and of the antiviral enzymes in the ec cello.
Work by Wood and Hovanessian (1979) and Hovanessian et al. (1981) 
has shown that in interferon-treated cells only one of the antiviral 
enzymes normally associated with interferon sensitivity is produced.
PCCA ec cells treated with interferon show an elevation of 2'5' oligo A 
synthetase butnot on elevation of the protein kinase. Wood and 
Hovanessian (1979) proposed that the lack of interferon sensitivity seen
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in ec cells was due to lack of production of one of the anti-viral 
enzymes and not due to a failure of transduction of the inducer signal 
to the appropriate genes. However, as has been described in the 
Introduction, although the presence of these anti-viral enzymes is 
associated with the anti-viral state in interferon treated cells, 
direct measurement of these enzymes can be misleading. Meurs ejt^ al^ . 
(1980) have examined a human cell line which develops an anti-viral 
state in response to interferon treatment, but does not show elevation 
of the two anti-viral enzymes. In addition Epstein et al. (1981) have 
reported an NIH3T3 cell line which fails to develop an antiviral 
state in response to interferon treatment but shows elevated levels 
of these enzymes. This cell line has been shown to lack production 
of the endonuclease which is activated by 2'5' A oligonucleotide 
synthetase. Recently Nilsen et^  al_. (1980) have shown that although 
interferon treated PCC4 ec cells do not exhibit an anti-viral state 
when infected with VSV virus, they do exhibit this state when infected 
with picornovirus (EMC or Mengo) or with temperature sensitive mutants 
of VSV. These results support the view that interferon inhibits viral 
replication in a variety of ways, and that interferon sensitivity needs 
to be examined using a range of viruses. Ec cells from PC13 cl 5 and 
from F9 cell lines were examined to see if these cells could exhibit 
an antiviral state when infected with EMC. Such a state was not found 
in either of these cell lines, in addition, the minimal sensitivity 
shown by Nulli 2A was not increased when the ec cells were infected with 
EMC (data not given). These results suggest that the PCC4 line, on 
which many interesting features have been demonstrated, may differ 
considerably from the 'nullipotent' ec cell lines used in this
Differentiation of_'nullipotent' ec cells treated with retinoic_acid
' \
Examination of the morphology of retinoic acid treated ec cells 
(see figure 34 b) shows that although changes in phenotype are apparent 
by day five, the fully differentiated phenotype does not appear until 
between days five to ten. The differentiating cells show an increase 
in cell size until a confluent cell culture is obtained. A decrease 
in cell area is then seen as the cell density increases. The photo­
graphs presented in figure 34 b were taken from a culture of PC13 cl 5 
cells treated with retinoic acid (shown in figure 34 a) which showed 
that although 100?i of cells were differentiated by morphological 
characteristics, a nevertheless small percentage of cells did not assume 
the elongated, flattened shapes seen in the latter photographs of 
gigure 34 b, but instead continued to resemble the cells which formed
O
after five days treatment with retinoic acid. The behaviour of F9 
and Nulli 2A differed slightly from that of the PC13 cl 5 cells; Nulli 
2A showed a more rapid transition to the flattened, elongated phenotype 
and no morphologically undifferentiated cells could be detected. F9 
cultures, in contrast, contained many scattered foci of apparently 
undifferentiated cells which persisted despite repeated trypsinisation 
and reseeding of the differentiating cultures onto non-gelatinised 
plates; the undifferentiated cells in the reseeded cultures were found 
growing in clumps on top of the differentiated cell, which were able to 
attach to the substrate. Strickland and Mahdavi (1978) report that 
morphological changes can be seen in the cells after> 24 hours treatment 
with retinoic acid, when cells were observed to move apart and become 
better attached; such changes were not observed in the cells used in 
thi3 study until after two to three days treatment with retinoic acid.
As described above, the attachment of the ec cells to the substrate is
mpoor, and these cells when confluent can be removed from the culture 
dish by simply pipetting in a versene solution. The attachment of the 
cells to the substrate increases during differentiation, for ec cells 
cultured for a few days in retinoic acid require incubation with 
trypsin (80.0^jg/ml for 3-4 minutes at 37°C) to remove the cells.
The microdensitometer scans presented in figures 35 and 36 show 
that considerable changes in protein synthesis occur as ec cells 
differentiate. These changes are already noticable by day two and are 
in advance of observable changes in morphology. The autoradiograph 
scans presented in these figures were from gel tracks which received 
an equal loading of acid-precipitable counts. Despite this procedure 
the weight of the area under the scans from the tracks which contained 
ec cells treated with retinoic acid, are considerably reduced compared 
to that from ec cells not treated with retinoic acid. There is no simple 
explanation for this. It is possible that more labelled protein was 
loaded onto the tracks containing the ec cells and the cells treated 
for short periods in retinoic acid than was indicated from the counts 
per minute obtained after acid precipitation. This might occur if the 
ec cells contained a large amount of unlabelled protein which quenched 
the emissions from the labelled protein. However this is just 
speculation and it is not clear why this phenomenon should be observed. 
This behaviour does not seem to be an aberration of the gel system since 
all samples were run on the same gel. The effect was greater the longer 
the cells were exposed to retinoic acid and also the effect was obtained 
repeatedly with different samples and different gel systems. It has 
been reported by Paulin et ol_. (1978) that undifferentiated and 
differentiated teratocarcinoma cells contain similar amounts of actin 
and tubulin which undergoes reorganisation to form microfilaments and 
microtubules during differentiation. The only polypeptide seen not to
\
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alter in relative amount in figure 35, was one slightly smaller than 
49Kd MWt, which is prooably actin. Lovell-Badge and Evans (1980) have 
examined the change in protein synthesis in differentiating terato- 
carcinoma cells using a two-dimensional gel system. Changes in 
protein synthesis were seen to occur in advance of morphological 
change in the cells, but the alterations in protein synthesis were few 
in number compared to the total number of polypeptides involved.
The process of differentiation in teratocarcinoma cells can be 
followed by measuring the levels of expression of some biochemical 
products. There have been some reports however that retinoic acid can 
influence the levels of some of these biochemical markers in 'normal' 
differentiated cells not undergoing differentiation. Wilson and Reich 
(1979) report that retinoic acid increases the level of plasminogen 
activator factor (PAF) ten fold in chick embryo fibroblasts. Jetten 
et^  jal. (1979) have shown that retinoic acid increases the cell surface 
incorporation of fibronectin and glycosaminoglycans, and Jetten (1980) 
has shown that retinoic acid increases the number of epidermal growth 
factor (EGF) receptors on the surface of mouse fibroblasts. All of 
these products have been shown to increase as teratocarcinoma cells 
are caused to differentiate (Linney and Levinson 1977, Wartiovaara 
et al_. 1978 a, b, Rees jrt £l. 1979). The action of retinoic acid in 
influencing the yield of these products from 'normal' differentiated 
cells differs from its action on differentiating cells in that the action 
is reversible; Jetten (1980) reports that the numbers of EOF receptors 
returns to normal three days after the retinoic acid is removed.
Pretreatment of 'normal' differentiated cells with retinoic acid 
does not alter subsequent interferon yields, but addition of this 
vitamin after the cells have been induced to produce interferon has 
been shown to influence yields. Blalock and Gifford (1976, 1977)
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report that retinoic acid inhibits interferon synthesis if applied 
soon after the interferon inducer, and this inhibition: is thought to 
occur via an effect on transcription. Abb and Dienhardt (I960) also 
report that retinoic acid inhibits the production of gamma interferon 
from mitogen stimulated lymphocytes whilst enhancing DNA synthesis in 
the same cells. Thus the reports that exist show that interferon 
synthesis is supressed only if retinoic acid is applied after the 
inducer; therefore all cells treated with retinoic acid in this study 
were induced to produce interferon in the absence of retinoic acid.
The use of interferon production and sensitivity as_a marker_of cell 
differentiation in teratocarcinoma cell cultures
Treatment of ec cell cultures with retinoic acid allows the 
development of interferon inducibility and sensitivity over a period 
of approximately 15 days (see figure 38). The pattern of interferon 
production in these cultures follows the pattern observed in the 
change in cell size (see figure 34). Both interferon production and 
sensitivity .and cell size are found to be maximal at approximately day 
15, when the culture has just reached confluence, and theftdecrease 
thereafter. The increase in cell size is difficult to quantify 
exactly as the cell borders are indistinct in older cultures and the 
cells become extremely flattened, but approximate measurements can be 
made. During the period five to ten days after the addition of retinoic 
acid, cell size increases two fold whilst interferon production increases 
five fold. For the period five to fifteen days after the addition of 
retinoic acid cell size increases three fold while interferon production 
increases thirty-four fold. And finally, during the period five to 
twenty days after the addition of retinoic acid cell size increases
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two fold while interferon production increases twenty-fold. Thus 
although the pattern of change in interferon yield does follow that of 
the change in cell size, the degree of change does not correlate. This 
comparison suggests that a proportion of the observed changes in 
interferon production are secondary to the retinoic acid induced change 
in cell size (the larger the cell the greater the synthetic ability). 
However because the changes in interferon production do not correlate 
exactly with the changes in cell size other factors must be involved 
in regulating the increased yield.
The maximum level of interferon production at both the single 
cell and the population level in a differentiating teratocarcinoma 
culture, can be seen to vary greatly (see figure 38); this variation was 
also seen in results obtained from differentiated teratocarcinoma cell 
lines (see figure 37). Thus it would seem that this variation in 
interferon production does not reflect the degree of differentiation 
obtained in the culture but can be attributed to the biological variation 
normally seen between different cell lines.
The majority of the reports concerning the measurement of bio­
chemical products, during teratocarcinoma differentiation, measure levels 
at any time between three to twelve days after the addition of retinoic 
acid, and therefore an understanding of the kinetics of the development 
of the differentiated state is not available. There are however, some 
exceptions. Ree3 et al. (1979) and Adamson et ol. (1979) report that 
maximum activity of EGF receptors and of collagen synthesis in 
differentiating cultures of PC13 cl 5, occurred at approximately six 
days after the addition of retinoic acid to these cultures.
The numbers of single cell interferon producers i3 seen to increase 
during differentiation to reach' maximum levels which varied from 3-26?o
\
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of the cells in culture (see figure 38). With any assay it is not
* S
possible to say that no product is present, merely that the assay system 
in use can detect no product. With this in mind, the results from the 
single cell assay suggest that as the ec cells are caused to 
differentiate the number of single cells able to produce interferon 
increases to reach a maximum level. Since interferon production is not 
expressed in all single cells in a differentiated culture (see section 
one) this assay system can only provide limited information on the 
differentiation of individual teratocarcinoma cells.
There are many parameters used to follow the differentiation of 
ec cells vitro. These have been described in the Introduction in 
general terms. As described above, the ec cell lines used in this 
study differentiate into endoderm-like cells which have characteristics 
resembling either visceral or parietal endoderm. These two types of 
endoderm are generated in the six day old mouse embryo from the 
primitive endoderm. It has been shown (Dziadek and Adamson 1978) that 
visceral endoderm cells secrete alphafetoprotein (AFP), whilst cells 
from the parietal endoderm do not secrete AFP but instead secret plasmino­
gen activator factor (PAF) (Strickland and Sawey 1980). It has however 
been demonstrated by Bode and Dziadek (1979) that PAF can be detected 
in the visceral endoderm of the mouse embryo and it is thus not a 
unique marker for parietal endoderm; but this secretion is apparently 
not detected in cultures of differentiating ec cello which produce 
visceral endoderm (Strickland et al. 1980). Appropriate use of AFP 
(and possibly PAF) can be used to examine the generation of these 
two types of endoderm In vitro; Hogan et al. (1981) have demonstrated 
that F9 ec cells (known to produce parietal on exposure to retinoic 
acid) will generate cells with a visceral endoderm morphology which 
secrete AFP if allowed to differentiate in retinoic acid media in the
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form of cell aggregates. The same cells treated as a monolayer with 
retinoic acid plus Dibutry1-cAMP will differentiate into parietal 
endoderm-like cells which do not secrete AFP.
The information obtained from examination of the interferon system 
in differentiating teratocarcinoma cell cultures shows that there is 
no difference in the activation of the interferon system between 
cultures that produce differentiated cells resembling either visceral 
or parietal endoderm. The activation of the interferon system can 
therefore be used as a marker of differentiation in all cultures of 
teratocarcinoma cells.
The experiment presented in figure 41, which shows that trypsin- 
isation and passage of the differentiating cultures onto non-gelatinised 
dishes can increase the percentage of single cell interferon producers; 
indicates that the differentiated population is heterogerfbus. At all 
times during the differentiation period (ie: 5 to 20 days) passage of 
the cells increased the number of single cell producers in the culture. 
The procedure involved in passage would be expected to select against 
the undifferentiated cell, because the ec cell is less tolerant of the 
concentration of trypsin used (80.0 }jg/ml) and cannot readily attach to 
a non-gelatinised dish. However because this enrichment was seen in 
cultures already producing maximum levels of interferon (ie: day 15) 
this experiment suggests that at this period there exist a population of 
cells which differ in their reaction to passage when compared to the 
cells producing interferon. By morphological and other biochemical 
criteria two cell populations do not exist, but ns judged by the 
behaviour of the cells on passage, two cell populations do exist.
Examination of the reversibility of the effect of retinoic acid 
on the interferon system in differentiating teratocarcinoma cello (see 
figure 43), ha3 shown that the increase in interferon yield in these
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cultures is not reversible. Removal of retinoic acid does not cause 
a decrease in interferon yield but, it does prevent the full development 
of the interferon system; the ec cells were shown to require treatment 
for up to eight days with retinoic acid before maximum interferon yields 
were obtained. In contrast to the effect of retinoic acid upon 
interferon production, the effect of this vitamin upon growth of these 
cells was seen to be reversible. At all times up to ten days treatment 
with retinoic acid, removal of the vitamin allowed a burst of cell 
replication. This increase in cell number may be due to the presence 
in the culture of a sub-population of cells si^ceptible to the growth 
inhibitory effects of retinoic acid, but unable to differentiate. The 
effect of retinoic acid upon interferon production in these cultures is 
not reversible and is therefore a consequence of differentiation itself.
Treatment of differentiating teratocarcinoma cells with combin­
ations of retinoic acid and of DiButrylcAMP was not found to enhance 
interferon production in either F9 or PC13 cl 5 cells. However this 
experiment did highlight a difference in behaviour between these two 
cell lines. The replication of undifferentiated and differentiated 
PC13 cl 5 cells was completely inhibited by addition of DiButrylcAMP, 
whereas the growth of F9 was unaffected by treatment with this chemical. 
This suggests that both the ec and differentiated cells of these two 
cell lines are widely different. Strickland et^  £l. (1980) has reported 
that F9 ec cells treated sequentially with first retinoic acid and then 
DiButrylcAMP show an enhanced differentiation; laminin synthesis, in 
addition to increases in PAF and collagen synthesis can be detected.
Kuff and Fewell (1980) also report a similar increased differentiation 
as measured by acetyl cholinesterase activity, in F9 cells similarly
\
treated.
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0°i£_£l_i!2Î:£EÎ££2L! in i£e control of growth and differentiation
Reports were described in the Introduction concerning the possible 
biological role for interferon in the regulation of normal growth and 
differentiation in vivo. Some evidence has been presented to support 
this role for interferon in regulating the behaviour of cells derived 
from the bone marrow stem cells (Kimchi jet ad. 1981 a and b, Dolei et al 
1980). The production of spontaneous interferon in cultures of differe­
ntiating teratocarcinoma cells was examined during a period of ten days 
in culture and found to be negative (data not given). Since it has been 
shown earlier that the ec cells are insensitive to the anti-proliferative 
and anti-viral actions of interferon, this result although not 
surprising is worth obtaining, for interferon has frequently been shown 
to produce paradoxical effects when applied at high or low concentrations 
(Rossi et 1979b and 1980, and Dolei jet_ al_ 1980). Thus these results 
show that interferon is probably not involved in regulating growth and 
differentiation in teratocarcinoma cells. It is possible that the 
explanation for the lack of involvement of interferon in these processess 
in ec cells, lies in the fact that interferons can be induced under 
various pathological conditions. Therefore the production of interferon 
is not under adequate control, and it is possible that embryonic cells 
(as typified by the ec cells) have evolved to lack an interferon system 
to avoid any possible external and uncontrolled influence upon 
crucial differentiation stages.
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SUMMARY OF SECTION TWO
It has been shown that cloned 'nul.lipotent' embryonal carcinoma 
cells do not possess an active interferon system and that the lack of 
this system may be related to a block at the level of transcription 
in these cells. When these ec cells are treated with retinoic acid 
there is a development of interferon inducibility and sensitivity which 
extends over a period of fifteen to twenty days, and is coincident 
with changes in cell morphology. The kinetics of the development of 
the interferon system coincide, but are not absolutely correlated, 
with changes in the cell size within the differentiating culture. It 
has been shown from the use of the single cell assay for interferon 
production .that as the culture differentiates, there is an increase in 
both the percentage of cells able to produce interferon and in the 
yield of interferon per cell. Thus the process of differentiation is 
marked in tnese cultures by the recruitment of differentiated (inter­
feron producing) cells and also by processes which modulate interferon 
yields from those cells, this latter involving both changes in the cell 
size and in the activity of the genes regulating the interferon system 
within the cell. The structure of the differentiating population i3 
seen to be more complex than previously thought, for not only can the 
percentage of 'single cell interferon producers' be increased by means 
which select for a more differentiated phenotype, but a proportion of 
cells exist in these cultures whose growth is only temporarily 
affected by retinoic acid. Thus it would seem that the response of the 
cell population to retinoic acid is not uniform, despite the many 
accepted published reports that 100?i of teratocarcinomu cells ore
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changed by treatment with this vitamin.
The activation of the interferon system can thus be used as a 
marker of cell differentiation in a culture of, but not in individual, 
teratocarcinoma cells. The regulation of the developing interferon 
system in differentiating teratocarcinoma cells, may differ to that 
regulating production of other biochemical markers of differentiation 
in this system since the activity of the interferon system is not 
increased by a chemical which has been shown to increase production 
of some other biochemical markers; these differences could be related 
to the fact that interferon production and sensitivity is an inducible 
system. In addition the development of the interferon system does not 
distinguish between embryonic carcinoma cells caused to differentiate 
into either visceral or parietal endoderm-like cells, this may be related 
to the use of interferon in vivo which is not restricted to any one tissue
\
type but is active throughout the body.
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SECTION THREE---- RESULTS
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The work described in this section was performed in collaboration 
with B. R. Randle, of the Zoology department, Oxford University.
Interferon production was examined in embryonic mice at various 
stages of development. These mice were the progeny of matings between 
129J females and F, C57BL/CBA males. Pregnant mice of four to fifteen 
days of gestation (day one of embryonic development is the day that 
the fertilisation plug is observed), were killed by cervical fracture 
and the conceptus removed into alpha media containing 5?ó (v/v) fetal 
calf serum. (All dissections were performed by B. R. Randle.) Small 
pieces of embryo tissue and transferred to 10 ;ul wells containing 
fresh media (and 5?ó fetal calf serum) in a 'Terasaki' microtitre 
plate. The plate was flooded with sterile liquid paraffin and placed 
in a gassed (with 5% Cf^ in air (v/v) ) and humidified lunch box; the 
samples were then transferred to Warwick University contained inside 
a large polystyrene box to prevent dramatic temperature changes. • 
Dissections were undertaken in the morning and the samples were 
transferred to Warwick by mid-afternoon for assay in the early evening. 
By this time, the majority of samples had rounded up and attached 
loosely to the base of the plates but had not obviously increased in 
size. It was found that samples needed to be approximately 0.5 mm in 
diameter to survive and remain intact during the procedures involved 
in the assay, and to give repeatable results within the assay.
The presence of interferon inducibility in the various embryonic 
tissues was examined using the modified single cell assay described in
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section one. The samples were manipulated during the assay procedure 
using finely drawn capillary tubes and a mouth pipette, with the aid 
of a dissecting microscope. On arrival at Warwick, all samples were 
induced to produce interferon and incorporated into the single cell 
assay system; the samples were placed in the centre of a circle drawn 
on the reverse of the assay dish and held in place with a drop of 0.3% 
(v/v) agar/media. When the agar holding the samples in position had 
set the whole plate was flooded with 0.3% (v/v) agar/media and the assay 
continued with as described in Methods. As previously, the presence of 
interferon production from the samples was marked by the production of 
a foci of protected cells within the area of the circle containing 
the sample. The procedures involved in the assay of embryo samples 
for interferon are illustrated in figure 45.
Since the use of the modified single cell assay to detect interferon 
production from embryo samples necessitated the use of large aggregates 
of cells and frequently involved obtaining negative results, it was 
necessary to run several control experiments concurrently with the 
embryo samples. It was thought necessary to demonstrate three things 
with each assay; firstly, that the release of inducing virus from the 
embryo cell aggregate was inactivated by the antiserum stage; secondly, 
that the negative results obtained with the assay were not due to a 
lack of viability of the sample or to a failure of the assay, and 
thirdly, that the principle under assay was the result of virus induc­
tion and not due to spontaneous production of non-interferon interfering 
factors.
The three control experiments which were incorporated into the 
assay ore illustrated in figure 46. Plate A, in this figure shows the 
result obtained from an assay performed as illustrated in figure 45 but 
using aggregates of embryonal carcinoma cells instead of the embryo
\
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FIGIIRF U\ The procpedures involved in the assay for interferon 
production from embryonic tissue.
Dissected trophoblast layer 
reduced to small aggregates
Samples induced to 
produce interferon 
& placed in assay.
Samples positioned on 
monolayer inside circles 
marked on base of dish.
Agar and samples removed and 
monolayer infected with a 
cytopathic virus.
Staining reveals foci 
of protected cells 
amongst a background 
of dead cells.
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FIGURE 46. Control experiments run concurrently with the single cell
assay used to examine interferon inducibility in mouse
embryo tissue.
Plate A.
Plate B.
Plate C.
Plate As virus induced embryonal carcinoma cell aggregates incorporated 
into the assay as described in figure 45, the incomplete 
circle contained a non-virus induced sample-
Plate B: virus induced uterus samples taken from a 13day
mouse and incorporated into the assay as described in 
figure 45, the incomplete circle contained a non-virus 
induced sample.
Plate C: virus induced parietal endoderm taken from a 13 day
embryo and incorporated into the assay as described in
figure 45, the incomplete circle contained a non-virus induced
sample.
209
samples. As demonstrated in section two, embryonal carcinoma cells 
do not produce interferon, and therefore virus infection of 
aggregates of these cells and their subsequent incorporation into the 
single cell assay system should not produce foci. As can be seen from 
plate A, no foci are produced when embryonal carcinoma cell aggregates 
are placed in the assay, the small dark spot present in the centre 
of each circle are the remains of the ec cells themselves. Thus the 
results from this assay demonstrated that the cell aggregates do not 
release additional amounts of inducing virus, and that the foci 
obtained within the assay are the result of interferon and not the 
result of a direct interaction between the inducing virus and the 
indicator monolayer. Plate B, from figure 46 shows the result of an 
assay in which the samples were taken from the pregnant mouse uterus 
and incorporated into the assay as described in figure 45. All adult 
tissues are thought capable of producing interferon (see Introduction) 
and positive results from these samples would indicate that the 
samples had survived until placed in the assay, and it would also 
indicate that the assay was functioning correctly. This plate also 
illustrates a commonly found feature, frequently some virus infected 
samples which were expected to produce interferon did not produce foci 
in the assay. The proportion of positive control samples which failed 
to produce interferon was approximately 20?» for the control samples 
used (ie: uterus and decidua), and for this reason ten or more samples 
from each tissue were included in each assay, and all the results are 
expressed as the percentage of foci obtained. The last plate C from 
figure 46, shown typical results obtained from an embryo sample.
Parietal endoderm from a 13 day embryo was induced to porduce interferon 
and placed in the assay. The incomplete circle contained a non-virus 
induced sample, the remainder contained virus induced samples. Only
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virus induced samples of embryonic or maternal origin produced foci 
throughout the time the assay was in use.
Dat'a from an examination of interferon production in the 7th 
to 8th day embryo are presented in figure 47; this data is transposed 
onto diagrams of the embryo in figures 48 a and b. Figure 47 shows 
the data obtained from embryos aged from seven to eight days., .
In this figure interferon inducibility is indicated by a percentage 
obtained from the number of foci produced in the assay divided by the 
number of samples added to the assay. Values of between 70% to 100% 
indicate maximum interferon inducibility and those of between 10% to 
20% indicate minimum inducibility. It was found that when samples of 
smaller size were unavoidably used in the assay, the percentage figure 
obtained was variable and frequently reduced. Consistent results 
could only be obtained with samples of approximately 0.5 mm diameter. 
The data in figure 47 shows that the extent of interferon inducibility 
changes considerably in the embryo during the seventh to eighth day of 
development. The early seventh day embryo shows only minimal interferon 
inducibility which is limited to the trophoblast cells. These cells 
are the first differentiated cells to appear during embryogenesis 
and constititute the fetal maternal barrier during the first half of 
gestation. The remainder of the embryo is seen to be unable to produce 
interferon in response to a viral infection. In addition it can be 
seen that the inducibility of the control uterus and decidua samples 
is depressed. The mid-late seventh day embryo shows a spectrum of 
interferon inducibility. The periphery of the embryo consisting of 
extra-embryonic tissue (ie: the ectoplacental cone, trophoblaot and 
parietal endoderm) show maximum interferon inducibility. The interior 
extra-embryonic tissues, the extra-embryonic ectoderm and the visceral 
embryonic endoderm show minimal interferon inducibility, whilst the
\
211
Figure 47. Interferon production in the early post-implantation
mouse embryo.
Early 7th Mid- late 7th Late 7th early 8th
dy embryo day embryo dy embryo dy embryo
Ectoplacental cone:
è?o«o 75S 7 1S ND
Trophoblast------: 25S,40S "I 33S** !
Parietal endoderm : ND,0S >15% ND ►SOS
Visceral extra- 
embryonic endoderm: o ès o 1 OS 1
Extra-embryonic 
ectoderm — t---- -: OS, 0?ó
►ns
ND
>9 IS
Visceral embryonic #
endoderm---------: OS, OS 7% 73S
Embryonic ectoderm: o s , os OS OS
à?CMCOA
Control experiments 
Uterus (virus induced): 33S.40S 92S 73S 90S
Uterus (not induced) -: OS, OS OS OS OS
Decidua(virus induced): OS, 40S 100S 70S 90S
Decidua (not induced)-: OS, OS OS OS OS
Embryo tissue (not 
induced)-----— *----- : OS, OS OS OS OS
embryonal carcinoma 
cell aggregates —---- : OS, OS OS OS OS
Samples of embryonic tissue, and the control samples, were induced to 
produce interferon and placed in the single cell assay, as described 
in figure 45. Results are expressed as the percentage of interferon 
protected foci produced in the assay per number of samples added to 
the assay. Resuits bracketed together were obtained from two adjacent 
tissues which could not be cleanly separated during the dissection.
ND : not done. * : visceral embryonic endoderm;plus mesoderm.
•** : samples smaller in size than those previously assayed.
Figure 4f!o. Interferon production in the early post-implantation
mouse embryo.
Early 7th day 
embryo.
( G  ) Maximal interferon inducibility.
( □  ) Minimal interferon inducibility.
( Q  ) Nil interferon inducibility. 
epe: ectoplacentol cone, ex.emb.ect: extra embryonic ectoderm, 
enb.cct: embryonic ectoderm, pe: parietal endoderm, tb: trophoblast, 
v.ex.emb.end: visceral extra embryonic endoderm, v.emb.end: visceral
embryonic endoderm.
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Tiqure 4Ct>. Interferon production in the early post-implantation
mouse embryo.
Late 7th day 
embryo.
( O  ) Maximal interferon inducibility. 
( ED ) Minimal interferon inducibility. 
( □  ) Mil interferon inducibility.
KEY: as figure 40a.
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embryonic ectoderm (the source of the embryo proper) and the visceral 
extra-embryonic endoderm (which form part of the second extra-embryonic 
membrane) show nil interferon inducibility. The control samples of 
uterus and decidua for this and later stages of development show the 
expected maximum interferon inducibility.
The late seventh day embryo is unchanged except for the increased 
interferon inducibility shown by the visceral embryonic endoderm and 
mesoderm. It was not possible to separately obtain results for the 
extra-embryonic ectoderm from this stage and it is possible that an 
increase in inducibility in this tissue went unnoticed. The data 
obtained from the early eighth day embryo was obtained from combinations 
which contained two neighbouring tissues. All tissue combinations 
showed maximum interferon inducibility, thus indicating that the degree 
of inducibility has increased at least in the extra-embryonic ectoderm. 
The results from this stage cannot however confirm that interferon 
inducibility can be seen in the embryonic ectoderm and in the 
visceral extra-embryonic endoderm, but they suggest, that this is so.
The diagrams presented in figures 48a and 48b illustrate thè 
onset of interferon inducibility during these stages of embryogenesis 
and demonstrate clearly that this phenomenon originates in the outer 
extra-embryonic tissue and develops progressively inwards. The 
situation presented for the early eighth day embryo was not explicitly 
identified and remains an interpretation from the data obtained; this 
data confirmed that functionally the whole embryo is capable of 
producing interferon in response to a virus infection at this stage of 
development.
Interferon inducibility in response to virus infection was also 
examined in the 13th day mouse embryo. The embryo by this stage of 
gestation has undergone inversion of the germ layers (see Introduction)
\
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and it is surrounded by three embryonic derived membranes. The
S
data presented in figures 49 and 50 show the extent of interferon 
inducibility in the embryonic membranes and from various parts of 
the embryo. These data show that tissue representative of the three 
embryonic germ layers (ie: ectoderm, mesoderm and endoderm) are 
capable of maximal interferon inducibility, and suggest that the whole 
of the embryo can similarly produce interferon in response to virus 
infection. The three extra-embryonic membranes can also be seen to 
show maximum interferon inducibility. The trophoblast which forms the 
outer layer of the third membrane is however seen to be unable to 
produce interferon. The trophoblast was the first embryo derived tissue 
shown to be capable of producing interferon (see figure 47) and the 
ability to produce interferon extended over a period of six days in 
this tissue.
The results presented in figure 47 suggested that the uterus and 
decidua of the early 7th day gestation mouse is acting either to inhibit 
the production or action of interferon. Since there has been an isolated 
report that the mouse embryo may contain an inhibitor to the action of 
interferon (Cembrzymska-Nowak 1977), it was decided to examine the 
ability of various extracts of reproductive tissue to inhibit the anti­
viral action of interferon. The results of this experiment are 
presented in figure 51, and it can be seen that all samples whether 
from pregnant or non-pregnant animals were able to depress the anti­
viral action of interferon. The extent of this depression was 
approximately 40?i for the majority of the samples (including the 
decidua from 7th day pregnant' animals) but increased to approximately 
80?i for the sample obtained from 7th day pregnant' uterus.
\
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Figure 49. Interferon production in the mid-gestational mouse
embryo.
13th day mouse embryo.
Trophoblast------------ o.o?; 1 1 . os o.o?;
Parietal endoderm------ 90.0?; 40.o?;* loo.o?;
Visceral yolk sac------ 90.0?; 2o.o?;* loo.o?;
Amnion ---------------- loo.o?;
*#
o.o?; loo.o?;
Brain--------------- ;— 80.0?; 70.0?; 50.0?;
Heart------------------ loo.o?;
##
o.o?; ND
Gut region------------- 89.0?; 75.0?; ND
Placenta -------------- NO N O loo.o?;
Control experiments
Uterus (virus induced)- 78.0?; 7 1 .0?; 75.0?;
Uterus (not induced)— o.o?; o.o?; o.o?;
Embryo tissue (not 
induced);-------------- o.o?; o.o?; o. o s
Embryonal carcinoma 
(virus induced)--------
c“Oo o.o?; o.o?;
Samples of embryonic and control tissues were induced to produce 
interferon and incorporated into the single cell assay, as descr­
ibed in figure 45. Results are expressed as the percentage, of 
interferon protected foci compared to the number of samples added 
per assay.
ND: not done, *: reduced result due to use of very small samples. 
**: large and apparently healthy samples used, but negative result 
obtained.
( G ) Maximal interferon indticibility.
( G ) Nil interferon inducibility.
P: Placenta, EMB: Embryo, A: Amnion, VYS: Visceral yolk sac (ie: 
visceral extra embryonic endoderm plus extra embryonic mesoderm), 
PE: Parietal endoderm, TB: Trophoblast.
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rinURE 51. Depression of the anti^viral action of interferon 
by the reproductive tissues of the mouse.
IfN titre (percentage of control)
female pregnant and non-pregnant mice were killed by cervical fracture 
and the uteri removed. Samples were homogenised to 20?u (w/v) with alpha 
media. The homogenates were spun at 4 000 rpm for 20 minutes and the 
supernatants harvested and stored at "20°C until assay. The control 
sample consisted of alpha media plu3 20$ new born calf serum (NDCS), 
each bar represents the mean from two samples.
To assess the inhibitory effects of the homogenates an equal 
volume of each homogenate were added to replicate dilution series 
made from a sample of interferon of known titre. A reduction of 
interferon titre below that of the control indicates that the exper­
imental sample depressed the anti-viral activity of interferon.
\
SECTION THREE---  DISCUSSION
The data presented in figures 48 and 50 which illustrate the 
degree of interferon inducibility of various embryonic tissue, shows 
that samples which produced less than 20?o foci are considered to 
have minimum interferon inducibility whilst those producing more than 
70?i foci are considered to have maximum inducibility. It has been 
demonstrated in sections one and two that the level of interferon 
production from various tissue culture cell lines was correlated with 
the number of single cell interferon producers in that population.
Thus if interferon production is examined in an aggregate of cells 
taken from a cell population capable only of low interferon production, 
it might be expected that such aggregates will produce a smaller 
number of foci than that seen from aggregates taken from a cell 
population capable of high interferon production. This is because, 
with the former population, the probability of the cell aggregates 
containing sufficient single cell interferon producers to cause 
production of a foci will be reduced. Thus the designation of the 
embryonic tissues in figures 48 and 50 as those capable of either 
maximum or minimum interferon inducibility is based upon the known 
correlation between the level of interferon production and the number 
of single cell interferon producers in that population.
The data presented in figure 47 shows that the early post­
implantation embryo is capable only of minimum interferon production 
and this is limited to the trophoblast layer. This layer consists 
mostly of primary giant trophoblast cells which originated from the 
trophectoderm cells of the pre-implantation blastocyst. At the early 
blastocyst developmental stage the embryo consists of two cell
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populations, these are the undifferentiated inner cell mass and the 
surrounding differentiated trophectoderm cells. The former give rise 
to the extra-embryonic endoderm and mesoderm plus the three germ 
layers of the embryo, and the latter give rise to the primary giant 
trophoblast cells, the ectoplacental cone and the extra-embryonic 
ectoderm (see Introduction).
Examination of interferon production from intact blastocysts 
(data not given) has shown that no interferon can be detected from 
this developmental stage. Since only minimal production is seen in 
the post implantation trophoblast cells, it does however, remain a 
possibility that the trophectoderm cells are producing interferon in 
amounts too low to be detected in the single cell assay. Despite this 
the results do suggest that interferon production in response to viral 
infection, develops after implantation of the mouse embryo,' and that 
this phenomenon initially is seen in a derivative of the first 
differentiated embryonic tissue to form during development.
It can be seen from the results of the control experiments 
described in figure 47 that the interferon inducibility of the control 
maternal tissue was transiently depressed in the earliest stage 
examined. These results may suggest that the maternal uterus and 
decidua was capable of producing a substance which could inhibit either 
the production or the action of interferon. Mendelson et^  al^ . (1970) 
have reported that interferon production from tissues of a 12 day
rat embryo was completely inhibited iji utoro, in contrast 
to interferon production from the tissues of a 19 day rat 
embryo. In addition, Cembrzynska-Nowak et jîl. (1976) and Cembrzynska- 
Nowak (1977) claim to have identified an interferon inhibitor in the 
tissue of a 15 day Porton strain mouse embryo. Examination
of reproductive tissues from non-pregnant and pre and early post­
implantation development stages (see figure 51) revealed that homogenates 
from all these tissues could substantially inhibit the action of 
interferon. The uterus from the 7th day pregnanti animal was seen 
to exert a greater inhibition than that seen with the other tissue 
samples. Two features of these results suggest that this depression 
of the anti-viral action of interferon may not be due to a specific 
inhibition of interferon. Firstly all samples showed a substantial 
depression of the activity of interferon. Secondly, although inter­
feron production in the decidua was seen to be transiently decreased 
in figure 47, the depression of the anti-viral action of interferon 
was similar to that shown by the remaining tissues. It is possible 
that the inhibitory activity from these tissue homogenates is due to 
the presence of substances, which could be carrier proteins for 
reproduction associated hormones, which bind interferon non-specifically 
and remove it from solution.
The results obtained from the pre-implantation and the early 
post-implantation embryo suggest that the interferon system is inactive 
duiing the first ¡third of pregnancy in the mouse. Since the 
embryonic cell and humoral mediated immune response is not seen until 
the latter part of the -second'third of pregnancy (Ritter, 1975), 
the early embryo is itself not able to respond to the presence of a 
virus pathogen by either interferon production or antibody production. 
Thus any viral pathogen will potentially multiply unchecked within 
early embryonic tissues, causing damage to tissue organisation and 
organogenesis. It is known that virus infections of the embryo which 
occur during the first trimester of pregnancy in humans and in other
animals will result in teratological damage and even death of the fetus
\
(Mims 1968, 1977). It has been reported that the maternal immune 
response is slightly depressed during pregnancy (Billington and Wild
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1979, Mims 1977). However production of maternal antibody will occur 
during intra-uterine infections and these can reach the embryo via 
the extra-embryonic membranes. However it has been shown, through a 
study of viral infections of adult mice, that the early production 
of interferon, which occurs in these infections, is an important and 
necessary component of host anti-viral resistance. Without this early 
production of interferon many, normally harmless, viral infections 
become fulminating causing rapid death. Gresser et al. (1976 a, b) 
have shown that innoculation of adult mice with EMC, VSV, NDV or Herpes 
simplex type II virus whilst the animals are under treatment with anti­
serum to mouse interferon, results in enhanced replication of the virus 
and accelerated death of the experimental animal. It is not clear 
whether or not maternal interferon can be absorbed via the extra- 
embryonic membranes in a similar fashion to maternal antibôdy absorbtion. 
The results from figure 51 indicate that the maternal reproductive 
tissue may remove a substantial amount of interferon from uterine 
fluids, and thus prevent it from reaching the embryo. However, whether 
or not the embryo has access to maternal interferon is most likely 
irrelevant. The data from section two showed that interferon production 
and sensitivity arose together in differentiating embryonal carcinoma 
cells, this would suggest that these two aspects of the interferon 
system ore similarly linked in embryonic cells. Thus, since interferon 
is absent from embryonic cells during the first third ' ' c of pregnancy, 
it would be expected that these cello also lack sensitivity to the 
anti-viral effects of interferon.
Interferon inducibility can be seen to develop rapidly during the 
7th and 8th day of development \ maximum induction is initially shown 
by the trophoblast and parietal endoderm cells and also by the ecto- 
placental cone. By late 7th day, the visceral extra-embryonic endoderm
(v.ex.emb.end.) and the embryonic ectoderm (emb.ect.) are the only 
tissues in the embryo not capable of producing interferon in response 
to virus infection. Thus at this stage a significant difference is 
seen in the behaviour of the visceral endoderm, for the visceral 
embryonic endoderm (v.emb.end.) shows maximum interferon inducibility 
whereas the v.ex.emb.end. shows nil inducibility.
There have been reports in the recent literature describing 
similar differences between these two visceral endoderms during the 
7 to 8 day period of development Dziadek and Adamson (1978) report 
that Alphafetoprotein synthesis can be detected in the v.emb.end. but 
not in the v.ex.emb.end., and Bode and Dziadek (1979) describe a 
similar difference between these two forms of endoderm in the secretion 
of plasminogen activator. The production of certain biochemical 
products from the visceral endoderm is now thought to be modulated by 
the cell contacts experienced by the v.emb.end. and the v.ex.emb.end., 
for the former is exposed to the embryonic ectoderm and the latter to 
the extra-embryonic ectoderm. Dziadek (1978) has reported that although 
the v.ex.emb.end. cannot produce aiphafetoprotein at the 8th day 
gestation stage, but this tissue becomes able to synthesise this protein 
after a period in culture in isolation from the extra-embryonic 
ectoderm. Furthermore, if the v.emb.end. is mixed with the extra- 
embryonic ectoderm in culture, then alphafetoprotein synthesis is in­
hibited in this tissue; this inhibition has been shown not to be due 
to the release of a soluble factor by the extra embryonic ectoderm but 
is thought to be mediated via cell contacts with thi3 tissue. Hogan 
and Tilly (1981) report that the phenotype of the v.ex.emb.end is 
labile whilst in contact with the extra-embryonic ectoderm; for when 
cultured in proximity to primary giant trophoblast cells this tissue 
differentiates into cells which are characteristic of parietal endoderm.
\Thus the above reports all suggest that the expression of certain 
biochemical products (previously shown to mark cell differentiation 
in teratocarcinoma cells), by the visceral endoderm, is regulated by 
cell interactions with neighbouring tissues. These reports also 
suggest that contact with the extra-embryonic ectoderm inhibits the 
expression of these markers of cell differentiation and therefore could 
be described as inhibiting the actual process of differentiation to 
endoderm in the v.ex.emb.end cells. The data presented in figure 47 
also indicates that the expression of interferon inducibility is, like 
the expression of alphafetoprotein and plasminogen activator, modulated 
by cell contact. Visceral endoderm in contact with extra-embryonic 
ectoderm cannot be induced to produce interferon whilst visceral 
endoderm in contact with embryonic ectoderm can be so induced. Since 
the data from section two shows that the activation of the interferon 
system coincides with cell differentiation, this data can be inter­
preted as suggesting that the extra-embryonic ectoderm acts to prevent 
differentiation in the v.ex.emb.end. cells.
The data from figure 47 shows that interferon production is first 
seen in the trophoblast cells and arises next in two areas; in tissues 
thought to be derivatives of trophectoderm (ie: the ectoplacental cone 
and extra-embryonic ectoderm) and also in tissues known not to be 
derivatives of trophectoderm (ie: v.emb.end.). Thus the activation of 
the interferon system, like the production of alphafetoprotein and 
plasminogen activator, is not associated with a particular cell linage 
but is associated both with specific cell interactions and with cell 
differentiation. The activation of the interferon system in 
teratocarcinoma cells coincides with the differentiation of the embryonal 
carcinoma cells to an endoderm-like cell, this stage is considered to 
represent the transition of embryonic ectoderm to endoderm in embryo-
2 2 4
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genesis. The results from figure 47 partially support this in that 
the v.emb.end is shown to be capable of interferon production whilst 
the embryonic ectoderm lacks this function. However, the v.ex.emb.end. 
is unable to produce interferon at the same stage of development.
This anomaly, may suggest that the cells designated as v.ex.emb.end. 
have not yet differentiated into endoderm proper (which may only occur 
as these cells are removed from the influence of the extra-embryonic 
ectoderm during gastrulation), or alternatively this may suggest that 
some forms of endoderm do not produce interferon.
The results from the early Bth day embryo extends the
previous results slightly and suggests that functionally the whole 
embryo is capable of producing interferon in response to a virus 
infection. In addition the data confirm: that tissues shown to be 
unable to produce interferon do not exert an inhibitory effect on 
interferon production from neighbouring tissues.
Thus at the begining of the second third of pregnancy it is 
probable that the whole embryo can produce interferon in response to a 
virus infection. It was assumed above, from the information obtained 
from section two, that sensitivity to the pleiotropic effects of inter­
feron arose coincidentally with interferon production in differentiating 
cells. Drasner et al. (1979) have shown that sensitivity to the 
anti-proliferative effects of interferon is not present in in vitrp 
cultures established from pre and early post-implantation mouse embryos, 
and is first detected in cultures established from 8 day gestation 
embryos. It is therefore reasonable to assume that the development of 
sensitivity to the anti-viral effects of interferon follows a similar 
pattern as that established for interferon production,and sensitivity 
to the anti-proliferative effects of interferon. Thus if the mid^gest 
ationali ' embryo is exposed to a virus the interferon system will he
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activated, resulting in the inhibition of virus replication and also 
of cell replication. The embryo, at the beginning of the mid-ge'stational 
Period^cr undergoes gastrulation and organogenesis, and inhibition of 
cell growth by interferon, induced through viru3 infection of the 
embryo, may result in teratological damage similar to that caused by an 
uncontrolled virus- infection of earlier embryo stages. The effect 
of interferon upon this development stage is unknown. However, Gresser 
ot al. (1978 a, b) has shown that neonatal mice, in contrast to adult 
mice, can suffer irreversible damage to the liver and kidney tissue 
resulting in death, if these animals are treated with high levels of 
interferon (approximately 20 000 units/gm body weight) from birth.
This result implies that embryogénie production of interferon during 
the second and third périodsr of pregnancy, when the embryo is known 
to be sensitive to this agent, could produce similar damage to the 
developing fetus.
It has been shown by Fowler el al. (1980) that there exists a 
pregnancy-associated elevation of interferon in the reproductive 
tissues only, of NIH mice. This spontaneously produced interferon was 
detected from ten days gestation and was present until term, and could 
also be detected in pathogen free animals. Extremely high levels of 
interferon were detected in homogenates of placental tissue (up to 
3 000 units per ml), and the levels found in the homogenates of the 
uterus and decidua were reduced compared to the placenta. Thus this 
report suggests that in normal uterine life the embryo is exposed to 
interferon during the second and thirdp'eriod of gestation’ when the 
embryo is known to be sensitive to the effects of interferon. Thus 
these results conflict with the known effects of interferon on the later 
embryos. Furthermore the data presented in figures 47 and 49 demon­
strates that none of the embryonic or maternal samples used in the assay
226
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mice, can suffer irreversible damage to the liver and kidney tissue 
resulting in death, if these animals are treated with high levels of 
interferon (approximately 20 000 units/gm body weight) from birth.
This result implies that embryogénie production of interferon during 
the second and third périodsr of pregnancy, when the embryo is known 
to be sensitive to this agent, could produce similar damage to the 
developing fetus.
It has been shown by Fowler et al. (1980) that there exists a 
pregnancy-associated elevation of interferon in the reproductive 
tissues only, of NIH mice. This spontaneously produced interferon was 
detected from ten days gestation and was present until term, and could 
also be detected in pathogen free animals. Extremely high levels of 
interferon were detected in homogenates of placental tissue (up to 
3 000 units per ml), and the levels found in the homogenates of the 
uterus and decidua were reduced compared to the placenta. Thus this 
report suggests that in normal uterine life the embryo is exposed to 
interferon during the second and thirdp'eriod of gestation' when the 
embryo is known to be sensitive to the effects of interferon. Thus 
these results conflict with the known effects of interferon on the later 
embryos. Furthermore the data presented in figures 47 and 49 demon­
strates that none of the embryonic or maternal samples used in the assay
spontaneously produced interferon. In addition samples were obtained 
from homogenates of reproductive tissue from an NIH mouse; serum and 
uterus of pregnant lind non pregnant animals, and samples of embryo, 
placenta and amniotic fluid from 15 day pregnant-' animals, were all 
found not to contain spontaneously';' produced interferon (data not shown). 
It remains possible that production of interferon during pregnancy 
indicates an abnormality in that pregnancy, which may or may not 
represent a pathogenic infection of embryo or maternal host.
It is not yet clear whether or not maternal interferon is able 
to pass via the placenta into the embryonic circulation. Overall and 
Glasgow (1970) have found that the placenta was an effective barrier 
to exogenous interferon whether administered to the foetus or the 
maternal host. However, Williams and Reed (1981) have reported the 
presence of the interferon-induced anti-viral enzyme 2*5* oligo A 
synthetase in mononuclear cells from paired maternal-cord blood 
samples. This was interpreted to suggest that either interferon or 
the anti-viral induced enzymes were able to cross the placenta. However 
the work of Shimizu and Sokawa (1979) and of Kimchi et al_. (1979, 1981) 
has shown that cells of bone marrow origin contain elevated levels 
of this enzyme when in a quiescient state, and thus the presence of 
this enzyme in embryonic and maternal mononuclear cells may indicate 
that the growth of these cells is inhibited.
The data presented in figure 49 shows that all three extra- 
embryonic membranes, and probably all embryonic tissue from the mid­
term embryo is capable of producing interferon in response to virus 
infection. The parietal endoderm can be seen to produce interferon at 
this stage, the visceral endoderm together with the extra-embryonic 
endoderm is also positive. The trophoblast layer of the third embryonic
membrane was however found to show nil interferon inducibility at this 
stage; as described^n the introduction, both layers of this membrane 
atrophy and disappear at approximately days 14 - 15 gestation but 
despite this, the trophoblast cells appeared microscopically healthy 
when used in the assay. Thus interferon inducibility appears only 
transiently in the trophoblast cells, which are positive by early day 
seven but negative on or before day 13 of development.
The presence of maximum interferon inducibility in the three 
embryonic membranes, implies that these membranes would function as a 
multiple barrier to potential viral pathogens during the latter half 
of pregnancy. Virus replication could be envisaged as being 
successively inhibited by the induced interferon production from each 
layer, thus reducing the probability of infective virus reaching the 
embryo from a uterine source.
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SECTION THREE'--  SUMMARY
The data presented in this section demonstrates that maximum 
interferon inducibility, in response to virus infection, can be seen 
in the mouse embryo during the second and third period of pregnancy. 
The interferon system is thus active before the development of the 
foetal cell and humoral mediated immune response, and probably plays 
a vital role in the protection of the foetus from viral pathogens during 
this period of development. The early onset of the interferon system, 
and the known inhibitory effect of interferon on cell replication 
suggests that induction of this molecule during morphogenetic events 
could result in teratological damage to the embryo.
Interferon inducibility is not present in the tissues of the 
pre-implantation mouse embryo, and is first detected in the trophoblast 
cells of the early 7th day embryo,becoming established in all extra- 
embryonic tissues by the end of the 7th day. The pattern of development 
of interferon inducibility showed that this was not limited to cells 
derived from any one cell lineage, but instead, arose simultaneously 
in the tissues derived from the two cell populations present at the 
blastocyst stage. Production of interferon was found to be absent in 
the trophoblast cells of the 13th day embryo, but could be demonstrated 
in the remaining extra-embryonic and embryonic tissues from this embryo. 
The production of interferon from the maternal 'control' tissues was 
found to be transiently depressed during the early part of the 7th 
day of development, and it was suggested that this was due to the non­
specific binding of interferon. In contrast to a published report 
(fowler £l 1980) spontaneous production of interferon was not dete­
cted in any of the maternal or embryonic samples used in this assay.
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behave differently with respect to interferon production. This is in 
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which have demonstrated that contact between the visceral endoderm 
and the extra-embryonic ectoderm inhibited the expression of various 
markers of differentiation from the former tissue. *
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